The first lichen planus case coexisting bronchiolitis obliterans without malignant tumors(タイトル和訳中)

Nikaido Takefumi, Tanino Yoshinori, Sato Yuki, Togawa Ryuichi, Watanabe Natsumi, Wang Xintao, Fukuhara Naoko, Harigane Rina, Saito Koshi, Kazama Kentaro, Yamada Ryuki, Sato Riko, Tomita Hikaru, Rikimaru Mami, Suzuki Yasuhito, Minemura Hiroyuki, Saito Junpei, Kanazawa Kenya, Yamamoto Toshiyuki, Hashimoto Yuko, Hebisawa Akira, Shibata Yoko

Pathology International   74 ( 6 )   352 - 355   2024年6月（ ISSN:1320-5463 ）

Efficacy of combination antibiotic therapy including inhaled tobramycin on Burkholderia cepacia pneumonia in a non-cystic fibrosis patient.

Suzuki Y, Lee T, Togawa R, Sato R, Yamada R, Tomita H, Watanabe N, Kawamata T, Rikimaru M, Morimoto J, Sato Y, Minemura H, Nikaido T, Saito J, Kanazawa K, Tanino Y, Shibata Y

IDCases   38   e02081   2024年（ ISSN:2214-2509 ）

Association between specific human leukocyte antigen alleles and development of thyroid immune-related adverse event.

Sasaki E, Natori Y, Tokuda E, Kimura-Tsuchiya R, Suga J, Kanazawa K, Koguchi T, Kikuchi N, Okabe N, Murono S, Tachibana K, Soeda S, Shimabukuro M, Saji S

Immunotherapy   16 ( 11 )   723 - 732   2024年（ ISSN:1750-743X ）

Real-world clinical outcomes of treatment with molnupiravir for patients with mild-to-moderate coronavirus disease 2019 during the Omicron variant pandemic.

Suzuki Y, Shibata Y, Minemura H, Nikaido T, Tanino Y, Fukuhara A, Kanno R, Saito H, Suzuki S, Inokoshi Y, Sando E, Sakuma H, Kobayashi T, Kume H, Kamimoto M, Aoki H, Takama A, Iizuka T, Kamiyama T, Nakayama M, Saito K, Tanigawa K, Sato M, Waragai Y, Kambe T, Kanzaki N, Azuma T, Okamoto H, Sakamoto K, Nakamura Y, Ohtani H, Waragai M, Maeda S, Ishida T, Sugino K, Abe W, Tsukada Y, Lee T, Yamada R, Sato R, Onuma T, Tomita H, Saito M, Watanabe N, Rikimaru M, Kawamata T, Morimoto J, Togawa R, Sato Y, Saito J, Kanazawa K, Hamaguchi S, Iseki K

Clinical and experimental medicine   23 ( 6 )   2715 - 2723   2023年10月（ ISSN:1591-8890 ）

Real-world clinical outcomes of treatment with molnupiravir for patients with mild-to-moderate coronavirus disease 2019 during the Omicron variant pandemic.

Suzuki Y, Shibata Y, Minemura H, Nikaido T, Tanino Y, Fukuhara A, Kanno R, Saito H, Suzuki S, Inokoshi Y, Sando E, Sakuma H, Kobayashi T, Kume H, Kamimoto M, Aoki H, Takama A, Iizuka T, Kamiyama T, Nakayama M, Saito K, Tanigawa K, Sato M, Waragai Y, Kambe T, Kanzaki N, Azuma T, Okamoto H, Sakamoto K, Nakamura Y, Ohtani H, Waragai M, Maeda S, Ishida T, Sugino K, Abe W, Tsukada Y, Lee T, Yamada R, Sato R, Onuma T, Tomita H, Saito M, Watanabe N, Rikimaru M, Kawamata T, Morimoto J, Togawa R, Sato Y, Saito J, Kanazawa K, Hamaguchi S, Iseki K

Clinical and experimental medicine   23 ( 6 )   2715 - 2723   2023年10月（ ISSN:1591-8890 ）

Real-world clinical outcomes of treatment with molnupiravir for patients with mild-to-moderate coronavirus disease 2019 during the Omicron variant pandemic.

Suzuki Y, Shibata Y, Minemura H, Nikaido T, Tanino Y, Fukuhara A, Kanno R, Saito H, Suzuki S, Inokoshi Y, Sando E, Sakuma H, Kobayashi T, Kume H, Kamimoto M, Aoki H, Takama A, Iizuka T, Kamiyama T, Nakayama M, Saito K, Tanigawa K, Sato M, Waragai Y, Kambe T, Kanzaki N, Azuma T, Okamoto H, Sakamoto K, Nakamura Y, Ohtani H, Waragai M, Maeda S, Ishida T, Sugino K, Abe W, Tsukada Y, Lee T, Yamada R, Sato R, Onuma T, Tomita H, Saito M, Watanabe N, Rikimaru M, Kawamata T, Morimoto J, Togawa R, Sato Y, Saito J, Kanazawa K, Hamaguchi S, Iseki K

Clinical and experimental medicine   23 ( 6 )   2715 - 2723   2023年10月（ ISSN:1591-8890 ）

Real-world clinical outcomes of treatment with molnupiravir for patients with mild-to-moderate coronavirus disease 2019 during the Omicron variant pandemic.

Suzuki Y, Shibata Y, Minemura H, Nikaido T, Tanino Y, Fukuhara A, Kanno R, Saito H, Suzuki S, Inokoshi Y, Sando E, Sakuma H, Kobayashi T, Kume H, Kamimoto M, Aoki H, Takama A, Iizuka T, Kamiyama T, Nakayama M, Saito K, Tanigawa K, Sato M, Waragai Y, Kambe T, Kanzaki N, Azuma T, Okamoto H, Sakamoto K, Nakamura Y, Ohtani H, Waragai M, Maeda S, Ishida T, Sugino K, Abe W, Tsukada Y, Lee T, Yamada R, Sato R, Onuma T, Tomita H, Saito M, Watanabe N, Rikimaru M, Kawamata T, Morimoto J, Togawa R, Sato Y, Saito J, Kanazawa K, Hamaguchi S, Iseki K

Clinical and experimental medicine   23 ( 6 )   2715 - 2723   2023年10月（ ISSN:1591-8890 ）

Real-world clinical outcomes of treatment with molnupiravir for patients with mild-to-moderate coronavirus disease 2019 during the Omicron variant pandemic.

Suzuki Y, Shibata Y, Minemura H, Nikaido T, Tanino Y, Fukuhara A, Kanno R, Saito H, Suzuki S, Inokoshi Y, Sando E, Sakuma H, Kobayashi T, Kume H, Kamimoto M, Aoki H, Takama A, Iizuka T, Kamiyama T, Nakayama M, Saito K, Tanigawa K, Sato M, Waragai Y, Kambe T, Kanzaki N, Azuma T, Okamoto H, Sakamoto K, Nakamura Y, Ohtani H, Waragai M, Maeda S, Ishida T, Sugino K, Abe W, Tsukada Y, Lee T, Yamada R, Sato R, Onuma T, Tomita H, Saito M, Watanabe N, Rikimaru M, Kawamata T, Morimoto J, Togawa R, Sato Y, Saito J, Kanazawa K, Hamaguchi S, Iseki K

Clinical and experimental medicine   23 ( 6 )   2715 - 2723   2023年10月（ ISSN:1591-8890 ）

Real-world clinical outcomes of treatment with molnupiravir for patients with mild-to-moderate coronavirus disease 2019 during the Omicron variant pandemic.

Suzuki Y, Shibata Y, Minemura H, Nikaido T, Tanino Y, Fukuhara A, Kanno R, Saito H, Suzuki S, Inokoshi Y, Sando E, Sakuma H, Kobayashi T, Kume H, Kamimoto M, Aoki H, Takama A, Iizuka T, Kamiyama T, Nakayama M, Saito K, Tanigawa K, Sato M, Waragai Y, Kambe T, Kanzaki N, Azuma T, Okamoto H, Sakamoto K, Nakamura Y, Ohtani H, Waragai M, Maeda S, Ishida T, Sugino K, Abe W, Tsukada Y, Lee T, Yamada R, Sato R, Onuma T, Tomita H, Saito M, Watanabe N, Rikimaru M, Kawamata T, Morimoto J, Togawa R, Sato Y, Saito J, Kanazawa K, Hamaguchi S, Iseki K

Clinical and experimental medicine   23 ( 6 )   2715 - 2723   2023年10月（ ISSN:1591-8890 ）

Real-world clinical outcomes of treatment with molnupiravir for patients with mild-to-moderate coronavirus disease 2019 during the Omicron variant pandemic.

Suzuki Y, Shibata Y, Minemura H, Nikaido T, Tanino Y, Fukuhara A, Kanno R, Saito H, Suzuki S, Inokoshi Y, Sando E, Sakuma H, Kobayashi T, Kume H, Kamimoto M, Aoki H, Takama A, Iizuka T, Kamiyama T, Nakayama M, Saito K, Tanigawa K, Sato M, Waragai Y, Kambe T, Kanzaki N, Azuma T, Okamoto H, Sakamoto K, Nakamura Y, Ohtani H, Waragai M, Maeda S, Ishida T, Sugino K, Abe W, Tsukada Y, Lee T, Yamada R, Sato R, Onuma T, Tomita H, Saito M, Watanabe N, Rikimaru M, Kawamata T, Morimoto J, Togawa R, Sato Y, Saito J, Kanazawa K, Hamaguchi S, Iseki K

Clinical and experimental medicine   23 ( 6 )   2715 - 2723   2023年10月（ ISSN:1591-8890 ）

Real-world clinical outcomes of treatment with molnupiravir for patients with mild-to-moderate coronavirus disease 2019 during the Omicron variant pandemic.

Suzuki Y, Shibata Y, Minemura H, Nikaido T, Tanino Y, Fukuhara A, Kanno R, Saito H, Suzuki S, Inokoshi Y, Sando E, Sakuma H, Kobayashi T, Kume H, Kamimoto M, Aoki H, Takama A, Iizuka T, Kamiyama T, Nakayama M, Saito K, Tanigawa K, Sato M, Waragai Y, Kambe T, Kanzaki N, Azuma T, Okamoto H, Sakamoto K, Nakamura Y, Ohtani H, Waragai M, Maeda S, Ishida T, Sugino K, Abe W, Tsukada Y, Lee T, Yamada R, Sato R, Onuma T, Tomita H, Saito M, Watanabe N, Rikimaru M, Kawamata T, Morimoto J, Togawa R, Sato Y, Saito J, Kanazawa K, Hamaguchi S, Iseki K

Clinical and experimental medicine   23 ( 6 )   2715 - 2723   2023年10月（ ISSN:1591-8890 ）

Real-world clinical outcomes of treatment with molnupiravir for patients with mild-to-moderate coronavirus disease 2019 during the Omicron variant pandemic.

Suzuki Y, Shibata Y, Minemura H, Nikaido T, Tanino Y, Fukuhara A, Kanno R, Saito H, Suzuki S, Inokoshi Y, Sando E, Sakuma H, Kobayashi T, Kume H, Kamimoto M, Aoki H, Takama A, Iizuka T, Kamiyama T, Nakayama M, Saito K, Tanigawa K, Sato M, Waragai Y, Kambe T, Kanzaki N, Azuma T, Okamoto H, Sakamoto K, Nakamura Y, Ohtani H, Waragai M, Maeda S, Ishida T, Sugino K, Abe W, Tsukada Y, Lee T, Yamada R, Sato R, Onuma T, Tomita H, Saito M, Watanabe N, Rikimaru M, Kawamata T, Morimoto J, Togawa R, Sato Y, Saito J, Kanazawa K, Hamaguchi S, Iseki K

Clinical and experimental medicine   23 ( 6 )   2715 - 2723   2023年10月（ ISSN:1591-8890 ）

Real-world clinical outcomes of treatment with molnupiravir for patients with mild-to-moderate coronavirus disease 2019 during the Omicron variant pandemic.

Suzuki Y, Shibata Y, Minemura H, Nikaido T, Tanino Y, Fukuhara A, Kanno R, Saito H, Suzuki S, Inokoshi Y, Sando E, Sakuma H, Kobayashi T, Kume H, Kamimoto M, Aoki H, Takama A, Iizuka T, Kamiyama T, Nakayama M, Saito K, Tanigawa K, Sato M, Waragai Y, Kambe T, Kanzaki N, Azuma T, Okamoto H, Sakamoto K, Nakamura Y, Ohtani H, Waragai M, Maeda S, Ishida T, Sugino K, Abe W, Tsukada Y, Lee T, Yamada R, Sato R, Onuma T, Tomita H, Saito M, Watanabe N, Rikimaru M, Kawamata T, Morimoto J, Togawa R, Sato Y, Saito J, Kanazawa K, Hamaguchi S, Iseki K

Clinical and experimental medicine   23 ( 6 )   2715 - 2723   2023年10月（ ISSN:1591-8890 ）

Real-world clinical outcomes of treatment with molnupiravir for patients with mild-to-moderate coronavirus disease 2019 during the Omicron variant pandemic.

Suzuki Y, Shibata Y, Minemura H, Nikaido T, Tanino Y, Fukuhara A, Kanno R, Saito H, Suzuki S, Inokoshi Y, Sando E, Sakuma H, Kobayashi T, Kume H, Kamimoto M, Aoki H, Takama A, Iizuka T, Kamiyama T, Nakayama M, Saito K, Tanigawa K, Sato M, Waragai Y, Kambe T, Kanzaki N, Azuma T, Okamoto H, Sakamoto K, Nakamura Y, Ohtani H, Waragai M, Maeda S, Ishida T, Sugino K, Abe W, Tsukada Y, Lee T, Yamada R, Sato R, Onuma T, Tomita H, Saito M, Watanabe N, Rikimaru M, Kawamata T, Morimoto J, Togawa R, Sato Y, Saito J, Kanazawa K, Hamaguchi S, Iseki K

Clinical and experimental medicine   23 ( 6 )   2715 - 2723   2023年10月（ ISSN:1591-8890 ）

Real-world clinical outcomes of treatment with molnupiravir for patients with mild-to-moderate coronavirus disease 2019 during the Omicron variant pandemic.

Suzuki Y, Shibata Y, Minemura H, Nikaido T, Tanino Y, Fukuhara A, Kanno R, Saito H, Suzuki S, Inokoshi Y, Sando E, Sakuma H, Kobayashi T, Kume H, Kamimoto M, Aoki H, Takama A, Iizuka T, Kamiyama T, Nakayama M, Saito K, Tanigawa K, Sato M, Waragai Y, Kambe T, Kanzaki N, Azuma T, Okamoto H, Sakamoto K, Nakamura Y, Ohtani H, Waragai M, Maeda S, Ishida T, Sugino K, Abe W, Tsukada Y, Lee T, Yamada R, Sato R, Onuma T, Tomita H, Saito M, Watanabe N, Rikimaru M, Kawamata T, Morimoto J, Togawa R, Sato Y, Saito J, Kanazawa K, Hamaguchi S, Iseki K

Clinical and experimental medicine   23 ( 6 )   2715 - 2723   2023年10月（ ISSN:1591-8890 ）

Real-world clinical outcomes of treatment with molnupiravir for patients with mild-to-moderate coronavirus disease 2019 during the Omicron variant pandemic.

Suzuki Y, Shibata Y, Minemura H, Nikaido T, Tanino Y, Fukuhara A, Kanno R, Saito H, Suzuki S, Inokoshi Y, Sando E, Sakuma H, Kobayashi T, Kume H, Kamimoto M, Aoki H, Takama A, Iizuka T, Kamiyama T, Nakayama M, Saito K, Tanigawa K, Sato M, Waragai Y, Kambe T, Kanzaki N, Azuma T, Okamoto H, Sakamoto K, Nakamura Y, Ohtani H, Waragai M, Maeda S, Ishida T, Sugino K, Abe W, Tsukada Y, Lee T, Yamada R, Sato R, Onuma T, Tomita H, Saito M, Watanabe N, Rikimaru M, Kawamata T, Morimoto J, Togawa R, Sato Y, Saito J, Kanazawa K, Hamaguchi S, Iseki K

Clinical and experimental medicine   23 ( 6 )   2715 - 2723   2023年10月（ ISSN:1591-8890 ）

Real-world clinical outcomes of treatment with molnupiravir for patients with mild-to-moderate coronavirus disease 2019 during the Omicron variant pandemic.

Suzuki Y, Shibata Y, Minemura H, Nikaido T, Tanino Y, Fukuhara A, Kanno R, Saito H, Suzuki S, Inokoshi Y, Sando E, Sakuma H, Kobayashi T, Kume H, Kamimoto M, Aoki H, Takama A, Iizuka T, Kamiyama T, Nakayama M, Saito K, Tanigawa K, Sato M, Waragai Y, Kambe T, Kanzaki N, Azuma T, Okamoto H, Sakamoto K, Nakamura Y, Ohtani H, Waragai M, Maeda S, Ishida T, Sugino K, Abe W, Tsukada Y, Lee T, Yamada R, Sato R, Onuma T, Tomita H, Saito M, Watanabe N, Rikimaru M, Kawamata T, Morimoto J, Togawa R, Sato Y, Saito J, Kanazawa K, Hamaguchi S, Iseki K

Clinical and experimental medicine   23 ( 6 )   2715 - 2723   2023年10月（ ISSN:1591-8890 ）

Real-world clinical outcomes of treatment with molnupiravir for patients with mild-to-moderate coronavirus disease 2019 during the Omicron variant pandemic.

Suzuki Y, Shibata Y, Minemura H, Nikaido T, Tanino Y, Fukuhara A, Kanno R, Saito H, Suzuki S, Inokoshi Y, Sando E, Sakuma H, Kobayashi T, Kume H, Kamimoto M, Aoki H, Takama A, Iizuka T, Kamiyama T, Nakayama M, Saito K, Tanigawa K, Sato M, Waragai Y, Kambe T, Kanzaki N, Azuma T, Okamoto H, Sakamoto K, Nakamura Y, Ohtani H, Waragai M, Maeda S, Ishida T, Sugino K, Abe W, Tsukada Y, Lee T, Yamada R, Sato R, Onuma T, Tomita H, Saito M, Watanabe N, Rikimaru M, Kawamata T, Morimoto J, Togawa R, Sato Y, Saito J, Kanazawa K, Hamaguchi S, Iseki K

Clinical and experimental medicine   23 ( 6 )   2715 - 2723   2023年10月（ ISSN:1591-8890 ）

Real-world clinical outcomes of treatment with molnupiravir for patients with mild-to-moderate coronavirus disease 2019 during the Omicron variant pandemic.

Suzuki Y, Shibata Y, Minemura H, Nikaido T, Tanino Y, Fukuhara A, Kanno R, Saito H, Suzuki S, Inokoshi Y, Sando E, Sakuma H, Kobayashi T, Kume H, Kamimoto M, Aoki H, Takama A, Iizuka T, Kamiyama T, Nakayama M, Saito K, Tanigawa K, Sato M, Waragai Y, Kambe T, Kanzaki N, Azuma T, Okamoto H, Sakamoto K, Nakamura Y, Ohtani H, Waragai M, Maeda S, Ishida T, Sugino K, Abe W, Tsukada Y, Lee T, Yamada R, Sato R, Onuma T, Tomita H, Saito M, Watanabe N, Rikimaru M, Kawamata T, Morimoto J, Togawa R, Sato Y, Saito J, Kanazawa K, Hamaguchi S, Iseki K

Clinical and experimental medicine   23 ( 6 )   2715 - 2723   2023年10月（ ISSN:1591-8890 ）

Real-world clinical outcomes of treatment with molnupiravir for patients with mild-to-moderate coronavirus disease 2019 during the Omicron variant pandemic.

Suzuki Y, Shibata Y, Minemura H, Nikaido T, Tanino Y, Fukuhara A, Kanno R, Saito H, Suzuki S, Inokoshi Y, Sando E, Sakuma H, Kobayashi T, Kume H, Kamimoto M, Aoki H, Takama A, Iizuka T, Kamiyama T, Nakayama M, Saito K, Tanigawa K, Sato M, Waragai Y, Kambe T, Kanzaki N, Azuma T, Okamoto H, Sakamoto K, Nakamura Y, Ohtani H, Waragai M, Maeda S, Ishida T, Sugino K, Abe W, Tsukada Y, Lee T, Yamada R, Sato R, Onuma T, Tomita H, Saito M, Watanabe N, Rikimaru M, Kawamata T, Morimoto J, Togawa R, Sato Y, Saito J, Kanazawa K, Hamaguchi S, Iseki K

Clinical and experimental medicine   23 ( 6 )   2715 - 2723   2023年10月（ ISSN:1591-8890 ）

Real-world clinical outcomes of treatment with molnupiravir for patients with mild-to-moderate coronavirus disease 2019 during the Omicron variant pandemic.

Suzuki Y, Shibata Y, Minemura H, Nikaido T, Tanino Y, Fukuhara A, Kanno R, Saito H, Suzuki S, Inokoshi Y, Sando E, Sakuma H, Kobayashi T, Kume H, Kamimoto M, Aoki H, Takama A, Iizuka T, Kamiyama T, Nakayama M, Saito K, Tanigawa K, Sato M, Waragai Y, Kambe T, Kanzaki N, Azuma T, Okamoto H, Sakamoto K, Nakamura Y, Ohtani H, Waragai M, Maeda S, Ishida T, Sugino K, Abe W, Tsukada Y, Lee T, Yamada R, Sato R, Onuma T, Tomita H, Saito M, Watanabe N, Rikimaru M, Kawamata T, Morimoto J, Togawa R, Sato Y, Saito J, Kanazawa K, Hamaguchi S, Iseki K

Clinical and experimental medicine   23 ( 6 )   2715 - 2723   2023年10月（ ISSN:1591-8890 ）

Real-world clinical outcomes of treatment with molnupiravir for patients with mild-to-moderate coronavirus disease 2019 during the Omicron variant pandemic.

Suzuki Y, Shibata Y, Minemura H, Nikaido T, Tanino Y, Fukuhara A, Kanno R, Saito H, Suzuki S, Inokoshi Y, Sando E, Sakuma H, Kobayashi T, Kume H, Kamimoto M, Aoki H, Takama A, Iizuka T, Kamiyama T, Nakayama M, Saito K, Tanigawa K, Sato M, Waragai Y, Kambe T, Kanzaki N, Azuma T, Okamoto H, Sakamoto K, Nakamura Y, Ohtani H, Waragai M, Maeda S, Ishida T, Sugino K, Abe W, Tsukada Y, Lee T, Yamada R, Sato R, Onuma T, Tomita H, Saito M, Watanabe N, Rikimaru M, Kawamata T, Morimoto J, Togawa R, Sato Y, Saito J, Kanazawa K, Hamaguchi S, Iseki K

Clinical and experimental medicine   23 ( 6 )   2715 - 2723   2023年10月（ ISSN:1591-8890 ）

Real-world clinical outcomes of treatment with molnupiravir for patients with mild-to-moderate coronavirus disease 2019 during the Omicron variant pandemic.

Suzuki Y, Shibata Y, Minemura H, Nikaido T, Tanino Y, Fukuhara A, Kanno R, Saito H, Suzuki S, Inokoshi Y, Sando E, Sakuma H, Kobayashi T, Kume H, Kamimoto M, Aoki H, Takama A, Iizuka T, Kamiyama T, Nakayama M, Saito K, Tanigawa K, Sato M, Waragai Y, Kambe T, Kanzaki N, Azuma T, Okamoto H, Sakamoto K, Nakamura Y, Ohtani H, Waragai M, Maeda S, Ishida T, Sugino K, Abe W, Tsukada Y, Lee T, Yamada R, Sato R, Onuma T, Tomita H, Saito M, Watanabe N, Rikimaru M, Kawamata T, Morimoto J, Togawa R, Sato Y, Saito J, Kanazawa K, Hamaguchi S, Iseki K

Clinical and experimental medicine   23 ( 6 )   2715 - 2723   2023年10月（ ISSN:1591-8890 ）

Development and external validation of the DOAT and DOATS scores: simple decision support tools to identify disease progression among nonelderly patients with mild/moderate COVID-19.

Shibata Y, Omae K, Minemura H, Suzuki Y, Nikaido T, Tanino Y, Fukuhara A, Kanno R, Saito H, Suzuki S, Ishii T, Inokoshi Y, Sando E, Sakuma H, Kobayashi T, Kume H, Kamimoto M, Aoki H, Takama A, Kamiyama T, Nakayama M, Saito K, Tanigawa K, Sato M, Kambe T, Kanzaki N, Azuma T, Sakamoto K, Nakamura Y, Ohtani H, Waragai M, Maeda S, Ishida T, Sugino K, Inage M, Hirama N, Furuyama K, Fukushima S, Saito H, Machiya JI, Machida H, Abe K, Iwabuchi K, Katagiri Y, Aida Y, Abe Y, Ota T, Ishizawa Y, Tsukada Y, Yamada R, Sato R, Onuma T, Tomita H, Saito M, Watanabe N, Rikimaru M, Kawamata T, Umeda T, Morimoto J, Togawa R, Sato Y, Saito J, Kanazawa K, Kurita N, Iseki K

BMC pulmonary medicine   23 ( 1 )   312   2023年8月

Development and external validation of the DOAT and DOATS scores: simple decision support tools to identify disease progression among nonelderly patients with mild/moderate COVID-19.

Shibata Y, Omae K, Minemura H, Suzuki Y, Nikaido T, Tanino Y, Fukuhara A, Kanno R, Saito H, Suzuki S, Ishii T, Inokoshi Y, Sando E, Sakuma H, Kobayashi T, Kume H, Kamimoto M, Aoki H, Takama A, Kamiyama T, Nakayama M, Saito K, Tanigawa K, Sato M, Kambe T, Kanzaki N, Azuma T, Sakamoto K, Nakamura Y, Ohtani H, Waragai M, Maeda S, Ishida T, Sugino K, Inage M, Hirama N, Furuyama K, Fukushima S, Saito H, Machiya JI, Machida H, Abe K, Iwabuchi K, Katagiri Y, Aida Y, Abe Y, Ota T, Ishizawa Y, Tsukada Y, Yamada R, Sato R, Onuma T, Tomita H, Saito M, Watanabe N, Rikimaru M, Kawamata T, Umeda T, Morimoto J, Togawa R, Sato Y, Saito J, Kanazawa K, Kurita N, Iseki K

BMC pulmonary medicine   23 ( 1 )   312   2023年8月

Development and external validation of the DOAT and DOATS scores: simple decision support tools to identify disease progression among nonelderly patients with mild/moderate COVID-19.

Shibata Y, Omae K, Minemura H, Suzuki Y, Nikaido T, Tanino Y, Fukuhara A, Kanno R, Saito H, Suzuki S, Ishii T, Inokoshi Y, Sando E, Sakuma H, Kobayashi T, Kume H, Kamimoto M, Aoki H, Takama A, Kamiyama T, Nakayama M, Saito K, Tanigawa K, Sato M, Kambe T, Kanzaki N, Azuma T, Sakamoto K, Nakamura Y, Ohtani H, Waragai M, Maeda S, Ishida T, Sugino K, Inage M, Hirama N, Furuyama K, Fukushima S, Saito H, Machiya JI, Machida H, Abe K, Iwabuchi K, Katagiri Y, Aida Y, Abe Y, Ota T, Ishizawa Y, Tsukada Y, Yamada R, Sato R, Onuma T, Tomita H, Saito M, Watanabe N, Rikimaru M, Kawamata T, Umeda T, Morimoto J, Togawa R, Sato Y, Saito J, Kanazawa K, Kurita N, Iseki K

BMC pulmonary medicine   23 ( 1 )   312   2023年8月

Development and external validation of the DOAT and DOATS scores: simple decision support tools to identify disease progression among nonelderly patients with mild/moderate COVID-19.

Shibata Y, Omae K, Minemura H, Suzuki Y, Nikaido T, Tanino Y, Fukuhara A, Kanno R, Saito H, Suzuki S, Ishii T, Inokoshi Y, Sando E, Sakuma H, Kobayashi T, Kume H, Kamimoto M, Aoki H, Takama A, Kamiyama T, Nakayama M, Saito K, Tanigawa K, Sato M, Kambe T, Kanzaki N, Azuma T, Sakamoto K, Nakamura Y, Ohtani H, Waragai M, Maeda S, Ishida T, Sugino K, Inage M, Hirama N, Furuyama K, Fukushima S, Saito H, Machiya JI, Machida H, Abe K, Iwabuchi K, Katagiri Y, Aida Y, Abe Y, Ota T, Ishizawa Y, Tsukada Y, Yamada R, Sato R, Onuma T, Tomita H, Saito M, Watanabe N, Rikimaru M, Kawamata T, Umeda T, Morimoto J, Togawa R, Sato Y, Saito J, Kanazawa K, Kurita N, Iseki K

BMC pulmonary medicine   23 ( 1 )   312   2023年8月

Development and external validation of the DOAT and DOATS scores: simple decision support tools to identify disease progression among nonelderly patients with mild/moderate COVID-19.

Shibata Y, Omae K, Minemura H, Suzuki Y, Nikaido T, Tanino Y, Fukuhara A, Kanno R, Saito H, Suzuki S, Ishii T, Inokoshi Y, Sando E, Sakuma H, Kobayashi T, Kume H, Kamimoto M, Aoki H, Takama A, Kamiyama T, Nakayama M, Saito K, Tanigawa K, Sato M, Kambe T, Kanzaki N, Azuma T, Sakamoto K, Nakamura Y, Ohtani H, Waragai M, Maeda S, Ishida T, Sugino K, Inage M, Hirama N, Furuyama K, Fukushima S, Saito H, Machiya JI, Machida H, Abe K, Iwabuchi K, Katagiri Y, Aida Y, Abe Y, Ota T, Ishizawa Y, Tsukada Y, Yamada R, Sato R, Onuma T, Tomita H, Saito M, Watanabe N, Rikimaru M, Kawamata T, Umeda T, Morimoto J, Togawa R, Sato Y, Saito J, Kanazawa K, Kurita N, Iseki K

BMC pulmonary medicine   23 ( 1 )   312   2023年8月

Development and external validation of the DOAT and DOATS scores: simple decision support tools to identify disease progression among nonelderly patients with mild/moderate COVID-19.

Shibata Y, Omae K, Minemura H, Suzuki Y, Nikaido T, Tanino Y, Fukuhara A, Kanno R, Saito H, Suzuki S, Ishii T, Inokoshi Y, Sando E, Sakuma H, Kobayashi T, Kume H, Kamimoto M, Aoki H, Takama A, Kamiyama T, Nakayama M, Saito K, Tanigawa K, Sato M, Kambe T, Kanzaki N, Azuma T, Sakamoto K, Nakamura Y, Ohtani H, Waragai M, Maeda S, Ishida T, Sugino K, Inage M, Hirama N, Furuyama K, Fukushima S, Saito H, Machiya JI, Machida H, Abe K, Iwabuchi K, Katagiri Y, Aida Y, Abe Y, Ota T, Ishizawa Y, Tsukada Y, Yamada R, Sato R, Onuma T, Tomita H, Saito M, Watanabe N, Rikimaru M, Kawamata T, Umeda T, Morimoto J, Togawa R, Sato Y, Saito J, Kanazawa K, Kurita N, Iseki K

BMC pulmonary medicine   23 ( 1 )   312   2023年8月

Development and external validation of the DOAT and DOATS scores: simple decision support tools to identify disease progression among nonelderly patients with mild/moderate COVID-19.

Shibata Y, Omae K, Minemura H, Suzuki Y, Nikaido T, Tanino Y, Fukuhara A, Kanno R, Saito H, Suzuki S, Ishii T, Inokoshi Y, Sando E, Sakuma H, Kobayashi T, Kume H, Kamimoto M, Aoki H, Takama A, Kamiyama T, Nakayama M, Saito K, Tanigawa K, Sato M, Kambe T, Kanzaki N, Azuma T, Sakamoto K, Nakamura Y, Ohtani H, Waragai M, Maeda S, Ishida T, Sugino K, Inage M, Hirama N, Furuyama K, Fukushima S, Saito H, Machiya JI, Machida H, Abe K, Iwabuchi K, Katagiri Y, Aida Y, Abe Y, Ota T, Ishizawa Y, Tsukada Y, Yamada R, Sato R, Onuma T, Tomita H, Saito M, Watanabe N, Rikimaru M, Kawamata T, Umeda T, Morimoto J, Togawa R, Sato Y, Saito J, Kanazawa K, Kurita N, Iseki K

BMC pulmonary medicine   23 ( 1 )   312   2023年8月

Development and external validation of the DOAT and DOATS scores: simple decision support tools to identify disease progression among nonelderly patients with mild/moderate COVID-19.

Shibata Y, Omae K, Minemura H, Suzuki Y, Nikaido T, Tanino Y, Fukuhara A, Kanno R, Saito H, Suzuki S, Ishii T, Inokoshi Y, Sando E, Sakuma H, Kobayashi T, Kume H, Kamimoto M, Aoki H, Takama A, Kamiyama T, Nakayama M, Saito K, Tanigawa K, Sato M, Kambe T, Kanzaki N, Azuma T, Sakamoto K, Nakamura Y, Ohtani H, Waragai M, Maeda S, Ishida T, Sugino K, Inage M, Hirama N, Furuyama K, Fukushima S, Saito H, Machiya JI, Machida H, Abe K, Iwabuchi K, Katagiri Y, Aida Y, Abe Y, Ota T, Ishizawa Y, Tsukada Y, Yamada R, Sato R, Onuma T, Tomita H, Saito M, Watanabe N, Rikimaru M, Kawamata T, Umeda T, Morimoto J, Togawa R, Sato Y, Saito J, Kanazawa K, Kurita N, Iseki K

BMC pulmonary medicine   23 ( 1 )   312   2023年8月

Development and external validation of the DOAT and DOATS scores: simple decision support tools to identify disease progression among nonelderly patients with mild/moderate COVID-19.

Shibata Y, Omae K, Minemura H, Suzuki Y, Nikaido T, Tanino Y, Fukuhara A, Kanno R, Saito H, Suzuki S, Ishii T, Inokoshi Y, Sando E, Sakuma H, Kobayashi T, Kume H, Kamimoto M, Aoki H, Takama A, Kamiyama T, Nakayama M, Saito K, Tanigawa K, Sato M, Kambe T, Kanzaki N, Azuma T, Sakamoto K, Nakamura Y, Ohtani H, Waragai M, Maeda S, Ishida T, Sugino K, Inage M, Hirama N, Furuyama K, Fukushima S, Saito H, Machiya JI, Machida H, Abe K, Iwabuchi K, Katagiri Y, Aida Y, Abe Y, Ota T, Ishizawa Y, Tsukada Y, Yamada R, Sato R, Onuma T, Tomita H, Saito M, Watanabe N, Rikimaru M, Kawamata T, Umeda T, Morimoto J, Togawa R, Sato Y, Saito J, Kanazawa K, Kurita N, Iseki K

BMC pulmonary medicine   23 ( 1 )   312   2023年8月

Development and external validation of the DOAT and DOATS scores: simple decision support tools to identify disease progression among nonelderly patients with mild/moderate COVID-19.

Shibata Y, Omae K, Minemura H, Suzuki Y, Nikaido T, Tanino Y, Fukuhara A, Kanno R, Saito H, Suzuki S, Ishii T, Inokoshi Y, Sando E, Sakuma H, Kobayashi T, Kume H, Kamimoto M, Aoki H, Takama A, Kamiyama T, Nakayama M, Saito K, Tanigawa K, Sato M, Kambe T, Kanzaki N, Azuma T, Sakamoto K, Nakamura Y, Ohtani H, Waragai M, Maeda S, Ishida T, Sugino K, Inage M, Hirama N, Furuyama K, Fukushima S, Saito H, Machiya JI, Machida H, Abe K, Iwabuchi K, Katagiri Y, Aida Y, Abe Y, Ota T, Ishizawa Y, Tsukada Y, Yamada R, Sato R, Onuma T, Tomita H, Saito M, Watanabe N, Rikimaru M, Kawamata T, Umeda T, Morimoto J, Togawa R, Sato Y, Saito J, Kanazawa K, Kurita N, Iseki K

BMC pulmonary medicine   23 ( 1 )   312   2023年8月

Development and external validation of the DOAT and DOATS scores: simple decision support tools to identify disease progression among nonelderly patients with mild/moderate COVID-19.

Shibata Y, Omae K, Minemura H, Suzuki Y, Nikaido T, Tanino Y, Fukuhara A, Kanno R, Saito H, Suzuki S, Ishii T, Inokoshi Y, Sando E, Sakuma H, Kobayashi T, Kume H, Kamimoto M, Aoki H, Takama A, Kamiyama T, Nakayama M, Saito K, Tanigawa K, Sato M, Kambe T, Kanzaki N, Azuma T, Sakamoto K, Nakamura Y, Ohtani H, Waragai M, Maeda S, Ishida T, Sugino K, Inage M, Hirama N, Furuyama K, Fukushima S, Saito H, Machiya JI, Machida H, Abe K, Iwabuchi K, Katagiri Y, Aida Y, Abe Y, Ota T, Ishizawa Y, Tsukada Y, Yamada R, Sato R, Onuma T, Tomita H, Saito M, Watanabe N, Rikimaru M, Kawamata T, Umeda T, Morimoto J, Togawa R, Sato Y, Saito J, Kanazawa K, Kurita N, Iseki K

BMC pulmonary medicine   23 ( 1 )   312   2023年8月

Development and external validation of the DOAT and DOATS scores: simple decision support tools to identify disease progression among nonelderly patients with mild/moderate COVID-19.

Shibata Y, Omae K, Minemura H, Suzuki Y, Nikaido T, Tanino Y, Fukuhara A, Kanno R, Saito H, Suzuki S, Ishii T, Inokoshi Y, Sando E, Sakuma H, Kobayashi T, Kume H, Kamimoto M, Aoki H, Takama A, Kamiyama T, Nakayama M, Saito K, Tanigawa K, Sato M, Kambe T, Kanzaki N, Azuma T, Sakamoto K, Nakamura Y, Ohtani H, Waragai M, Maeda S, Ishida T, Sugino K, Inage M, Hirama N, Furuyama K, Fukushima S, Saito H, Machiya JI, Machida H, Abe K, Iwabuchi K, Katagiri Y, Aida Y, Abe Y, Ota T, Ishizawa Y, Tsukada Y, Yamada R, Sato R, Onuma T, Tomita H, Saito M, Watanabe N, Rikimaru M, Kawamata T, Umeda T, Morimoto J, Togawa R, Sato Y, Saito J, Kanazawa K, Kurita N, Iseki K

BMC pulmonary medicine   23 ( 1 )   312   2023年8月

Development and external validation of the DOAT and DOATS scores: simple decision support tools to identify disease progression among nonelderly patients with mild/moderate COVID-19.

Shibata Y, Omae K, Minemura H, Suzuki Y, Nikaido T, Tanino Y, Fukuhara A, Kanno R, Saito H, Suzuki S, Ishii T, Inokoshi Y, Sando E, Sakuma H, Kobayashi T, Kume H, Kamimoto M, Aoki H, Takama A, Kamiyama T, Nakayama M, Saito K, Tanigawa K, Sato M, Kambe T, Kanzaki N, Azuma T, Sakamoto K, Nakamura Y, Ohtani H, Waragai M, Maeda S, Ishida T, Sugino K, Inage M, Hirama N, Furuyama K, Fukushima S, Saito H, Machiya JI, Machida H, Abe K, Iwabuchi K, Katagiri Y, Aida Y, Abe Y, Ota T, Ishizawa Y, Tsukada Y, Yamada R, Sato R, Onuma T, Tomita H, Saito M, Watanabe N, Rikimaru M, Kawamata T, Umeda T, Morimoto J, Togawa R, Sato Y, Saito J, Kanazawa K, Kurita N, Iseki K

BMC pulmonary medicine   23 ( 1 )   312   2023年8月

Development and external validation of the DOAT and DOATS scores: simple decision support tools to identify disease progression among nonelderly patients with mild/moderate COVID-19.

Shibata Y, Omae K, Minemura H, Suzuki Y, Nikaido T, Tanino Y, Fukuhara A, Kanno R, Saito H, Suzuki S, Ishii T, Inokoshi Y, Sando E, Sakuma H, Kobayashi T, Kume H, Kamimoto M, Aoki H, Takama A, Kamiyama T, Nakayama M, Saito K, Tanigawa K, Sato M, Kambe T, Kanzaki N, Azuma T, Sakamoto K, Nakamura Y, Ohtani H, Waragai M, Maeda S, Ishida T, Sugino K, Inage M, Hirama N, Furuyama K, Fukushima S, Saito H, Machiya JI, Machida H, Abe K, Iwabuchi K, Katagiri Y, Aida Y, Abe Y, Ota T, Ishizawa Y, Tsukada Y, Yamada R, Sato R, Onuma T, Tomita H, Saito M, Watanabe N, Rikimaru M, Kawamata T, Umeda T, Morimoto J, Togawa R, Sato Y, Saito J, Kanazawa K, Kurita N, Iseki K

BMC pulmonary medicine   23 ( 1 )   312   2023年8月

Development and external validation of the DOAT and DOATS scores: simple decision support tools to identify disease progression among nonelderly patients with mild/moderate COVID-19.

Shibata Y, Omae K, Minemura H, Suzuki Y, Nikaido T, Tanino Y, Fukuhara A, Kanno R, Saito H, Suzuki S, Ishii T, Inokoshi Y, Sando E, Sakuma H, Kobayashi T, Kume H, Kamimoto M, Aoki H, Takama A, Kamiyama T, Nakayama M, Saito K, Tanigawa K, Sato M, Kambe T, Kanzaki N, Azuma T, Sakamoto K, Nakamura Y, Ohtani H, Waragai M, Maeda S, Ishida T, Sugino K, Inage M, Hirama N, Furuyama K, Fukushima S, Saito H, Machiya JI, Machida H, Abe K, Iwabuchi K, Katagiri Y, Aida Y, Abe Y, Ota T, Ishizawa Y, Tsukada Y, Yamada R, Sato R, Onuma T, Tomita H, Saito M, Watanabe N, Rikimaru M, Kawamata T, Umeda T, Morimoto J, Togawa R, Sato Y, Saito J, Kanazawa K, Kurita N, Iseki K

BMC pulmonary medicine   23 ( 1 )   312   2023年8月

Development and external validation of the DOAT and DOATS scores: simple decision support tools to identify disease progression among nonelderly patients with mild/moderate COVID-19.

Shibata Y, Omae K, Minemura H, Suzuki Y, Nikaido T, Tanino Y, Fukuhara A, Kanno R, Saito H, Suzuki S, Ishii T, Inokoshi Y, Sando E, Sakuma H, Kobayashi T, Kume H, Kamimoto M, Aoki H, Takama A, Kamiyama T, Nakayama M, Saito K, Tanigawa K, Sato M, Kambe T, Kanzaki N, Azuma T, Sakamoto K, Nakamura Y, Ohtani H, Waragai M, Maeda S, Ishida T, Sugino K, Inage M, Hirama N, Furuyama K, Fukushima S, Saito H, Machiya JI, Machida H, Abe K, Iwabuchi K, Katagiri Y, Aida Y, Abe Y, Ota T, Ishizawa Y, Tsukada Y, Yamada R, Sato R, Onuma T, Tomita H, Saito M, Watanabe N, Rikimaru M, Kawamata T, Umeda T, Morimoto J, Togawa R, Sato Y, Saito J, Kanazawa K, Kurita N, Iseki K

BMC pulmonary medicine   23 ( 1 )   312   2023年8月

Development and external validation of the DOAT and DOATS scores: simple decision support tools to identify disease progression among nonelderly patients with mild/moderate COVID-19.

Shibata Y, Omae K, Minemura H, Suzuki Y, Nikaido T, Tanino Y, Fukuhara A, Kanno R, Saito H, Suzuki S, Ishii T, Inokoshi Y, Sando E, Sakuma H, Kobayashi T, Kume H, Kamimoto M, Aoki H, Takama A, Kamiyama T, Nakayama M, Saito K, Tanigawa K, Sato M, Kambe T, Kanzaki N, Azuma T, Sakamoto K, Nakamura Y, Ohtani H, Waragai M, Maeda S, Ishida T, Sugino K, Inage M, Hirama N, Furuyama K, Fukushima S, Saito H, Machiya JI, Machida H, Abe K, Iwabuchi K, Katagiri Y, Aida Y, Abe Y, Ota T, Ishizawa Y, Tsukada Y, Yamada R, Sato R, Onuma T, Tomita H, Saito M, Watanabe N, Rikimaru M, Kawamata T, Umeda T, Morimoto J, Togawa R, Sato Y, Saito J, Kanazawa K, Kurita N, Iseki K

BMC pulmonary medicine   23 ( 1 )   312   2023年8月

Development and external validation of the DOAT and DOATS scores: simple decision support tools to identify disease progression among nonelderly patients with mild/moderate COVID-19.

Shibata Y, Omae K, Minemura H, Suzuki Y, Nikaido T, Tanino Y, Fukuhara A, Kanno R, Saito H, Suzuki S, Ishii T, Inokoshi Y, Sando E, Sakuma H, Kobayashi T, Kume H, Kamimoto M, Aoki H, Takama A, Kamiyama T, Nakayama M, Saito K, Tanigawa K, Sato M, Kambe T, Kanzaki N, Azuma T, Sakamoto K, Nakamura Y, Ohtani H, Waragai M, Maeda S, Ishida T, Sugino K, Inage M, Hirama N, Furuyama K, Fukushima S, Saito H, Machiya JI, Machida H, Abe K, Iwabuchi K, Katagiri Y, Aida Y, Abe Y, Ota T, Ishizawa Y, Tsukada Y, Yamada R, Sato R, Onuma T, Tomita H, Saito M, Watanabe N, Rikimaru M, Kawamata T, Umeda T, Morimoto J, Togawa R, Sato Y, Saito J, Kanazawa K, Kurita N, Iseki K

BMC pulmonary medicine   23 ( 1 )   312   2023年8月

Development and external validation of the DOAT and DOATS scores: simple decision support tools to identify disease progression among nonelderly patients with mild/moderate COVID-19.

Shibata Y, Omae K, Minemura H, Suzuki Y, Nikaido T, Tanino Y, Fukuhara A, Kanno R, Saito H, Suzuki S, Ishii T, Inokoshi Y, Sando E, Sakuma H, Kobayashi T, Kume H, Kamimoto M, Aoki H, Takama A, Kamiyama T, Nakayama M, Saito K, Tanigawa K, Sato M, Kambe T, Kanzaki N, Azuma T, Sakamoto K, Nakamura Y, Ohtani H, Waragai M, Maeda S, Ishida T, Sugino K, Inage M, Hirama N, Furuyama K, Fukushima S, Saito H, Machiya JI, Machida H, Abe K, Iwabuchi K, Katagiri Y, Aida Y, Abe Y, Ota T, Ishizawa Y, Tsukada Y, Yamada R, Sato R, Onuma T, Tomita H, Saito M, Watanabe N, Rikimaru M, Kawamata T, Umeda T, Morimoto J, Togawa R, Sato Y, Saito J, Kanazawa K, Kurita N, Iseki K

BMC pulmonary medicine   23 ( 1 )   312   2023年8月

Development and external validation of the DOAT and DOATS scores: simple decision support tools to identify disease progression among nonelderly patients with mild/moderate COVID-19.

Shibata Y, Omae K, Minemura H, Suzuki Y, Nikaido T, Tanino Y, Fukuhara A, Kanno R, Saito H, Suzuki S, Ishii T, Inokoshi Y, Sando E, Sakuma H, Kobayashi T, Kume H, Kamimoto M, Aoki H, Takama A, Kamiyama T, Nakayama M, Saito K, Tanigawa K, Sato M, Kambe T, Kanzaki N, Azuma T, Sakamoto K, Nakamura Y, Ohtani H, Waragai M, Maeda S, Ishida T, Sugino K, Inage M, Hirama N, Furuyama K, Fukushima S, Saito H, Machiya JI, Machida H, Abe K, Iwabuchi K, Katagiri Y, Aida Y, Abe Y, Ota T, Ishizawa Y, Tsukada Y, Yamada R, Sato R, Onuma T, Tomita H, Saito M, Watanabe N, Rikimaru M, Kawamata T, Umeda T, Morimoto J, Togawa R, Sato Y, Saito J, Kanazawa K, Kurita N, Iseki K

BMC pulmonary medicine   23 ( 1 )   312   2023年8月

Effect of Colchicine on Recurrent Serositis in Familial Mediterranean Fever.

Suzuki Y, Saito J, Fukuhara A, Rikimaru M, Morimoto J, Lee T, Sato R, Yamada R, Onuma T, Tomita H, Saito M, Watanabe N, Umeda T, Kawamata T, Togawa R, Sato Y, Minemura H, Nikaido T, Kanazawa K, Tanino Y, Shibata Y

The American journal of medicine   136 ( 6 )   e117 - e118   2023年6月（ ISSN:0002-9343 ）

Effect of Colchicine on Recurrent Serositis in Familial Mediterranean Fever.

Suzuki Y, Saito J, Fukuhara A, Rikimaru M, Morimoto J, Lee T, Sato R, Yamada R, Onuma T, Tomita H, Saito M, Watanabe N, Umeda T, Kawamata T, Togawa R, Sato Y, Minemura H, Nikaido T, Kanazawa K, Tanino Y, Shibata Y

The American journal of medicine   136 ( 6 )   e117 - e118   2023年6月（ ISSN:0002-9343 ）

Effect of Colchicine on Recurrent Serositis in Familial Mediterranean Fever.

Suzuki Y, Saito J, Fukuhara A, Rikimaru M, Morimoto J, Lee T, Sato R, Yamada R, Onuma T, Tomita H, Saito M, Watanabe N, Umeda T, Kawamata T, Togawa R, Sato Y, Minemura H, Nikaido T, Kanazawa K, Tanino Y, Shibata Y

The American journal of medicine   136 ( 6 )   e117 - e118   2023年6月（ ISSN:0002-9343 ）

Effect of Colchicine on Recurrent Serositis in Familial Mediterranean Fever.

Suzuki Y, Saito J, Fukuhara A, Rikimaru M, Morimoto J, Lee T, Sato R, Yamada R, Onuma T, Tomita H, Saito M, Watanabe N, Umeda T, Kawamata T, Togawa R, Sato Y, Minemura H, Nikaido T, Kanazawa K, Tanino Y, Shibata Y

The American journal of medicine   136 ( 6 )   e117 - e118   2023年6月（ ISSN:0002-9343 ）

Effect of Colchicine on Recurrent Serositis in Familial Mediterranean Fever.

Suzuki Y, Saito J, Fukuhara A, Rikimaru M, Morimoto J, Lee T, Sato R, Yamada R, Onuma T, Tomita H, Saito M, Watanabe N, Umeda T, Kawamata T, Togawa R, Sato Y, Minemura H, Nikaido T, Kanazawa K, Tanino Y, Shibata Y

The American journal of medicine   136 ( 6 )   e117 - e118   2023年6月（ ISSN:0002-9343 ）

Effect of Colchicine on Recurrent Serositis in Familial Mediterranean Fever.

Suzuki Y, Saito J, Fukuhara A, Rikimaru M, Morimoto J, Lee T, Sato R, Yamada R, Onuma T, Tomita H, Saito M, Watanabe N, Umeda T, Kawamata T, Togawa R, Sato Y, Minemura H, Nikaido T, Kanazawa K, Tanino Y, Shibata Y

The American journal of medicine   136 ( 6 )   e117 - e118   2023年6月（ ISSN:0002-9343 ）

Effect of Colchicine on Recurrent Serositis in Familial Mediterranean Fever.

Suzuki Y, Saito J, Fukuhara A, Rikimaru M, Morimoto J, Lee T, Sato R, Yamada R, Onuma T, Tomita H, Saito M, Watanabe N, Umeda T, Kawamata T, Togawa R, Sato Y, Minemura H, Nikaido T, Kanazawa K, Tanino Y, Shibata Y

The American journal of medicine   136 ( 6 )   e117 - e118   2023年6月（ ISSN:0002-9343 ）

Effect of Colchicine on Recurrent Serositis in Familial Mediterranean Fever.

Suzuki Y, Saito J, Fukuhara A, Rikimaru M, Morimoto J, Lee T, Sato R, Yamada R, Onuma T, Tomita H, Saito M, Watanabe N, Umeda T, Kawamata T, Togawa R, Sato Y, Minemura H, Nikaido T, Kanazawa K, Tanino Y, Shibata Y

The American journal of medicine   136 ( 6 )   e117 - e118   2023年6月（ ISSN:0002-9343 ）

Effect of Colchicine on Recurrent Serositis in Familial Mediterranean Fever.

Suzuki Y, Saito J, Fukuhara A, Rikimaru M, Morimoto J, Lee T, Sato R, Yamada R, Onuma T, Tomita H, Saito M, Watanabe N, Umeda T, Kawamata T, Togawa R, Sato Y, Minemura H, Nikaido T, Kanazawa K, Tanino Y, Shibata Y

The American journal of medicine   136 ( 6 )   e117 - e118   2023年6月（ ISSN:0002-9343 ）

Effect of Colchicine on Recurrent Serositis in Familial Mediterranean Fever.

Suzuki Y, Saito J, Fukuhara A, Rikimaru M, Morimoto J, Lee T, Sato R, Yamada R, Onuma T, Tomita H, Saito M, Watanabe N, Umeda T, Kawamata T, Togawa R, Sato Y, Minemura H, Nikaido T, Kanazawa K, Tanino Y, Shibata Y

The American journal of medicine   136 ( 6 )   e117 - e118   2023年6月（ ISSN:0002-9343 ）

Effect of Colchicine on Recurrent Serositis in Familial Mediterranean Fever.

Suzuki Y, Saito J, Fukuhara A, Rikimaru M, Morimoto J, Lee T, Sato R, Yamada R, Onuma T, Tomita H, Saito M, Watanabe N, Umeda T, Kawamata T, Togawa R, Sato Y, Minemura H, Nikaido T, Kanazawa K, Tanino Y, Shibata Y

The American journal of medicine   136 ( 6 )   e117 - e118   2023年6月（ ISSN:0002-9343 ）

Effect of Colchicine on Recurrent Serositis in Familial Mediterranean Fever.

Suzuki Y, Saito J, Fukuhara A, Rikimaru M, Morimoto J, Lee T, Sato R, Yamada R, Onuma T, Tomita H, Saito M, Watanabe N, Umeda T, Kawamata T, Togawa R, Sato Y, Minemura H, Nikaido T, Kanazawa K, Tanino Y, Shibata Y

The American journal of medicine   136 ( 6 )   e117 - e118   2023年6月（ ISSN:0002-9343 ）

Effect of Colchicine on Recurrent Serositis in Familial Mediterranean Fever.

Suzuki Y, Saito J, Fukuhara A, Rikimaru M, Morimoto J, Lee T, Sato R, Yamada R, Onuma T, Tomita H, Saito M, Watanabe N, Umeda T, Kawamata T, Togawa R, Sato Y, Minemura H, Nikaido T, Kanazawa K, Tanino Y, Shibata Y

The American journal of medicine   136 ( 6 )   e117 - e118   2023年6月（ ISSN:0002-9343 ）

Effect of Colchicine on Recurrent Serositis in Familial Mediterranean Fever.

Suzuki Y, Saito J, Fukuhara A, Rikimaru M, Morimoto J, Lee T, Sato R, Yamada R, Onuma T, Tomita H, Saito M, Watanabe N, Umeda T, Kawamata T, Togawa R, Sato Y, Minemura H, Nikaido T, Kanazawa K, Tanino Y, Shibata Y

The American journal of medicine   136 ( 6 )   e117 - e118   2023年6月（ ISSN:0002-9343 ）

Effect of Colchicine on Recurrent Serositis in Familial Mediterranean Fever.

Suzuki Y, Saito J, Fukuhara A, Rikimaru M, Morimoto J, Lee T, Sato R, Yamada R, Onuma T, Tomita H, Saito M, Watanabe N, Umeda T, Kawamata T, Togawa R, Sato Y, Minemura H, Nikaido T, Kanazawa K, Tanino Y, Shibata Y

The American journal of medicine   136 ( 6 )   e117 - e118   2023年6月（ ISSN:0002-9343 ）

Effect of Colchicine on Recurrent Serositis in Familial Mediterranean Fever.

Suzuki Y, Saito J, Fukuhara A, Rikimaru M, Morimoto J, Lee T, Sato R, Yamada R, Onuma T, Tomita H, Saito M, Watanabe N, Umeda T, Kawamata T, Togawa R, Sato Y, Minemura H, Nikaido T, Kanazawa K, Tanino Y, Shibata Y

The American journal of medicine   136 ( 6 )   e117 - e118   2023年6月（ ISSN:0002-9343 ）

Effect of Colchicine on Recurrent Serositis in Familial Mediterranean Fever.

Suzuki Y, Saito J, Fukuhara A, Rikimaru M, Morimoto J, Lee T, Sato R, Yamada R, Onuma T, Tomita H, Saito M, Watanabe N, Umeda T, Kawamata T, Togawa R, Sato Y, Minemura H, Nikaido T, Kanazawa K, Tanino Y, Shibata Y

The American journal of medicine   136 ( 6 )   e117 - e118   2023年6月（ ISSN:0002-9343 ）

Effect of Colchicine on Recurrent Serositis in Familial Mediterranean Fever.

Suzuki Y, Saito J, Fukuhara A, Rikimaru M, Morimoto J, Lee T, Sato R, Yamada R, Onuma T, Tomita H, Saito M, Watanabe N, Umeda T, Kawamata T, Togawa R, Sato Y, Minemura H, Nikaido T, Kanazawa K, Tanino Y, Shibata Y

The American journal of medicine   136 ( 6 )   e117 - e118   2023年6月（ ISSN:0002-9343 ）

Effect of Colchicine on Recurrent Serositis in Familial Mediterranean Fever.

Suzuki Y, Saito J, Fukuhara A, Rikimaru M, Morimoto J, Lee T, Sato R, Yamada R, Onuma T, Tomita H, Saito M, Watanabe N, Umeda T, Kawamata T, Togawa R, Sato Y, Minemura H, Nikaido T, Kanazawa K, Tanino Y, Shibata Y

The American journal of medicine   136 ( 6 )   e117 - e118   2023年6月（ ISSN:0002-9343 ）

Effect of Colchicine on Recurrent Serositis in Familial Mediterranean Fever.

Suzuki Y, Saito J, Fukuhara A, Rikimaru M, Morimoto J, Lee T, Sato R, Yamada R, Onuma T, Tomita H, Saito M, Watanabe N, Umeda T, Kawamata T, Togawa R, Sato Y, Minemura H, Nikaido T, Kanazawa K, Tanino Y, Shibata Y

The American journal of medicine   136 ( 6 )   e117 - e118   2023年6月（ ISSN:0002-9343 ）

Usefulness of diurnal variation of fractional exhaled nitric oxide for predicting early therapeutic response to asthma treatment.

Uematsu M, Saito J, Sato S, Fukuhara A, Suzuki Y, Rikimaru M, Onuma T, Tomita H, Watanabe N, Saito M, Morimoto J, Kawamata T, Umeda T, Togawa R, Sato Y, Koizumi T, Hirai K, Minemura H, Nikaido T, Kanazawa K, Tanino Y, Munakata M, Shibata Y

The Journal of asthma : official journal of the Association for the Care of Asthma   59 ( 10 )   2039 - 2050   2022年10月（ ISSN:0277-0903 ）

Efficacy and safety of amrubicin monotherapy after atezolizumab plus carboplatin and etoposide in patients with relapsed small-cell lung cancer.

Imai H, Nagai Y, Minemura H, Tsuda T, Yamada Y, Wasamoto S, Kishikawa T, Shiono A, Shiihara J, Yamaguchi O, Mouri A, Kaira K, Kanazawa K, Taniguchi H, Minato K, Kagamu H

Investigational new drugs   40 ( 5 )   1066 - 1079   2022年10月（ ISSN:0167-6997 ）

Post-progression survival after atezolizumab plus carboplatin and etoposide as first-line chemotherapy in small cell lung cancer has a significant impact on overall survival.

Masubuchi K, Imai H, Wasamoto S, Tsuda T, Minemura H, Nagai Y, Yamada Y, Kishikawa T, Umeda Y, Shiono A, Takechi H, Shiihara J, Kaira K, Kanazawa K, Taniguchi H, Kaburagi T, Kagamu H, Minato K

Thoracic cancer   13 ( 19 )   2776 - 2785   2022年10月（ ISSN:1759-7706 ）

Efficacy and safety of amrubicin monotherapy after atezolizumab plus carboplatin and etoposide in patients with relapsed small-cell lung cancer.

Imai H, Nagai Y, Minemura H, Tsuda T, Yamada Y, Wasamoto S, Kishikawa T, Shiono A, Shiihara J, Yamaguchi O, Mouri A, Kaira K, Kanazawa K, Taniguchi H, Minato K, Kagamu H

Investigational new drugs   40 ( 5 )   1066 - 1079   2022年10月（ ISSN:0167-6997 ）

Post-progression survival after atezolizumab plus carboplatin and etoposide as first-line chemotherapy in small cell lung cancer has a significant impact on overall survival.

Masubuchi K, Imai H, Wasamoto S, Tsuda T, Minemura H, Nagai Y, Yamada Y, Kishikawa T, Umeda Y, Shiono A, Takechi H, Shiihara J, Kaira K, Kanazawa K, Taniguchi H, Kaburagi T, Kagamu H, Minato K

Thoracic cancer   13 ( 19 )   2776 - 2785   2022年10月（ ISSN:1759-7706 ）

Efficacy and safety of amrubicin monotherapy after atezolizumab plus carboplatin and etoposide in patients with relapsed small-cell lung cancer.

Imai H, Nagai Y, Minemura H, Tsuda T, Yamada Y, Wasamoto S, Kishikawa T, Shiono A, Shiihara J, Yamaguchi O, Mouri A, Kaira K, Kanazawa K, Taniguchi H, Minato K, Kagamu H

Investigational new drugs   40 ( 5 )   1066 - 1079   2022年10月（ ISSN:0167-6997 ）

Post-progression survival after atezolizumab plus carboplatin and etoposide as first-line chemotherapy in small cell lung cancer has a significant impact on overall survival.

Masubuchi K, Imai H, Wasamoto S, Tsuda T, Minemura H, Nagai Y, Yamada Y, Kishikawa T, Umeda Y, Shiono A, Takechi H, Shiihara J, Kaira K, Kanazawa K, Taniguchi H, Kaburagi T, Kagamu H, Minato K

Thoracic cancer   13 ( 19 )   2776 - 2785   2022年10月（ ISSN:1759-7706 ）

Efficacy and safety of amrubicin monotherapy after atezolizumab plus carboplatin and etoposide in patients with relapsed small-cell lung cancer.

Imai H, Nagai Y, Minemura H, Tsuda T, Yamada Y, Wasamoto S, Kishikawa T, Shiono A, Shiihara J, Yamaguchi O, Mouri A, Kaira K, Kanazawa K, Taniguchi H, Minato K, Kagamu H

Investigational new drugs   40 ( 5 )   1066 - 1079   2022年10月（ ISSN:0167-6997 ）

Post-progression survival after atezolizumab plus carboplatin and etoposide as first-line chemotherapy in small cell lung cancer has a significant impact on overall survival.

Masubuchi K, Imai H, Wasamoto S, Tsuda T, Minemura H, Nagai Y, Yamada Y, Kishikawa T, Umeda Y, Shiono A, Takechi H, Shiihara J, Kaira K, Kanazawa K, Taniguchi H, Kaburagi T, Kagamu H, Minato K

Thoracic cancer   13 ( 19 )   2776 - 2785   2022年10月（ ISSN:1759-7706 ）

Efficacy and safety of amrubicin monotherapy after atezolizumab plus carboplatin and etoposide in patients with relapsed small-cell lung cancer.

Imai H, Nagai Y, Minemura H, Tsuda T, Yamada Y, Wasamoto S, Kishikawa T, Shiono A, Shiihara J, Yamaguchi O, Mouri A, Kaira K, Kanazawa K, Taniguchi H, Minato K, Kagamu H

Investigational new drugs   40 ( 5 )   1066 - 1079   2022年10月（ ISSN:0167-6997 ）

Post-progression survival after atezolizumab plus carboplatin and etoposide as first-line chemotherapy in small cell lung cancer has a significant impact on overall survival.

Masubuchi K, Imai H, Wasamoto S, Tsuda T, Minemura H, Nagai Y, Yamada Y, Kishikawa T, Umeda Y, Shiono A, Takechi H, Shiihara J, Kaira K, Kanazawa K, Taniguchi H, Kaburagi T, Kagamu H, Minato K

Thoracic cancer   13 ( 19 )   2776 - 2785   2022年10月（ ISSN:1759-7706 ）

Efficacy and safety of amrubicin monotherapy after atezolizumab plus carboplatin and etoposide in patients with relapsed small-cell lung cancer.

Imai H, Nagai Y, Minemura H, Tsuda T, Yamada Y, Wasamoto S, Kishikawa T, Shiono A, Shiihara J, Yamaguchi O, Mouri A, Kaira K, Kanazawa K, Taniguchi H, Minato K, Kagamu H

Investigational new drugs   40 ( 5 )   1066 - 1079   2022年10月（ ISSN:0167-6997 ）

Post-progression survival after atezolizumab plus carboplatin and etoposide as first-line chemotherapy in small cell lung cancer has a significant impact on overall survival.

Masubuchi K, Imai H, Wasamoto S, Tsuda T, Minemura H, Nagai Y, Yamada Y, Kishikawa T, Umeda Y, Shiono A, Takechi H, Shiihara J, Kaira K, Kanazawa K, Taniguchi H, Kaburagi T, Kagamu H, Minato K

Thoracic cancer   13 ( 19 )   2776 - 2785   2022年10月（ ISSN:1759-7706 ）

Efficacy and safety of amrubicin monotherapy after atezolizumab plus carboplatin and etoposide in patients with relapsed small-cell lung cancer.

Imai H, Nagai Y, Minemura H, Tsuda T, Yamada Y, Wasamoto S, Kishikawa T, Shiono A, Shiihara J, Yamaguchi O, Mouri A, Kaira K, Kanazawa K, Taniguchi H, Minato K, Kagamu H

Investigational new drugs   40 ( 5 )   1066 - 1079   2022年10月（ ISSN:0167-6997 ）

Post-progression survival after atezolizumab plus carboplatin and etoposide as first-line chemotherapy in small cell lung cancer has a significant impact on overall survival.

Masubuchi K, Imai H, Wasamoto S, Tsuda T, Minemura H, Nagai Y, Yamada Y, Kishikawa T, Umeda Y, Shiono A, Takechi H, Shiihara J, Kaira K, Kanazawa K, Taniguchi H, Kaburagi T, Kagamu H, Minato K

Thoracic cancer   13 ( 19 )   2776 - 2785   2022年10月（ ISSN:1759-7706 ）

Efficacy and safety of amrubicin monotherapy after atezolizumab plus carboplatin and etoposide in patients with relapsed small-cell lung cancer.

Imai H, Nagai Y, Minemura H, Tsuda T, Yamada Y, Wasamoto S, Kishikawa T, Shiono A, Shiihara J, Yamaguchi O, Mouri A, Kaira K, Kanazawa K, Taniguchi H, Minato K, Kagamu H

Investigational new drugs   40 ( 5 )   1066 - 1079   2022年10月（ ISSN:0167-6997 ）

Post-progression survival after atezolizumab plus carboplatin and etoposide as first-line chemotherapy in small cell lung cancer has a significant impact on overall survival.

Masubuchi K, Imai H, Wasamoto S, Tsuda T, Minemura H, Nagai Y, Yamada Y, Kishikawa T, Umeda Y, Shiono A, Takechi H, Shiihara J, Kaira K, Kanazawa K, Taniguchi H, Kaburagi T, Kagamu H, Minato K

Thoracic cancer   13 ( 19 )   2776 - 2785   2022年10月（ ISSN:1759-7706 ）

Efficacy and safety of amrubicin monotherapy after atezolizumab plus carboplatin and etoposide in patients with relapsed small-cell lung cancer.

Imai H, Nagai Y, Minemura H, Tsuda T, Yamada Y, Wasamoto S, Kishikawa T, Shiono A, Shiihara J, Yamaguchi O, Mouri A, Kaira K, Kanazawa K, Taniguchi H, Minato K, Kagamu H

Investigational new drugs   40 ( 5 )   1066 - 1079   2022年10月（ ISSN:0167-6997 ）

Post-progression survival after atezolizumab plus carboplatin and etoposide as first-line chemotherapy in small cell lung cancer has a significant impact on overall survival.

Masubuchi K, Imai H, Wasamoto S, Tsuda T, Minemura H, Nagai Y, Yamada Y, Kishikawa T, Umeda Y, Shiono A, Takechi H, Shiihara J, Kaira K, Kanazawa K, Taniguchi H, Kaburagi T, Kagamu H, Minato K

Thoracic cancer   13 ( 19 )   2776 - 2785   2022年10月（ ISSN:1759-7706 ）

Efficacy and safety of amrubicin monotherapy after atezolizumab plus carboplatin and etoposide in patients with relapsed small-cell lung cancer.

Imai H, Nagai Y, Minemura H, Tsuda T, Yamada Y, Wasamoto S, Kishikawa T, Shiono A, Shiihara J, Yamaguchi O, Mouri A, Kaira K, Kanazawa K, Taniguchi H, Minato K, Kagamu H

Investigational new drugs   40 ( 5 )   1066 - 1079   2022年10月（ ISSN:0167-6997 ）

Post-progression survival after atezolizumab plus carboplatin and etoposide as first-line chemotherapy in small cell lung cancer has a significant impact on overall survival.

Masubuchi K, Imai H, Wasamoto S, Tsuda T, Minemura H, Nagai Y, Yamada Y, Kishikawa T, Umeda Y, Shiono A, Takechi H, Shiihara J, Kaira K, Kanazawa K, Taniguchi H, Kaburagi T, Kagamu H, Minato K

Thoracic cancer   13 ( 19 )   2776 - 2785   2022年10月（ ISSN:1759-7706 ）

Efficacy and safety of amrubicin monotherapy after atezolizumab plus carboplatin and etoposide in patients with relapsed small-cell lung cancer.

Imai H, Nagai Y, Minemura H, Tsuda T, Yamada Y, Wasamoto S, Kishikawa T, Shiono A, Shiihara J, Yamaguchi O, Mouri A, Kaira K, Kanazawa K, Taniguchi H, Minato K, Kagamu H

Investigational new drugs   40 ( 5 )   1066 - 1079   2022年10月（ ISSN:0167-6997 ）

Post-progression survival after atezolizumab plus carboplatin and etoposide as first-line chemotherapy in small cell lung cancer has a significant impact on overall survival.

Masubuchi K, Imai H, Wasamoto S, Tsuda T, Minemura H, Nagai Y, Yamada Y, Kishikawa T, Umeda Y, Shiono A, Takechi H, Shiihara J, Kaira K, Kanazawa K, Taniguchi H, Kaburagi T, Kagamu H, Minato K

Thoracic cancer   13 ( 19 )   2776 - 2785   2022年10月（ ISSN:1759-7706 ）

Efficacy and safety of amrubicin monotherapy after atezolizumab plus carboplatin and etoposide in patients with relapsed small-cell lung cancer.

Imai H, Nagai Y, Minemura H, Tsuda T, Yamada Y, Wasamoto S, Kishikawa T, Shiono A, Shiihara J, Yamaguchi O, Mouri A, Kaira K, Kanazawa K, Taniguchi H, Minato K, Kagamu H

Investigational new drugs   40 ( 5 )   1066 - 1079   2022年10月（ ISSN:0167-6997 ）

Post-progression survival after atezolizumab plus carboplatin and etoposide as first-line chemotherapy in small cell lung cancer has a significant impact on overall survival.

Masubuchi K, Imai H, Wasamoto S, Tsuda T, Minemura H, Nagai Y, Yamada Y, Kishikawa T, Umeda Y, Shiono A, Takechi H, Shiihara J, Kaira K, Kanazawa K, Taniguchi H, Kaburagi T, Kagamu H, Minato K

Thoracic cancer   13 ( 19 )   2776 - 2785   2022年10月（ ISSN:1759-7706 ）

Efficacy and safety of amrubicin monotherapy after atezolizumab plus carboplatin and etoposide in patients with relapsed small-cell lung cancer.

Imai H, Nagai Y, Minemura H, Tsuda T, Yamada Y, Wasamoto S, Kishikawa T, Shiono A, Shiihara J, Yamaguchi O, Mouri A, Kaira K, Kanazawa K, Taniguchi H, Minato K, Kagamu H

Investigational new drugs   40 ( 5 )   1066 - 1079   2022年10月（ ISSN:0167-6997 ）

Post-progression survival after atezolizumab plus carboplatin and etoposide as first-line chemotherapy in small cell lung cancer has a significant impact on overall survival.

Masubuchi K, Imai H, Wasamoto S, Tsuda T, Minemura H, Nagai Y, Yamada Y, Kishikawa T, Umeda Y, Shiono A, Takechi H, Shiihara J, Kaira K, Kanazawa K, Taniguchi H, Kaburagi T, Kagamu H, Minato K

Thoracic cancer   13 ( 19 )   2776 - 2785   2022年10月（ ISSN:1759-7706 ）

Efficacy and safety of amrubicin monotherapy after atezolizumab plus carboplatin and etoposide in patients with relapsed small-cell lung cancer.

Imai H, Nagai Y, Minemura H, Tsuda T, Yamada Y, Wasamoto S, Kishikawa T, Shiono A, Shiihara J, Yamaguchi O, Mouri A, Kaira K, Kanazawa K, Taniguchi H, Minato K, Kagamu H

Investigational new drugs   40 ( 5 )   1066 - 1079   2022年10月（ ISSN:0167-6997 ）

Post-progression survival after atezolizumab plus carboplatin and etoposide as first-line chemotherapy in small cell lung cancer has a significant impact on overall survival.

Masubuchi K, Imai H, Wasamoto S, Tsuda T, Minemura H, Nagai Y, Yamada Y, Kishikawa T, Umeda Y, Shiono A, Takechi H, Shiihara J, Kaira K, Kanazawa K, Taniguchi H, Kaburagi T, Kagamu H, Minato K

Thoracic cancer   13 ( 19 )   2776 - 2785   2022年10月（ ISSN:1759-7706 ）

Efficacy and safety of amrubicin monotherapy after atezolizumab plus carboplatin and etoposide in patients with relapsed small-cell lung cancer.

Imai H, Nagai Y, Minemura H, Tsuda T, Yamada Y, Wasamoto S, Kishikawa T, Shiono A, Shiihara J, Yamaguchi O, Mouri A, Kaira K, Kanazawa K, Taniguchi H, Minato K, Kagamu H

Investigational new drugs   40 ( 5 )   1066 - 1079   2022年10月（ ISSN:0167-6997 ）

Post-progression survival after atezolizumab plus carboplatin and etoposide as first-line chemotherapy in small cell lung cancer has a significant impact on overall survival.

Masubuchi K, Imai H, Wasamoto S, Tsuda T, Minemura H, Nagai Y, Yamada Y, Kishikawa T, Umeda Y, Shiono A, Takechi H, Shiihara J, Kaira K, Kanazawa K, Taniguchi H, Kaburagi T, Kagamu H, Minato K

Thoracic cancer   13 ( 19 )   2776 - 2785   2022年10月（ ISSN:1759-7706 ）

Efficacy and safety of amrubicin monotherapy after atezolizumab plus carboplatin and etoposide in patients with relapsed small-cell lung cancer.

Imai H, Nagai Y, Minemura H, Tsuda T, Yamada Y, Wasamoto S, Kishikawa T, Shiono A, Shiihara J, Yamaguchi O, Mouri A, Kaira K, Kanazawa K, Taniguchi H, Minato K, Kagamu H

Investigational new drugs   40 ( 5 )   1066 - 1079   2022年10月（ ISSN:0167-6997 ）

Post-progression survival after atezolizumab plus carboplatin and etoposide as first-line chemotherapy in small cell lung cancer has a significant impact on overall survival.

Masubuchi K, Imai H, Wasamoto S, Tsuda T, Minemura H, Nagai Y, Yamada Y, Kishikawa T, Umeda Y, Shiono A, Takechi H, Shiihara J, Kaira K, Kanazawa K, Taniguchi H, Kaburagi T, Kagamu H, Minato K

Thoracic cancer   13 ( 19 )   2776 - 2785   2022年10月（ ISSN:1759-7706 ）

Efficacy and safety of amrubicin monotherapy after atezolizumab plus carboplatin and etoposide in patients with relapsed small-cell lung cancer.

Imai H, Nagai Y, Minemura H, Tsuda T, Yamada Y, Wasamoto S, Kishikawa T, Shiono A, Shiihara J, Yamaguchi O, Mouri A, Kaira K, Kanazawa K, Taniguchi H, Minato K, Kagamu H

Investigational new drugs   40 ( 5 )   1066 - 1079   2022年10月（ ISSN:0167-6997 ）

Post-progression survival after atezolizumab plus carboplatin and etoposide as first-line chemotherapy in small cell lung cancer has a significant impact on overall survival.

Masubuchi K, Imai H, Wasamoto S, Tsuda T, Minemura H, Nagai Y, Yamada Y, Kishikawa T, Umeda Y, Shiono A, Takechi H, Shiihara J, Kaira K, Kanazawa K, Taniguchi H, Kaburagi T, Kagamu H, Minato K

Thoracic cancer   13 ( 19 )   2776 - 2785   2022年10月（ ISSN:1759-7706 ）

Efficacy and safety of amrubicin monotherapy after atezolizumab plus carboplatin and etoposide in patients with relapsed small-cell lung cancer.

Imai H, Nagai Y, Minemura H, Tsuda T, Yamada Y, Wasamoto S, Kishikawa T, Shiono A, Shiihara J, Yamaguchi O, Mouri A, Kaira K, Kanazawa K, Taniguchi H, Minato K, Kagamu H

Investigational new drugs   40 ( 5 )   1066 - 1079   2022年10月（ ISSN:0167-6997 ）

Post-progression survival after atezolizumab plus carboplatin and etoposide as first-line chemotherapy in small cell lung cancer has a significant impact on overall survival.

Masubuchi K, Imai H, Wasamoto S, Tsuda T, Minemura H, Nagai Y, Yamada Y, Kishikawa T, Umeda Y, Shiono A, Takechi H, Shiihara J, Kaira K, Kanazawa K, Taniguchi H, Kaburagi T, Kagamu H, Minato K

Thoracic cancer   13 ( 19 )   2776 - 2785   2022年10月（ ISSN:1759-7706 ）

Efficacy and safety of amrubicin monotherapy after atezolizumab plus carboplatin and etoposide in patients with relapsed small-cell lung cancer.

Imai H, Nagai Y, Minemura H, Tsuda T, Yamada Y, Wasamoto S, Kishikawa T, Shiono A, Shiihara J, Yamaguchi O, Mouri A, Kaira K, Kanazawa K, Taniguchi H, Minato K, Kagamu H

Investigational new drugs   40 ( 5 )   1066 - 1079   2022年10月（ ISSN:0167-6997 ）

Post-progression survival after atezolizumab plus carboplatin and etoposide as first-line chemotherapy in small cell lung cancer has a significant impact on overall survival.

Masubuchi K, Imai H, Wasamoto S, Tsuda T, Minemura H, Nagai Y, Yamada Y, Kishikawa T, Umeda Y, Shiono A, Takechi H, Shiihara J, Kaira K, Kanazawa K, Taniguchi H, Kaburagi T, Kagamu H, Minato K

Thoracic cancer   13 ( 19 )   2776 - 2785   2022年10月（ ISSN:1759-7706 ）

Efficacy and safety of amrubicin monotherapy after atezolizumab plus carboplatin and etoposide in patients with relapsed small-cell lung cancer.

Imai H, Nagai Y, Minemura H, Tsuda T, Yamada Y, Wasamoto S, Kishikawa T, Shiono A, Shiihara J, Yamaguchi O, Mouri A, Kaira K, Kanazawa K, Taniguchi H, Minato K, Kagamu H

Investigational new drugs   40 ( 5 )   1066 - 1079   2022年10月（ ISSN:0167-6997 ）

Post-progression survival after atezolizumab plus carboplatin and etoposide as first-line chemotherapy in small cell lung cancer has a significant impact on overall survival.

Masubuchi K, Imai H, Wasamoto S, Tsuda T, Minemura H, Nagai Y, Yamada Y, Kishikawa T, Umeda Y, Shiono A, Takechi H, Shiihara J, Kaira K, Kanazawa K, Taniguchi H, Kaburagi T, Kagamu H, Minato K

Thoracic cancer   13 ( 19 )   2776 - 2785   2022年10月（ ISSN:1759-7706 ）

A normal pattern of mitral inflow predicts a better prognosis following cardiovascular events in early advanced-age patients.

Watanabe T, Iwai-Takano M, Saitoh H, Kanazawa K, Igarashi T, Fujimiya T, Ohira T

Scientific reports   12 ( 1 )   9594   2022年6月

A normal pattern of mitral inflow predicts a better prognosis following cardiovascular events in early advanced-age patients.

Watanabe T, Iwai-Takano M, Saitoh H, Kanazawa K, Igarashi T, Fujimiya T, Ohira T

Scientific reports   12 ( 1 )   9594   2022年6月

A normal pattern of mitral inflow predicts a better prognosis following cardiovascular events in early advanced-age patients.

Watanabe T, Iwai-Takano M, Saitoh H, Kanazawa K, Igarashi T, Fujimiya T, Ohira T

Scientific reports   12 ( 1 )   9594   2022年6月

A normal pattern of mitral inflow predicts a better prognosis following cardiovascular events in early advanced-age patients.

Watanabe T, Iwai-Takano M, Saitoh H, Kanazawa K, Igarashi T, Fujimiya T, Ohira T

Scientific reports   12 ( 1 )   9594   2022年6月

A normal pattern of mitral inflow predicts a better prognosis following cardiovascular events in early advanced-age patients.

Watanabe T, Iwai-Takano M, Saitoh H, Kanazawa K, Igarashi T, Fujimiya T, Ohira T

Scientific reports   12 ( 1 )   9594   2022年6月

A normal pattern of mitral inflow predicts a better prognosis following cardiovascular events in early advanced-age patients.

Watanabe T, Iwai-Takano M, Saitoh H, Kanazawa K, Igarashi T, Fujimiya T, Ohira T

Scientific reports   12 ( 1 )   9594   2022年6月

A normal pattern of mitral inflow predicts a better prognosis following cardiovascular events in early advanced-age patients.

Watanabe T, Iwai-Takano M, Saitoh H, Kanazawa K, Igarashi T, Fujimiya T, Ohira T

Scientific reports   12 ( 1 )   9594   2022年6月

A normal pattern of mitral inflow predicts a better prognosis following cardiovascular events in early advanced-age patients.

Watanabe T, Iwai-Takano M, Saitoh H, Kanazawa K, Igarashi T, Fujimiya T, Ohira T

Scientific reports   12 ( 1 )   9594   2022年6月

A normal pattern of mitral inflow predicts a better prognosis following cardiovascular events in early advanced-age patients.

Watanabe T, Iwai-Takano M, Saitoh H, Kanazawa K, Igarashi T, Fujimiya T, Ohira T

Scientific reports   12 ( 1 )   9594   2022年6月

A normal pattern of mitral inflow predicts a better prognosis following cardiovascular events in early advanced-age patients.

Watanabe T, Iwai-Takano M, Saitoh H, Kanazawa K, Igarashi T, Fujimiya T, Ohira T

Scientific reports   12 ( 1 )   9594   2022年6月

A normal pattern of mitral inflow predicts a better prognosis following cardiovascular events in early advanced-age patients.

Watanabe T, Iwai-Takano M, Saitoh H, Kanazawa K, Igarashi T, Fujimiya T, Ohira T

Scientific reports   12 ( 1 )   9594   2022年6月

A normal pattern of mitral inflow predicts a better prognosis following cardiovascular events in early advanced-age patients.

Watanabe T, Iwai-Takano M, Saitoh H, Kanazawa K, Igarashi T, Fujimiya T, Ohira T

Scientific reports   12 ( 1 )   9594   2022年6月

A normal pattern of mitral inflow predicts a better prognosis following cardiovascular events in early advanced-age patients.

Watanabe T, Iwai-Takano M, Saitoh H, Kanazawa K, Igarashi T, Fujimiya T, Ohira T

Scientific reports   12 ( 1 )   9594   2022年6月

A normal pattern of mitral inflow predicts a better prognosis following cardiovascular events in early advanced-age patients.

Watanabe T, Iwai-Takano M, Saitoh H, Kanazawa K, Igarashi T, Fujimiya T, Ohira T

Scientific reports   12 ( 1 )   9594   2022年6月

A normal pattern of mitral inflow predicts a better prognosis following cardiovascular events in early advanced-age patients.

Watanabe T, Iwai-Takano M, Saitoh H, Kanazawa K, Igarashi T, Fujimiya T, Ohira T

Scientific reports   12 ( 1 )   9594   2022年6月

A normal pattern of mitral inflow predicts a better prognosis following cardiovascular events in early advanced-age patients.

Watanabe T, Iwai-Takano M, Saitoh H, Kanazawa K, Igarashi T, Fujimiya T, Ohira T

Scientific reports   12 ( 1 )   9594   2022年6月

A normal pattern of mitral inflow predicts a better prognosis following cardiovascular events in early advanced-age patients.

Watanabe T, Iwai-Takano M, Saitoh H, Kanazawa K, Igarashi T, Fujimiya T, Ohira T

Scientific reports   12 ( 1 )   9594   2022年6月

A normal pattern of mitral inflow predicts a better prognosis following cardiovascular events in early advanced-age patients.

Watanabe T, Iwai-Takano M, Saitoh H, Kanazawa K, Igarashi T, Fujimiya T, Ohira T

Scientific reports   12 ( 1 )   9594   2022年6月

A normal pattern of mitral inflow predicts a better prognosis following cardiovascular events in early advanced-age patients.

Watanabe T, Iwai-Takano M, Saitoh H, Kanazawa K, Igarashi T, Fujimiya T, Ohira T

Scientific reports   12 ( 1 )   9594   2022年6月

A normal pattern of mitral inflow predicts a better prognosis following cardiovascular events in early advanced-age patients.

Watanabe T, Iwai-Takano M, Saitoh H, Kanazawa K, Igarashi T, Fujimiya T, Ohira T

Scientific reports   12 ( 1 )   9594   2022年6月

Development of dermatomyositis after anti-transcriptional intermediary factor 1-γ antibody seroconversion during treatment for small cell lung cancer.

Sato Y, Tanino Y, Nikaido T, Togawa R, Kawamata T, Watanabe N, Sato R, Yamada R, Onuma T, Tomita H, Saito M, Rikimaru M, Morimoto J, Suzuki Y, Minemura H, Saito J, Kanazawa K, Yamada S, Hashimoto Y, Shibata Y

BMC pulmonary medicine   22 ( 1 )   191   2022年5月

Development of dermatomyositis after anti-transcriptional intermediary factor 1-γ antibody seroconversion during treatment for small cell lung cancer.

Sato Y, Tanino Y, Nikaido T, Togawa R, Kawamata T, Watanabe N, Sato R, Yamada R, Onuma T, Tomita H, Saito M, Rikimaru M, Morimoto J, Suzuki Y, Minemura H, Saito J, Kanazawa K, Yamada S, Hashimoto Y, Shibata Y

BMC pulmonary medicine   22 ( 1 )   191   2022年5月

Development of dermatomyositis after anti-transcriptional intermediary factor 1-γ antibody seroconversion during treatment for small cell lung cancer.

Sato Y, Tanino Y, Nikaido T, Togawa R, Kawamata T, Watanabe N, Sato R, Yamada R, Onuma T, Tomita H, Saito M, Rikimaru M, Morimoto J, Suzuki Y, Minemura H, Saito J, Kanazawa K, Yamada S, Hashimoto Y, Shibata Y

BMC pulmonary medicine   22 ( 1 )   191   2022年5月

Development of dermatomyositis after anti-transcriptional intermediary factor 1-γ antibody seroconversion during treatment for small cell lung cancer.

Sato Y, Tanino Y, Nikaido T, Togawa R, Kawamata T, Watanabe N, Sato R, Yamada R, Onuma T, Tomita H, Saito M, Rikimaru M, Morimoto J, Suzuki Y, Minemura H, Saito J, Kanazawa K, Yamada S, Hashimoto Y, Shibata Y

BMC pulmonary medicine   22 ( 1 )   191   2022年5月

Development of dermatomyositis after anti-transcriptional intermediary factor 1-γ antibody seroconversion during treatment for small cell lung cancer.

Sato Y, Tanino Y, Nikaido T, Togawa R, Kawamata T, Watanabe N, Sato R, Yamada R, Onuma T, Tomita H, Saito M, Rikimaru M, Morimoto J, Suzuki Y, Minemura H, Saito J, Kanazawa K, Yamada S, Hashimoto Y, Shibata Y

BMC pulmonary medicine   22 ( 1 )   191   2022年5月

Development of dermatomyositis after anti-transcriptional intermediary factor 1-γ antibody seroconversion during treatment for small cell lung cancer.

Sato Y, Tanino Y, Nikaido T, Togawa R, Kawamata T, Watanabe N, Sato R, Yamada R, Onuma T, Tomita H, Saito M, Rikimaru M, Morimoto J, Suzuki Y, Minemura H, Saito J, Kanazawa K, Yamada S, Hashimoto Y, Shibata Y

BMC pulmonary medicine   22 ( 1 )   191   2022年5月

Development of dermatomyositis after anti-transcriptional intermediary factor 1-γ antibody seroconversion during treatment for small cell lung cancer.

Sato Y, Tanino Y, Nikaido T, Togawa R, Kawamata T, Watanabe N, Sato R, Yamada R, Onuma T, Tomita H, Saito M, Rikimaru M, Morimoto J, Suzuki Y, Minemura H, Saito J, Kanazawa K, Yamada S, Hashimoto Y, Shibata Y

BMC pulmonary medicine   22 ( 1 )   191   2022年5月

Development of dermatomyositis after anti-transcriptional intermediary factor 1-γ antibody seroconversion during treatment for small cell lung cancer.

Sato Y, Tanino Y, Nikaido T, Togawa R, Kawamata T, Watanabe N, Sato R, Yamada R, Onuma T, Tomita H, Saito M, Rikimaru M, Morimoto J, Suzuki Y, Minemura H, Saito J, Kanazawa K, Yamada S, Hashimoto Y, Shibata Y

BMC pulmonary medicine   22 ( 1 )   191   2022年5月

Development of dermatomyositis after anti-transcriptional intermediary factor 1-γ antibody seroconversion during treatment for small cell lung cancer.

Sato Y, Tanino Y, Nikaido T, Togawa R, Kawamata T, Watanabe N, Sato R, Yamada R, Onuma T, Tomita H, Saito M, Rikimaru M, Morimoto J, Suzuki Y, Minemura H, Saito J, Kanazawa K, Yamada S, Hashimoto Y, Shibata Y

BMC pulmonary medicine   22 ( 1 )   191   2022年5月

Development of dermatomyositis after anti-transcriptional intermediary factor 1-γ antibody seroconversion during treatment for small cell lung cancer.

Sato Y, Tanino Y, Nikaido T, Togawa R, Kawamata T, Watanabe N, Sato R, Yamada R, Onuma T, Tomita H, Saito M, Rikimaru M, Morimoto J, Suzuki Y, Minemura H, Saito J, Kanazawa K, Yamada S, Hashimoto Y, Shibata Y

BMC pulmonary medicine   22 ( 1 )   191   2022年5月

Development of dermatomyositis after anti-transcriptional intermediary factor 1-γ antibody seroconversion during treatment for small cell lung cancer.

Sato Y, Tanino Y, Nikaido T, Togawa R, Kawamata T, Watanabe N, Sato R, Yamada R, Onuma T, Tomita H, Saito M, Rikimaru M, Morimoto J, Suzuki Y, Minemura H, Saito J, Kanazawa K, Yamada S, Hashimoto Y, Shibata Y

BMC pulmonary medicine   22 ( 1 )   191   2022年5月

Development of dermatomyositis after anti-transcriptional intermediary factor 1-γ antibody seroconversion during treatment for small cell lung cancer.

Sato Y, Tanino Y, Nikaido T, Togawa R, Kawamata T, Watanabe N, Sato R, Yamada R, Onuma T, Tomita H, Saito M, Rikimaru M, Morimoto J, Suzuki Y, Minemura H, Saito J, Kanazawa K, Yamada S, Hashimoto Y, Shibata Y

BMC pulmonary medicine   22 ( 1 )   191   2022年5月

Development of dermatomyositis after anti-transcriptional intermediary factor 1-γ antibody seroconversion during treatment for small cell lung cancer.

Sato Y, Tanino Y, Nikaido T, Togawa R, Kawamata T, Watanabe N, Sato R, Yamada R, Onuma T, Tomita H, Saito M, Rikimaru M, Morimoto J, Suzuki Y, Minemura H, Saito J, Kanazawa K, Yamada S, Hashimoto Y, Shibata Y

BMC pulmonary medicine   22 ( 1 )   191   2022年5月

Development of dermatomyositis after anti-transcriptional intermediary factor 1-γ antibody seroconversion during treatment for small cell lung cancer.

Sato Y, Tanino Y, Nikaido T, Togawa R, Kawamata T, Watanabe N, Sato R, Yamada R, Onuma T, Tomita H, Saito M, Rikimaru M, Morimoto J, Suzuki Y, Minemura H, Saito J, Kanazawa K, Yamada S, Hashimoto Y, Shibata Y

BMC pulmonary medicine   22 ( 1 )   191   2022年5月

Development of dermatomyositis after anti-transcriptional intermediary factor 1-γ antibody seroconversion during treatment for small cell lung cancer.

Sato Y, Tanino Y, Nikaido T, Togawa R, Kawamata T, Watanabe N, Sato R, Yamada R, Onuma T, Tomita H, Saito M, Rikimaru M, Morimoto J, Suzuki Y, Minemura H, Saito J, Kanazawa K, Yamada S, Hashimoto Y, Shibata Y

BMC pulmonary medicine   22 ( 1 )   191   2022年5月

Development of dermatomyositis after anti-transcriptional intermediary factor 1-γ antibody seroconversion during treatment for small cell lung cancer.

Sato Y, Tanino Y, Nikaido T, Togawa R, Kawamata T, Watanabe N, Sato R, Yamada R, Onuma T, Tomita H, Saito M, Rikimaru M, Morimoto J, Suzuki Y, Minemura H, Saito J, Kanazawa K, Yamada S, Hashimoto Y, Shibata Y

BMC pulmonary medicine   22 ( 1 )   191   2022年5月

Development of dermatomyositis after anti-transcriptional intermediary factor 1-γ antibody seroconversion during treatment for small cell lung cancer.

Sato Y, Tanino Y, Nikaido T, Togawa R, Kawamata T, Watanabe N, Sato R, Yamada R, Onuma T, Tomita H, Saito M, Rikimaru M, Morimoto J, Suzuki Y, Minemura H, Saito J, Kanazawa K, Yamada S, Hashimoto Y, Shibata Y

BMC pulmonary medicine   22 ( 1 )   191   2022年5月

Development of dermatomyositis after anti-transcriptional intermediary factor 1-γ antibody seroconversion during treatment for small cell lung cancer.

Sato Y, Tanino Y, Nikaido T, Togawa R, Kawamata T, Watanabe N, Sato R, Yamada R, Onuma T, Tomita H, Saito M, Rikimaru M, Morimoto J, Suzuki Y, Minemura H, Saito J, Kanazawa K, Yamada S, Hashimoto Y, Shibata Y

BMC pulmonary medicine   22 ( 1 )   191   2022年5月

Development of dermatomyositis after anti-transcriptional intermediary factor 1-γ antibody seroconversion during treatment for small cell lung cancer.

Sato Y, Tanino Y, Nikaido T, Togawa R, Kawamata T, Watanabe N, Sato R, Yamada R, Onuma T, Tomita H, Saito M, Rikimaru M, Morimoto J, Suzuki Y, Minemura H, Saito J, Kanazawa K, Yamada S, Hashimoto Y, Shibata Y

BMC pulmonary medicine   22 ( 1 )   191   2022年5月

Development of dermatomyositis after anti-transcriptional intermediary factor 1-γ antibody seroconversion during treatment for small cell lung cancer.

Sato Y, Tanino Y, Nikaido T, Togawa R, Kawamata T, Watanabe N, Sato R, Yamada R, Onuma T, Tomita H, Saito M, Rikimaru M, Morimoto J, Suzuki Y, Minemura H, Saito J, Kanazawa K, Yamada S, Hashimoto Y, Shibata Y

BMC pulmonary medicine   22 ( 1 )   191   2022年5月

Real-world clinical outcomes of treatment with casirivimab-imdevimab among patients with mild-to-moderate coronavirus disease 2019 during the Delta variant pandemic.

Suzuki Y, Shibata Y, Minemura H, Nikaido T, Tanino Y, Fukuhara A, Kanno R, Saito H, Suzuki S, Ishii T, Inokoshi Y, Sando E, Sakuma H, Kobayashi T, Kume H, Kamimoto M, Aoki H, Takama A, Kamiyama T, Nakayama M, Saito K, Tanigawa K, Sato M, Kanbe T, Kanzaki N, Azuma T, Sakamoto K, Nakamura Y, Ohtani H, Waragai M, Maeda S, Ishida T, Sugino K, Tsukada Y, Yamada R, Sato R, Onuma T, Tomita H, Saito M, Watanabe N, Rikimaru M, Kawamata T, Umeda T, Morimoto J, Togawa R, Sato Y, Saito J, Kanazawa K, Iseki K

International journal of medical sciences   19 ( 5 )   834 - 841   2022年（ ISSN:14491907 ）

Pretreatment glasgow prognostic score predicts survival among patients administered first-line atezolizumab plus carboplatin and etoposide for small cell lung cancer.

Wasamoto S, Imai H, Tsuda T, Nagai Y, Minemura H, Yamada Y, Umeda Y, Kishikawa T, Shiono A, Kozu Y, Shiihara J, Yamaguchi O, Mouri A, Kaira K, Kanazawa K, Taniguchi H, Kaburagi T, Minato K, Kagamu H

Frontiers in oncology   12   1080729   2022年（ ISSN:2234-943X ）

Clinical Outcomes of Postoperative Adjuvant Chemotherapy for Surgically Resected High-Grade Pulmonary Neuroendocrine Carcinoma.

Kotake M, Imai H, Kaira K, Endoh H, Yamada Y, Kaburagi T, Kiyoshima M, Sugiyama T, Nakamura Y, Kasai T, Matsuguma H, Minemura H, Kanazawa K, Suzuki H, Fujita A, Minato K

Chemotherapy   67 ( 3 )   142 - 151   2022年（ ISSN:0009-3157 ）

Pretreatment glasgow prognostic score predicts survival among patients administered first-line atezolizumab plus carboplatin and etoposide for small cell lung cancer.

Wasamoto S, Imai H, Tsuda T, Nagai Y, Minemura H, Yamada Y, Umeda Y, Kishikawa T, Shiono A, Kozu Y, Shiihara J, Yamaguchi O, Mouri A, Kaira K, Kanazawa K, Taniguchi H, Kaburagi T, Minato K, Kagamu H

Frontiers in oncology   12   1080729   2022年（ ISSN:2234-943X ）

Clinical Outcomes of Postoperative Adjuvant Chemotherapy for Surgically Resected High-Grade Pulmonary Neuroendocrine Carcinoma.

Kotake M, Imai H, Kaira K, Endoh H, Yamada Y, Kaburagi T, Kiyoshima M, Sugiyama T, Nakamura Y, Kasai T, Matsuguma H, Minemura H, Kanazawa K, Suzuki H, Fujita A, Minato K

Chemotherapy   67 ( 3 )   142 - 151   2022年（ ISSN:0009-3157 ）

Pretreatment glasgow prognostic score predicts survival among patients administered first-line atezolizumab plus carboplatin and etoposide for small cell lung cancer.

Wasamoto S, Imai H, Tsuda T, Nagai Y, Minemura H, Yamada Y, Umeda Y, Kishikawa T, Shiono A, Kozu Y, Shiihara J, Yamaguchi O, Mouri A, Kaira K, Kanazawa K, Taniguchi H, Kaburagi T, Minato K, Kagamu H

Frontiers in oncology   12   1080729   2022年（ ISSN:2234-943X ）

Clinical Outcomes of Postoperative Adjuvant Chemotherapy for Surgically Resected High-Grade Pulmonary Neuroendocrine Carcinoma.

Kotake M, Imai H, Kaira K, Endoh H, Yamada Y, Kaburagi T, Kiyoshima M, Sugiyama T, Nakamura Y, Kasai T, Matsuguma H, Minemura H, Kanazawa K, Suzuki H, Fujita A, Minato K

Chemotherapy   67 ( 3 )   142 - 151   2022年（ ISSN:0009-3157 ）

Pretreatment glasgow prognostic score predicts survival among patients administered first-line atezolizumab plus carboplatin and etoposide for small cell lung cancer.

Wasamoto S, Imai H, Tsuda T, Nagai Y, Minemura H, Yamada Y, Umeda Y, Kishikawa T, Shiono A, Kozu Y, Shiihara J, Yamaguchi O, Mouri A, Kaira K, Kanazawa K, Taniguchi H, Kaburagi T, Minato K, Kagamu H

Frontiers in oncology   12   1080729   2022年（ ISSN:2234-943X ）

Clinical Outcomes of Postoperative Adjuvant Chemotherapy for Surgically Resected High-Grade Pulmonary Neuroendocrine Carcinoma.

Kotake M, Imai H, Kaira K, Endoh H, Yamada Y, Kaburagi T, Kiyoshima M, Sugiyama T, Nakamura Y, Kasai T, Matsuguma H, Minemura H, Kanazawa K, Suzuki H, Fujita A, Minato K

Chemotherapy   67 ( 3 )   142 - 151   2022年（ ISSN:0009-3157 ）

Clinical Outcomes of Postoperative Adjuvant Chemotherapy for Surgically Resected High-Grade Pulmonary Neuroendocrine Carcinoma.

Kotake M, Imai H, Kaira K, Endoh H, Yamada Y, Kaburagi T, Kiyoshima M, Sugiyama T, Nakamura Y, Kasai T, Matsuguma H, Minemura H, Kanazawa K, Suzuki H, Fujita A, Minato K

Chemotherapy   67 ( 3 )   142 - 151   2022年（ ISSN:0009-3157 ）

Pretreatment glasgow prognostic score predicts survival among patients administered first-line atezolizumab plus carboplatin and etoposide for small cell lung cancer.

Wasamoto S, Imai H, Tsuda T, Nagai Y, Minemura H, Yamada Y, Umeda Y, Kishikawa T, Shiono A, Kozu Y, Shiihara J, Yamaguchi O, Mouri A, Kaira K, Kanazawa K, Taniguchi H, Kaburagi T, Minato K, Kagamu H

Frontiers in oncology   12   1080729   2022年（ ISSN:2234-943X ）

Clinical Outcomes of Postoperative Adjuvant Chemotherapy for Surgically Resected High-Grade Pulmonary Neuroendocrine Carcinoma.

Kotake M, Imai H, Kaira K, Endoh H, Yamada Y, Kaburagi T, Kiyoshima M, Sugiyama T, Nakamura Y, Kasai T, Matsuguma H, Minemura H, Kanazawa K, Suzuki H, Fujita A, Minato K

Chemotherapy   67 ( 3 )   142 - 151   2022年（ ISSN:0009-3157 ）

Pretreatment glasgow prognostic score predicts survival among patients administered first-line atezolizumab plus carboplatin and etoposide for small cell lung cancer.

Wasamoto S, Imai H, Tsuda T, Nagai Y, Minemura H, Yamada Y, Umeda Y, Kishikawa T, Shiono A, Kozu Y, Shiihara J, Yamaguchi O, Mouri A, Kaira K, Kanazawa K, Taniguchi H, Kaburagi T, Minato K, Kagamu H

Frontiers in oncology   12   1080729   2022年（ ISSN:2234-943X ）

Clinical Outcomes of Postoperative Adjuvant Chemotherapy for Surgically Resected High-Grade Pulmonary Neuroendocrine Carcinoma.

Kotake M, Imai H, Kaira K, Endoh H, Yamada Y, Kaburagi T, Kiyoshima M, Sugiyama T, Nakamura Y, Kasai T, Matsuguma H, Minemura H, Kanazawa K, Suzuki H, Fujita A, Minato K

Chemotherapy   67 ( 3 )   142 - 151   2022年（ ISSN:0009-3157 ）

Pretreatment glasgow prognostic score predicts survival among patients administered first-line atezolizumab plus carboplatin and etoposide for small cell lung cancer.

Wasamoto S, Imai H, Tsuda T, Nagai Y, Minemura H, Yamada Y, Umeda Y, Kishikawa T, Shiono A, Kozu Y, Shiihara J, Yamaguchi O, Mouri A, Kaira K, Kanazawa K, Taniguchi H, Kaburagi T, Minato K, Kagamu H

Frontiers in oncology   12   1080729   2022年（ ISSN:2234-943X ）

Clinical Outcomes of Postoperative Adjuvant Chemotherapy for Surgically Resected High-Grade Pulmonary Neuroendocrine Carcinoma.

Kotake M, Imai H, Kaira K, Endoh H, Yamada Y, Kaburagi T, Kiyoshima M, Sugiyama T, Nakamura Y, Kasai T, Matsuguma H, Minemura H, Kanazawa K, Suzuki H, Fujita A, Minato K

Chemotherapy   67 ( 3 )   142 - 151   2022年（ ISSN:0009-3157 ）

Pretreatment glasgow prognostic score predicts survival among patients administered first-line atezolizumab plus carboplatin and etoposide for small cell lung cancer.

Wasamoto S, Imai H, Tsuda T, Nagai Y, Minemura H, Yamada Y, Umeda Y, Kishikawa T, Shiono A, Kozu Y, Shiihara J, Yamaguchi O, Mouri A, Kaira K, Kanazawa K, Taniguchi H, Kaburagi T, Minato K, Kagamu H

Frontiers in oncology   12   1080729   2022年（ ISSN:2234-943X ）

Clinical Outcomes of Postoperative Adjuvant Chemotherapy for Surgically Resected High-Grade Pulmonary Neuroendocrine Carcinoma.

Kotake M, Imai H, Kaira K, Endoh H, Yamada Y, Kaburagi T, Kiyoshima M, Sugiyama T, Nakamura Y, Kasai T, Matsuguma H, Minemura H, Kanazawa K, Suzuki H, Fujita A, Minato K

Chemotherapy   67 ( 3 )   142 - 151   2022年（ ISSN:0009-3157 ）

Pretreatment glasgow prognostic score predicts survival among patients administered first-line atezolizumab plus carboplatin and etoposide for small cell lung cancer.

Wasamoto S, Imai H, Tsuda T, Nagai Y, Minemura H, Yamada Y, Umeda Y, Kishikawa T, Shiono A, Kozu Y, Shiihara J, Yamaguchi O, Mouri A, Kaira K, Kanazawa K, Taniguchi H, Kaburagi T, Minato K, Kagamu H

Frontiers in oncology   12   1080729   2022年（ ISSN:2234-943X ）

Clinical Outcomes of Postoperative Adjuvant Chemotherapy for Surgically Resected High-Grade Pulmonary Neuroendocrine Carcinoma.

Kotake M, Imai H, Kaira K, Endoh H, Yamada Y, Kaburagi T, Kiyoshima M, Sugiyama T, Nakamura Y, Kasai T, Matsuguma H, Minemura H, Kanazawa K, Suzuki H, Fujita A, Minato K

Chemotherapy   67 ( 3 )   142 - 151   2022年（ ISSN:0009-3157 ）

Pretreatment glasgow prognostic score predicts survival among patients administered first-line atezolizumab plus carboplatin and etoposide for small cell lung cancer.

Wasamoto S, Imai H, Tsuda T, Nagai Y, Minemura H, Yamada Y, Umeda Y, Kishikawa T, Shiono A, Kozu Y, Shiihara J, Yamaguchi O, Mouri A, Kaira K, Kanazawa K, Taniguchi H, Kaburagi T, Minato K, Kagamu H

Frontiers in oncology   12   1080729   2022年（ ISSN:2234-943X ）

Clinical Outcomes of Postoperative Adjuvant Chemotherapy for Surgically Resected High-Grade Pulmonary Neuroendocrine Carcinoma.

Kotake M, Imai H, Kaira K, Endoh H, Yamada Y, Kaburagi T, Kiyoshima M, Sugiyama T, Nakamura Y, Kasai T, Matsuguma H, Minemura H, Kanazawa K, Suzuki H, Fujita A, Minato K

Chemotherapy   67 ( 3 )   142 - 151   2022年（ ISSN:0009-3157 ）

Pretreatment glasgow prognostic score predicts survival among patients administered first-line atezolizumab plus carboplatin and etoposide for small cell lung cancer.

Wasamoto S, Imai H, Tsuda T, Nagai Y, Minemura H, Yamada Y, Umeda Y, Kishikawa T, Shiono A, Kozu Y, Shiihara J, Yamaguchi O, Mouri A, Kaira K, Kanazawa K, Taniguchi H, Kaburagi T, Minato K, Kagamu H

Frontiers in oncology   12   1080729   2022年（ ISSN:2234-943X ）

Clinical Outcomes of Postoperative Adjuvant Chemotherapy for Surgically Resected High-Grade Pulmonary Neuroendocrine Carcinoma.

Kotake M, Imai H, Kaira K, Endoh H, Yamada Y, Kaburagi T, Kiyoshima M, Sugiyama T, Nakamura Y, Kasai T, Matsuguma H, Minemura H, Kanazawa K, Suzuki H, Fujita A, Minato K

Chemotherapy   67 ( 3 )   142 - 151   2022年（ ISSN:0009-3157 ）

Pretreatment glasgow prognostic score predicts survival among patients administered first-line atezolizumab plus carboplatin and etoposide for small cell lung cancer.

Wasamoto S, Imai H, Tsuda T, Nagai Y, Minemura H, Yamada Y, Umeda Y, Kishikawa T, Shiono A, Kozu Y, Shiihara J, Yamaguchi O, Mouri A, Kaira K, Kanazawa K, Taniguchi H, Kaburagi T, Minato K, Kagamu H

Frontiers in oncology   12   1080729   2022年（ ISSN:2234-943X ）

Clinical Outcomes of Postoperative Adjuvant Chemotherapy for Surgically Resected High-Grade Pulmonary Neuroendocrine Carcinoma.

Kotake M, Imai H, Kaira K, Endoh H, Yamada Y, Kaburagi T, Kiyoshima M, Sugiyama T, Nakamura Y, Kasai T, Matsuguma H, Minemura H, Kanazawa K, Suzuki H, Fujita A, Minato K

Chemotherapy   67 ( 3 )   142 - 151   2022年（ ISSN:0009-3157 ）

Pretreatment glasgow prognostic score predicts survival among patients administered first-line atezolizumab plus carboplatin and etoposide for small cell lung cancer.

Wasamoto S, Imai H, Tsuda T, Nagai Y, Minemura H, Yamada Y, Umeda Y, Kishikawa T, Shiono A, Kozu Y, Shiihara J, Yamaguchi O, Mouri A, Kaira K, Kanazawa K, Taniguchi H, Kaburagi T, Minato K, Kagamu H

Frontiers in oncology   12   1080729   2022年（ ISSN:2234-943X ）

Clinical Outcomes of Postoperative Adjuvant Chemotherapy for Surgically Resected High-Grade Pulmonary Neuroendocrine Carcinoma.

Kotake M, Imai H, Kaira K, Endoh H, Yamada Y, Kaburagi T, Kiyoshima M, Sugiyama T, Nakamura Y, Kasai T, Matsuguma H, Minemura H, Kanazawa K, Suzuki H, Fujita A, Minato K

Chemotherapy   67 ( 3 )   142 - 151   2022年（ ISSN:0009-3157 ）

Pretreatment glasgow prognostic score predicts survival among patients administered first-line atezolizumab plus carboplatin and etoposide for small cell lung cancer.

Wasamoto S, Imai H, Tsuda T, Nagai Y, Minemura H, Yamada Y, Umeda Y, Kishikawa T, Shiono A, Kozu Y, Shiihara J, Yamaguchi O, Mouri A, Kaira K, Kanazawa K, Taniguchi H, Kaburagi T, Minato K, Kagamu H

Frontiers in oncology   12   1080729   2022年（ ISSN:2234-943X ）

Clinical Outcomes of Postoperative Adjuvant Chemotherapy for Surgically Resected High-Grade Pulmonary Neuroendocrine Carcinoma.

Kotake M, Imai H, Kaira K, Endoh H, Yamada Y, Kaburagi T, Kiyoshima M, Sugiyama T, Nakamura Y, Kasai T, Matsuguma H, Minemura H, Kanazawa K, Suzuki H, Fujita A, Minato K

Chemotherapy   67 ( 3 )   142 - 151   2022年（ ISSN:0009-3157 ）

Pretreatment glasgow prognostic score predicts survival among patients administered first-line atezolizumab plus carboplatin and etoposide for small cell lung cancer.

Wasamoto S, Imai H, Tsuda T, Nagai Y, Minemura H, Yamada Y, Umeda Y, Kishikawa T, Shiono A, Kozu Y, Shiihara J, Yamaguchi O, Mouri A, Kaira K, Kanazawa K, Taniguchi H, Kaburagi T, Minato K, Kagamu H

Frontiers in oncology   12   1080729   2022年（ ISSN:2234-943X ）

Clinical Outcomes of Postoperative Adjuvant Chemotherapy for Surgically Resected High-Grade Pulmonary Neuroendocrine Carcinoma.

Kotake M, Imai H, Kaira K, Endoh H, Yamada Y, Kaburagi T, Kiyoshima M, Sugiyama T, Nakamura Y, Kasai T, Matsuguma H, Minemura H, Kanazawa K, Suzuki H, Fujita A, Minato K

Chemotherapy   67 ( 3 )   142 - 151   2022年（ ISSN:0009-3157 ）

Pretreatment glasgow prognostic score predicts survival among patients administered first-line atezolizumab plus carboplatin and etoposide for small cell lung cancer.

Wasamoto S, Imai H, Tsuda T, Nagai Y, Minemura H, Yamada Y, Umeda Y, Kishikawa T, Shiono A, Kozu Y, Shiihara J, Yamaguchi O, Mouri A, Kaira K, Kanazawa K, Taniguchi H, Kaburagi T, Minato K, Kagamu H

Frontiers in oncology   12   1080729   2022年（ ISSN:2234-943X ）

Clinical Outcomes of Postoperative Adjuvant Chemotherapy for Surgically Resected High-Grade Pulmonary Neuroendocrine Carcinoma.

Kotake M, Imai H, Kaira K, Endoh H, Yamada Y, Kaburagi T, Kiyoshima M, Sugiyama T, Nakamura Y, Kasai T, Matsuguma H, Minemura H, Kanazawa K, Suzuki H, Fujita A, Minato K

Chemotherapy   67 ( 3 )   142 - 151   2022年（ ISSN:0009-3157 ）

Pretreatment glasgow prognostic score predicts survival among patients administered first-line atezolizumab plus carboplatin and etoposide for small cell lung cancer.

Wasamoto S, Imai H, Tsuda T, Nagai Y, Minemura H, Yamada Y, Umeda Y, Kishikawa T, Shiono A, Kozu Y, Shiihara J, Yamaguchi O, Mouri A, Kaira K, Kanazawa K, Taniguchi H, Kaburagi T, Minato K, Kagamu H

Frontiers in oncology   12   1080729   2022年（ ISSN:2234-943X ）

Clinical Outcomes of Postoperative Adjuvant Chemotherapy for Surgically Resected High-Grade Pulmonary Neuroendocrine Carcinoma.

Kotake M, Imai H, Kaira K, Endoh H, Yamada Y, Kaburagi T, Kiyoshima M, Sugiyama T, Nakamura Y, Kasai T, Matsuguma H, Minemura H, Kanazawa K, Suzuki H, Fujita A, Minato K

Chemotherapy   67 ( 3 )   142 - 151   2022年（ ISSN:0009-3157 ）

Pretreatment glasgow prognostic score predicts survival among patients administered first-line atezolizumab plus carboplatin and etoposide for small cell lung cancer.

Wasamoto S, Imai H, Tsuda T, Nagai Y, Minemura H, Yamada Y, Umeda Y, Kishikawa T, Shiono A, Kozu Y, Shiihara J, Yamaguchi O, Mouri A, Kaira K, Kanazawa K, Taniguchi H, Kaburagi T, Minato K, Kagamu H

Frontiers in oncology   12   1080729   2022年（ ISSN:2234-943X ）

Clinical Outcomes of Postoperative Adjuvant Chemotherapy for Surgically Resected High-Grade Pulmonary Neuroendocrine Carcinoma.

Kotake M, Imai H, Kaira K, Endoh H, Yamada Y, Kaburagi T, Kiyoshima M, Sugiyama T, Nakamura Y, Kasai T, Matsuguma H, Minemura H, Kanazawa K, Suzuki H, Fujita A, Minato K

Chemotherapy   67 ( 3 )   142 - 151   2022年（ ISSN:0009-3157 ）

Pretreatment glasgow prognostic score predicts survival among patients administered first-line atezolizumab plus carboplatin and etoposide for small cell lung cancer.

Wasamoto S, Imai H, Tsuda T, Nagai Y, Minemura H, Yamada Y, Umeda Y, Kishikawa T, Shiono A, Kozu Y, Shiihara J, Yamaguchi O, Mouri A, Kaira K, Kanazawa K, Taniguchi H, Kaburagi T, Minato K, Kagamu H

Frontiers in oncology   12   1080729   2022年（ ISSN:2234-943X ）

Clinical Outcomes of Postoperative Adjuvant Chemotherapy for Surgically Resected High-Grade Pulmonary Neuroendocrine Carcinoma.

Kotake M, Imai H, Kaira K, Endoh H, Yamada Y, Kaburagi T, Kiyoshima M, Sugiyama T, Nakamura Y, Kasai T, Matsuguma H, Minemura H, Kanazawa K, Suzuki H, Fujita A, Minato K

Chemotherapy   67 ( 3 )   142 - 151   2022年（ ISSN:0009-3157 ）

Pretreatment glasgow prognostic score predicts survival among patients administered first-line atezolizumab plus carboplatin and etoposide for small cell lung cancer.

Wasamoto S, Imai H, Tsuda T, Nagai Y, Minemura H, Yamada Y, Umeda Y, Kishikawa T, Shiono A, Kozu Y, Shiihara J, Yamaguchi O, Mouri A, Kaira K, Kanazawa K, Taniguchi H, Kaburagi T, Minato K, Kagamu H

Frontiers in oncology   12   1080729   2022年（ ISSN:2234-943X ）

Pretreatment Glasgow prognostic score predicts survival among patients with high PD-L1 expression administered first-line pembrolizumab monotherapy for non-small cell lung cancer.

Imai H, Kishikawa T, Minemura H, Yamada Y, Ibe T, Yamaguchi O, Mouri A, Hamamoto Y, Kanazawa K, Kasai T, Kaira K, Kaburagi T, Minato K, Kobayashi K, Kagamu H

Cancer medicine   10 ( 20 )   6971 - 6984   2021年10月

Pretreatment Glasgow prognostic score predicts survival among patients with high PD-L1 expression administered first-line pembrolizumab monotherapy for non-small cell lung cancer.

Imai H, Kishikawa T, Minemura H, Yamada Y, Ibe T, Yamaguchi O, Mouri A, Hamamoto Y, Kanazawa K, Kasai T, Kaira K, Kaburagi T, Minato K, Kobayashi K, Kagamu H

Cancer medicine   10 ( 20 )   6971 - 6984   2021年10月

Pretreatment Glasgow prognostic score predicts survival among patients with high PD-L1 expression administered first-line pembrolizumab monotherapy for non-small cell lung cancer.

Imai H, Kishikawa T, Minemura H, Yamada Y, Ibe T, Yamaguchi O, Mouri A, Hamamoto Y, Kanazawa K, Kasai T, Kaira K, Kaburagi T, Minato K, Kobayashi K, Kagamu H

Cancer medicine   10 ( 20 )   6971 - 6984   2021年10月

Pretreatment Glasgow prognostic score predicts survival among patients with high PD-L1 expression administered first-line pembrolizumab monotherapy for non-small cell lung cancer.

Imai H, Kishikawa T, Minemura H, Yamada Y, Ibe T, Yamaguchi O, Mouri A, Hamamoto Y, Kanazawa K, Kasai T, Kaira K, Kaburagi T, Minato K, Kobayashi K, Kagamu H

Cancer medicine   10 ( 20 )   6971 - 6984   2021年10月

Pretreatment Glasgow prognostic score predicts survival among patients with high PD-L1 expression administered first-line pembrolizumab monotherapy for non-small cell lung cancer.

Imai H, Kishikawa T, Minemura H, Yamada Y, Ibe T, Yamaguchi O, Mouri A, Hamamoto Y, Kanazawa K, Kasai T, Kaira K, Kaburagi T, Minato K, Kobayashi K, Kagamu H

Cancer medicine   10 ( 20 )   6971 - 6984   2021年10月

Pretreatment Glasgow prognostic score predicts survival among patients with high PD-L1 expression administered first-line pembrolizumab monotherapy for non-small cell lung cancer.

Imai H, Kishikawa T, Minemura H, Yamada Y, Ibe T, Yamaguchi O, Mouri A, Hamamoto Y, Kanazawa K, Kasai T, Kaira K, Kaburagi T, Minato K, Kobayashi K, Kagamu H

Cancer medicine   10 ( 20 )   6971 - 6984   2021年10月

Pretreatment Glasgow prognostic score predicts survival among patients with high PD-L1 expression administered first-line pembrolizumab monotherapy for non-small cell lung cancer.

Imai H, Kishikawa T, Minemura H, Yamada Y, Ibe T, Yamaguchi O, Mouri A, Hamamoto Y, Kanazawa K, Kasai T, Kaira K, Kaburagi T, Minato K, Kobayashi K, Kagamu H

Cancer medicine   10 ( 20 )   6971 - 6984   2021年10月

Pretreatment Glasgow prognostic score predicts survival among patients with high PD-L1 expression administered first-line pembrolizumab monotherapy for non-small cell lung cancer.

Imai H, Kishikawa T, Minemura H, Yamada Y, Ibe T, Yamaguchi O, Mouri A, Hamamoto Y, Kanazawa K, Kasai T, Kaira K, Kaburagi T, Minato K, Kobayashi K, Kagamu H

Cancer medicine   10 ( 20 )   6971 - 6984   2021年10月

Pretreatment Glasgow prognostic score predicts survival among patients with high PD-L1 expression administered first-line pembrolizumab monotherapy for non-small cell lung cancer.

Imai H, Kishikawa T, Minemura H, Yamada Y, Ibe T, Yamaguchi O, Mouri A, Hamamoto Y, Kanazawa K, Kasai T, Kaira K, Kaburagi T, Minato K, Kobayashi K, Kagamu H

Cancer medicine   10 ( 20 )   6971 - 6984   2021年10月

Pretreatment Glasgow prognostic score predicts survival among patients with high PD-L1 expression administered first-line pembrolizumab monotherapy for non-small cell lung cancer.

Imai H, Kishikawa T, Minemura H, Yamada Y, Ibe T, Yamaguchi O, Mouri A, Hamamoto Y, Kanazawa K, Kasai T, Kaira K, Kaburagi T, Minato K, Kobayashi K, Kagamu H

Cancer medicine   10 ( 20 )   6971 - 6984   2021年10月

Pretreatment Glasgow prognostic score predicts survival among patients with high PD-L1 expression administered first-line pembrolizumab monotherapy for non-small cell lung cancer.

Imai H, Kishikawa T, Minemura H, Yamada Y, Ibe T, Yamaguchi O, Mouri A, Hamamoto Y, Kanazawa K, Kasai T, Kaira K, Kaburagi T, Minato K, Kobayashi K, Kagamu H

Cancer medicine   10 ( 20 )   6971 - 6984   2021年10月

Pretreatment Glasgow prognostic score predicts survival among patients with high PD-L1 expression administered first-line pembrolizumab monotherapy for non-small cell lung cancer.

Imai H, Kishikawa T, Minemura H, Yamada Y, Ibe T, Yamaguchi O, Mouri A, Hamamoto Y, Kanazawa K, Kasai T, Kaira K, Kaburagi T, Minato K, Kobayashi K, Kagamu H

Cancer medicine   10 ( 20 )   6971 - 6984   2021年10月

Pretreatment Glasgow prognostic score predicts survival among patients with high PD-L1 expression administered first-line pembrolizumab monotherapy for non-small cell lung cancer.

Imai H, Kishikawa T, Minemura H, Yamada Y, Ibe T, Yamaguchi O, Mouri A, Hamamoto Y, Kanazawa K, Kasai T, Kaira K, Kaburagi T, Minato K, Kobayashi K, Kagamu H

Cancer medicine   10 ( 20 )   6971 - 6984   2021年10月

Pretreatment Glasgow prognostic score predicts survival among patients with high PD-L1 expression administered first-line pembrolizumab monotherapy for non-small cell lung cancer.

Imai H, Kishikawa T, Minemura H, Yamada Y, Ibe T, Yamaguchi O, Mouri A, Hamamoto Y, Kanazawa K, Kasai T, Kaira K, Kaburagi T, Minato K, Kobayashi K, Kagamu H

Cancer medicine   10 ( 20 )   6971 - 6984   2021年10月

Pretreatment Glasgow prognostic score predicts survival among patients with high PD-L1 expression administered first-line pembrolizumab monotherapy for non-small cell lung cancer.

Imai H, Kishikawa T, Minemura H, Yamada Y, Ibe T, Yamaguchi O, Mouri A, Hamamoto Y, Kanazawa K, Kasai T, Kaira K, Kaburagi T, Minato K, Kobayashi K, Kagamu H

Cancer medicine   10 ( 20 )   6971 - 6984   2021年10月

Pretreatment Glasgow prognostic score predicts survival among patients with high PD-L1 expression administered first-line pembrolizumab monotherapy for non-small cell lung cancer.

Imai H, Kishikawa T, Minemura H, Yamada Y, Ibe T, Yamaguchi O, Mouri A, Hamamoto Y, Kanazawa K, Kasai T, Kaira K, Kaburagi T, Minato K, Kobayashi K, Kagamu H

Cancer medicine   10 ( 20 )   6971 - 6984   2021年10月

Pretreatment Glasgow prognostic score predicts survival among patients with high PD-L1 expression administered first-line pembrolizumab monotherapy for non-small cell lung cancer.

Imai H, Kishikawa T, Minemura H, Yamada Y, Ibe T, Yamaguchi O, Mouri A, Hamamoto Y, Kanazawa K, Kasai T, Kaira K, Kaburagi T, Minato K, Kobayashi K, Kagamu H

Cancer medicine   10 ( 20 )   6971 - 6984   2021年10月

Pretreatment Glasgow prognostic score predicts survival among patients with high PD-L1 expression administered first-line pembrolizumab monotherapy for non-small cell lung cancer.

Imai H, Kishikawa T, Minemura H, Yamada Y, Ibe T, Yamaguchi O, Mouri A, Hamamoto Y, Kanazawa K, Kasai T, Kaira K, Kaburagi T, Minato K, Kobayashi K, Kagamu H

Cancer medicine   10 ( 20 )   6971 - 6984   2021年10月

Pretreatment Glasgow prognostic score predicts survival among patients with high PD-L1 expression administered first-line pembrolizumab monotherapy for non-small cell lung cancer.

Imai H, Kishikawa T, Minemura H, Yamada Y, Ibe T, Yamaguchi O, Mouri A, Hamamoto Y, Kanazawa K, Kasai T, Kaira K, Kaburagi T, Minato K, Kobayashi K, Kagamu H

Cancer medicine   10 ( 20 )   6971 - 6984   2021年10月

Pretreatment Glasgow prognostic score predicts survival among patients with high PD-L1 expression administered first-line pembrolizumab monotherapy for non-small cell lung cancer.

Imai H, Kishikawa T, Minemura H, Yamada Y, Ibe T, Yamaguchi O, Mouri A, Hamamoto Y, Kanazawa K, Kasai T, Kaira K, Kaburagi T, Minato K, Kobayashi K, Kagamu H

Cancer medicine   10 ( 20 )   6971 - 6984   2021年10月

Effectiveness and Safety of EGFR-TKI Rechallenge Treatment in Elderly Patients with Advanced Non-Small-Cell Lung Cancer Harboring Drug-Sensitive EGFR Mutations.

Yamada Y, Imai H, Sugiyama T, Minemura H, Kanazawa K, Kasai T, Minato K, Kaira K, Kaburagi T

Medicina (Kaunas, Lithuania)   57 ( 9 )   2021年9月（ ISSN:1010-660X ）

Outpatient Cardiac Rehabilitation Suppresses Deterioration of Renal Function in Patients ≥75 Years of Age With Heart Disease.

Sasamoto Y, Endo N, Kanazawa K, Utsumi T, Takahashi T, Endo Y, Nanba M, Takeda H, Takano T, Takahashi K, Tanji M, Kohzuki M

Circulation journal : official journal of the Japanese Circulation Society   85 ( 5 )   612 - 622   2021年4月（ ISSN:1346-9843 ）

Outpatient Cardiac Rehabilitation Suppresses Deterioration of Renal Function in Patients ≥75 Years of Age With Heart Disease.

Sasamoto Y, Endo N, Kanazawa K, Utsumi T, Takahashi T, Endo Y, Nanba M, Takeda H, Takano T, Takahashi K, Tanji M, Kohzuki M

Circulation journal : official journal of the Japanese Circulation Society   85 ( 5 )   612 - 622   2021年4月（ ISSN:1346-9843 ）

Outpatient Cardiac Rehabilitation Suppresses Deterioration of Renal Function in Patients ≥75 Years of Age With Heart Disease.

Sasamoto Y, Endo N, Kanazawa K, Utsumi T, Takahashi T, Endo Y, Nanba M, Takeda H, Takano T, Takahashi K, Tanji M, Kohzuki M

Circulation journal : official journal of the Japanese Circulation Society   85 ( 5 )   612 - 622   2021年4月（ ISSN:1346-9843 ）

Outpatient Cardiac Rehabilitation Suppresses Deterioration of Renal Function in Patients ≥75 Years of Age With Heart Disease.

Sasamoto Y, Endo N, Kanazawa K, Utsumi T, Takahashi T, Endo Y, Nanba M, Takeda H, Takano T, Takahashi K, Tanji M, Kohzuki M

Circulation journal : official journal of the Japanese Circulation Society   85 ( 5 )   612 - 622   2021年4月（ ISSN:1346-9843 ）

Outpatient Cardiac Rehabilitation Suppresses Deterioration of Renal Function in Patients ≥75 Years of Age With Heart Disease.

Sasamoto Y, Endo N, Kanazawa K, Utsumi T, Takahashi T, Endo Y, Nanba M, Takeda H, Takano T, Takahashi K, Tanji M, Kohzuki M

Circulation journal : official journal of the Japanese Circulation Society   85 ( 5 )   612 - 622   2021年4月（ ISSN:1346-9843 ）

Outpatient Cardiac Rehabilitation Suppresses Deterioration of Renal Function in Patients ≥75 Years of Age With Heart Disease.

Sasamoto Y, Endo N, Kanazawa K, Utsumi T, Takahashi T, Endo Y, Nanba M, Takeda H, Takano T, Takahashi K, Tanji M, Kohzuki M

Circulation journal : official journal of the Japanese Circulation Society   85 ( 5 )   612 - 622   2021年4月（ ISSN:1346-9843 ）

Outpatient Cardiac Rehabilitation Suppresses Deterioration of Renal Function in Patients ≥75 Years of Age With Heart Disease.

Sasamoto Y, Endo N, Kanazawa K, Utsumi T, Takahashi T, Endo Y, Nanba M, Takeda H, Takano T, Takahashi K, Tanji M, Kohzuki M

Circulation journal : official journal of the Japanese Circulation Society   85 ( 5 )   612 - 622   2021年4月（ ISSN:1346-9843 ）

Outpatient Cardiac Rehabilitation Suppresses Deterioration of Renal Function in Patients ≥75 Years of Age With Heart Disease.

Sasamoto Y, Endo N, Kanazawa K, Utsumi T, Takahashi T, Endo Y, Nanba M, Takeda H, Takano T, Takahashi K, Tanji M, Kohzuki M

Circulation journal : official journal of the Japanese Circulation Society   85 ( 5 )   612 - 622   2021年4月（ ISSN:1346-9843 ）

Outpatient Cardiac Rehabilitation Suppresses Deterioration of Renal Function in Patients ≥75 Years of Age With Heart Disease.

Sasamoto Y, Endo N, Kanazawa K, Utsumi T, Takahashi T, Endo Y, Nanba M, Takeda H, Takano T, Takahashi K, Tanji M, Kohzuki M

Circulation journal : official journal of the Japanese Circulation Society   85 ( 5 )   612 - 622   2021年4月（ ISSN:1346-9843 ）

Outpatient Cardiac Rehabilitation Suppresses Deterioration of Renal Function in Patients ≥75 Years of Age With Heart Disease.

Sasamoto Y, Endo N, Kanazawa K, Utsumi T, Takahashi T, Endo Y, Nanba M, Takeda H, Takano T, Takahashi K, Tanji M, Kohzuki M

Circulation journal : official journal of the Japanese Circulation Society   85 ( 5 )   612 - 622   2021年4月（ ISSN:1346-9843 ）

Outpatient Cardiac Rehabilitation Suppresses Deterioration of Renal Function in Patients ≥75 Years of Age With Heart Disease.

Sasamoto Y, Endo N, Kanazawa K, Utsumi T, Takahashi T, Endo Y, Nanba M, Takeda H, Takano T, Takahashi K, Tanji M, Kohzuki M

Circulation journal : official journal of the Japanese Circulation Society   85 ( 5 )   612 - 622   2021年4月（ ISSN:1346-9843 ）

Outpatient Cardiac Rehabilitation Suppresses Deterioration of Renal Function in Patients ≥75 Years of Age With Heart Disease.

Sasamoto Y, Endo N, Kanazawa K, Utsumi T, Takahashi T, Endo Y, Nanba M, Takeda H, Takano T, Takahashi K, Tanji M, Kohzuki M

Circulation journal : official journal of the Japanese Circulation Society   85 ( 5 )   612 - 622   2021年4月（ ISSN:1346-9843 ）

Outpatient Cardiac Rehabilitation Suppresses Deterioration of Renal Function in Patients ≥75 Years of Age With Heart Disease.

Sasamoto Y, Endo N, Kanazawa K, Utsumi T, Takahashi T, Endo Y, Nanba M, Takeda H, Takano T, Takahashi K, Tanji M, Kohzuki M

Circulation journal : official journal of the Japanese Circulation Society   85 ( 5 )   612 - 622   2021年4月（ ISSN:1346-9843 ）

Outpatient Cardiac Rehabilitation Suppresses Deterioration of Renal Function in Patients ≥75 Years of Age With Heart Disease.

Sasamoto Y, Endo N, Kanazawa K, Utsumi T, Takahashi T, Endo Y, Nanba M, Takeda H, Takano T, Takahashi K, Tanji M, Kohzuki M

Circulation journal : official journal of the Japanese Circulation Society   85 ( 5 )   612 - 622   2021年4月（ ISSN:1346-9843 ）

Outpatient Cardiac Rehabilitation Suppresses Deterioration of Renal Function in Patients ≥75 Years of Age With Heart Disease.

Sasamoto Y, Endo N, Kanazawa K, Utsumi T, Takahashi T, Endo Y, Nanba M, Takeda H, Takano T, Takahashi K, Tanji M, Kohzuki M

Circulation journal : official journal of the Japanese Circulation Society   85 ( 5 )   612 - 622   2021年4月（ ISSN:1346-9843 ）

Outpatient Cardiac Rehabilitation Suppresses Deterioration of Renal Function in Patients ≥75 Years of Age With Heart Disease.

Sasamoto Y, Endo N, Kanazawa K, Utsumi T, Takahashi T, Endo Y, Nanba M, Takeda H, Takano T, Takahashi K, Tanji M, Kohzuki M

Circulation journal : official journal of the Japanese Circulation Society   85 ( 5 )   612 - 622   2021年4月（ ISSN:1346-9843 ）

Outpatient Cardiac Rehabilitation Suppresses Deterioration of Renal Function in Patients ≥75 Years of Age With Heart Disease.

Sasamoto Y, Endo N, Kanazawa K, Utsumi T, Takahashi T, Endo Y, Nanba M, Takeda H, Takano T, Takahashi K, Tanji M, Kohzuki M

Circulation journal : official journal of the Japanese Circulation Society   85 ( 5 )   612 - 622   2021年4月（ ISSN:1346-9843 ）

Outpatient Cardiac Rehabilitation Suppresses Deterioration of Renal Function in Patients ≥75 Years of Age With Heart Disease.

Sasamoto Y, Endo N, Kanazawa K, Utsumi T, Takahashi T, Endo Y, Nanba M, Takeda H, Takano T, Takahashi K, Tanji M, Kohzuki M

Circulation journal : official journal of the Japanese Circulation Society   85 ( 5 )   612 - 622   2021年4月（ ISSN:1346-9843 ）

Outpatient Cardiac Rehabilitation Suppresses Deterioration of Renal Function in Patients ≥75 Years of Age With Heart Disease.

Sasamoto Y, Endo N, Kanazawa K, Utsumi T, Takahashi T, Endo Y, Nanba M, Takeda H, Takano T, Takahashi K, Tanji M, Kohzuki M

Circulation journal : official journal of the Japanese Circulation Society   85 ( 5 )   612 - 622   2021年4月（ ISSN:1346-9843 ）

Outpatient Cardiac Rehabilitation Suppresses Deterioration of Renal Function in Patients ≥75 Years of Age With Heart Disease.

Sasamoto Y, Endo N, Kanazawa K, Utsumi T, Takahashi T, Endo Y, Nanba M, Takeda H, Takano T, Takahashi K, Tanji M, Kohzuki M

Circulation journal : official journal of the Japanese Circulation Society   85 ( 5 )   612 - 622   2021年4月（ ISSN:1346-9843 ）

化学療法未施行の扁平上皮癌に対するカルボプラチン+ナブパクリタキセルとシスプラチン+ゲムシタビンの無作為化第II相試験　North Japan lung cancer study group 1302(Randomized phase II trial of carboplatin + nab-paclitaxel versus cisplatin + gemcitabine for chemotherapy-naieve squamous cell carcinoma: North Japan lung cancer study group 1302)

Kawashima Yosuke, Harada Toshiyuki, Fujita Yuka, Nakagawa Taku, Watanabe Kana, Morikawa Naoto, Takamura Kei, Kanazawa Kenya, Kuda Tomoya, Usui Kazuhiro, Sekine Akimasa, Inoue Akira, Sugawara Shunichi

International Journal of Clinical Oncology   26 ( 3 )   515 - 522   2021年3月（ ISSN:1341-9625 ）

Randomized phase II trial of carboplatin + nab-paclitaxel versus cisplatin + gemcitabine for chemotherapy-naïve squamous cell carcinoma: North Japan lung cancer study group 1302.

Kawashima Y, Harada T, Fujita Y, Nakagawa T, Watanabe K, Morikawa N, Takamura K, Kanazawa K, Kuda T, Usui K, Sekine A, Inoue A, Sugawara S

International journal of clinical oncology   26 ( 3 )   515 - 522   2021年3月（ ISSN:1341-9625 ）

化学療法未施行の扁平上皮癌に対するカルボプラチン+ナブパクリタキセルとシスプラチン+ゲムシタビンの無作為化第II相試験 North Japan lung cancer study group 1302(Randomized phase II trial of carboplatin + nab-paclitaxel versus cisplatin + gemcitabine for chemotherapy-naieve squamous cell carcinoma: North Japan lung cancer study group 1302)

Kawashima Yosuke, Harada Toshiyuki, Fujita Yuka, Nakagawa Taku, Watanabe Kana, Morikawa Naoto, Takamura Kei, Kanazawa Kenya, Kuda Tomoya, Usui Kazuhiro, Sekine Akimasa, Inoue Akira, Sugawara Shunichi

International Journal of Clinical Oncology   26 ( 3 )   515 - 522   2021年3月（ ISSN:1341-9625 ）

化学療法未施行の扁平上皮癌に対するカルボプラチン+ナブパクリタキセルとシスプラチン+ゲムシタビンの無作為化第II相試験 North Japan lung cancer study group 1302(Randomized phase II trial of carboplatin + nab-paclitaxel versus cisplatin + gemcitabine for chemotherapy-naieve squamous cell carcinoma: North Japan lung cancer study group 1302)

Kawashima Yosuke, Harada Toshiyuki, Fujita Yuka, Nakagawa Taku, Watanabe Kana, Morikawa Naoto, Takamura Kei, Kanazawa Kenya, Kuda Tomoya, Usui Kazuhiro, Sekine Akimasa, Inoue Akira, Sugawara Shunichi

International Journal of Clinical Oncology   26 ( 3 )   515 - 522   2021年3月（ ISSN:1341-9625 ）

化学療法未施行の扁平上皮癌に対するカルボプラチン+ナブパクリタキセルとシスプラチン+ゲムシタビンの無作為化第II相試験 North Japan lung cancer study group 1302(Randomized phase II trial of carboplatin + nab-paclitaxel versus cisplatin + gemcitabine for chemotherapy-naieve squamous cell carcinoma: North Japan lung cancer study group 1302)

Kawashima Yosuke, Harada Toshiyuki, Fujita Yuka, Nakagawa Taku, Watanabe Kana, Morikawa Naoto, Takamura Kei, Kanazawa Kenya, Kuda Tomoya, Usui Kazuhiro, Sekine Akimasa, Inoue Akira, Sugawara Shunichi

International Journal of Clinical Oncology   26 ( 3 )   515 - 522   2021年3月（ ISSN:1341-9625 ）

化学療法未施行の扁平上皮癌に対するカルボプラチン+ナブパクリタキセルとシスプラチン+ゲムシタビンの無作為化第II相試験 North Japan lung cancer study group 1302(Randomized phase II trial of carboplatin + nab-paclitaxel versus cisplatin + gemcitabine for chemotherapy-naieve squamous cell carcinoma: North Japan lung cancer study group 1302)

Kawashima Yosuke, Harada Toshiyuki, Fujita Yuka, Nakagawa Taku, Watanabe Kana, Morikawa Naoto, Takamura Kei, Kanazawa Kenya, Kuda Tomoya, Usui Kazuhiro, Sekine Akimasa, Inoue Akira, Sugawara Shunichi

International Journal of Clinical Oncology   26 ( 3 )   515 - 522   2021年3月（ ISSN:1341-9625 ）

化学療法未施行の扁平上皮癌に対するカルボプラチン+ナブパクリタキセルとシスプラチン+ゲムシタビンの無作為化第II相試験 North Japan lung cancer study group 1302(Randomized phase II trial of carboplatin + nab-paclitaxel versus cisplatin + gemcitabine for chemotherapy-naieve squamous cell carcinoma: North Japan lung cancer study group 1302)

Kawashima Yosuke, Harada Toshiyuki, Fujita Yuka, Nakagawa Taku, Watanabe Kana, Morikawa Naoto, Takamura Kei, Kanazawa Kenya, Kuda Tomoya, Usui Kazuhiro, Sekine Akimasa, Inoue Akira, Sugawara Shunichi

International Journal of Clinical Oncology   26 ( 3 )   515 - 522   2021年3月（ ISSN:1341-9625 ）

化学療法未施行の扁平上皮癌に対するカルボプラチン+ナブパクリタキセルとシスプラチン+ゲムシタビンの無作為化第II相試験 North Japan lung cancer study group 1302(Randomized phase II trial of carboplatin + nab-paclitaxel versus cisplatin + gemcitabine for chemotherapy-naieve squamous cell carcinoma: North Japan lung cancer study group 1302)

Kawashima Yosuke, Harada Toshiyuki, Fujita Yuka, Nakagawa Taku, Watanabe Kana, Morikawa Naoto, Takamura Kei, Kanazawa Kenya, Kuda Tomoya, Usui Kazuhiro, Sekine Akimasa, Inoue Akira, Sugawara Shunichi

International Journal of Clinical Oncology   26 ( 3 )   515 - 522   2021年3月（ ISSN:1341-9625 ）

化学療法未施行の扁平上皮癌に対するカルボプラチン+ナブパクリタキセルとシスプラチン+ゲムシタビンの無作為化第II相試験 North Japan lung cancer study group 1302(Randomized phase II trial of carboplatin + nab-paclitaxel versus cisplatin + gemcitabine for chemotherapy-naieve squamous cell carcinoma: North Japan lung cancer study group 1302)

Kawashima Yosuke, Harada Toshiyuki, Fujita Yuka, Nakagawa Taku, Watanabe Kana, Morikawa Naoto, Takamura Kei, Kanazawa Kenya, Kuda Tomoya, Usui Kazuhiro, Sekine Akimasa, Inoue Akira, Sugawara Shunichi

International Journal of Clinical Oncology   26 ( 3 )   515 - 522   2021年3月（ ISSN:1341-9625 ）

化学療法未施行の扁平上皮癌に対するカルボプラチン+ナブパクリタキセルとシスプラチン+ゲムシタビンの無作為化第II相試験 North Japan lung cancer study group 1302(Randomized phase II trial of carboplatin + nab-paclitaxel versus cisplatin + gemcitabine for chemotherapy-naieve squamous cell carcinoma: North Japan lung cancer study group 1302)

Kawashima Yosuke, Harada Toshiyuki, Fujita Yuka, Nakagawa Taku, Watanabe Kana, Morikawa Naoto, Takamura Kei, Kanazawa Kenya, Kuda Tomoya, Usui Kazuhiro, Sekine Akimasa, Inoue Akira, Sugawara Shunichi

International Journal of Clinical Oncology   26 ( 3 )   515 - 522   2021年3月（ ISSN:1341-9625 ）

化学療法未施行の扁平上皮癌に対するカルボプラチン+ナブパクリタキセルとシスプラチン+ゲムシタビンの無作為化第II相試験 North Japan lung cancer study group 1302(Randomized phase II trial of carboplatin + nab-paclitaxel versus cisplatin + gemcitabine for chemotherapy-naieve squamous cell carcinoma: North Japan lung cancer study group 1302)

Kawashima Yosuke, Harada Toshiyuki, Fujita Yuka, Nakagawa Taku, Watanabe Kana, Morikawa Naoto, Takamura Kei, Kanazawa Kenya, Kuda Tomoya, Usui Kazuhiro, Sekine Akimasa, Inoue Akira, Sugawara Shunichi

International Journal of Clinical Oncology   26 ( 3 )   515 - 522   2021年3月（ ISSN:1341-9625 ）

化学療法未施行の扁平上皮癌に対するカルボプラチン+ナブパクリタキセルとシスプラチン+ゲムシタビンの無作為化第II相試験 North Japan lung cancer study group 1302(Randomized phase II trial of carboplatin + nab-paclitaxel versus cisplatin + gemcitabine for chemotherapy-naieve squamous cell carcinoma: North Japan lung cancer study group 1302)

Kawashima Yosuke, Harada Toshiyuki, Fujita Yuka, Nakagawa Taku, Watanabe Kana, Morikawa Naoto, Takamura Kei, Kanazawa Kenya, Kuda Tomoya, Usui Kazuhiro, Sekine Akimasa, Inoue Akira, Sugawara Shunichi

International Journal of Clinical Oncology   26 ( 3 )   515 - 522   2021年3月（ ISSN:1341-9625 ）

化学療法未施行の扁平上皮癌に対するカルボプラチン+ナブパクリタキセルとシスプラチン+ゲムシタビンの無作為化第II相試験 North Japan lung cancer study group 1302(Randomized phase II trial of carboplatin + nab-paclitaxel versus cisplatin + gemcitabine for chemotherapy-naieve squamous cell carcinoma: North Japan lung cancer study group 1302)

Kawashima Yosuke, Harada Toshiyuki, Fujita Yuka, Nakagawa Taku, Watanabe Kana, Morikawa Naoto, Takamura Kei, Kanazawa Kenya, Kuda Tomoya, Usui Kazuhiro, Sekine Akimasa, Inoue Akira, Sugawara Shunichi

International Journal of Clinical Oncology   26 ( 3 )   515 - 522   2021年3月（ ISSN:1341-9625 ）

化学療法未施行の扁平上皮癌に対するカルボプラチン+ナブパクリタキセルとシスプラチン+ゲムシタビンの無作為化第II相試験 North Japan lung cancer study group 1302(Randomized phase II trial of carboplatin + nab-paclitaxel versus cisplatin + gemcitabine for chemotherapy-naieve squamous cell carcinoma: North Japan lung cancer study group 1302)

Kawashima Yosuke, Harada Toshiyuki, Fujita Yuka, Nakagawa Taku, Watanabe Kana, Morikawa Naoto, Takamura Kei, Kanazawa Kenya, Kuda Tomoya, Usui Kazuhiro, Sekine Akimasa, Inoue Akira, Sugawara Shunichi

International Journal of Clinical Oncology   26 ( 3 )   515 - 522   2021年3月（ ISSN:1341-9625 ）

化学療法未施行の扁平上皮癌に対するカルボプラチン+ナブパクリタキセルとシスプラチン+ゲムシタビンの無作為化第II相試験 North Japan lung cancer study group 1302(Randomized phase II trial of carboplatin + nab-paclitaxel versus cisplatin + gemcitabine for chemotherapy-naieve squamous cell carcinoma: North Japan lung cancer study group 1302)

Kawashima Yosuke, Harada Toshiyuki, Fujita Yuka, Nakagawa Taku, Watanabe Kana, Morikawa Naoto, Takamura Kei, Kanazawa Kenya, Kuda Tomoya, Usui Kazuhiro, Sekine Akimasa, Inoue Akira, Sugawara Shunichi

International Journal of Clinical Oncology   26 ( 3 )   515 - 522   2021年3月（ ISSN:1341-9625 ）

化学療法未施行の扁平上皮癌に対するカルボプラチン+ナブパクリタキセルとシスプラチン+ゲムシタビンの無作為化第II相試験 North Japan lung cancer study group 1302(Randomized phase II trial of carboplatin + nab-paclitaxel versus cisplatin + gemcitabine for chemotherapy-naieve squamous cell carcinoma: North Japan lung cancer study group 1302)

Kawashima Yosuke, Harada Toshiyuki, Fujita Yuka, Nakagawa Taku, Watanabe Kana, Morikawa Naoto, Takamura Kei, Kanazawa Kenya, Kuda Tomoya, Usui Kazuhiro, Sekine Akimasa, Inoue Akira, Sugawara Shunichi

International Journal of Clinical Oncology   26 ( 3 )   515 - 522   2021年3月（ ISSN:1341-9625 ）

化学療法未施行の扁平上皮癌に対するカルボプラチン+ナブパクリタキセルとシスプラチン+ゲムシタビンの無作為化第II相試験 North Japan lung cancer study group 1302(Randomized phase II trial of carboplatin + nab-paclitaxel versus cisplatin + gemcitabine for chemotherapy-naieve squamous cell carcinoma: North Japan lung cancer study group 1302)

Kawashima Yosuke, Harada Toshiyuki, Fujita Yuka, Nakagawa Taku, Watanabe Kana, Morikawa Naoto, Takamura Kei, Kanazawa Kenya, Kuda Tomoya, Usui Kazuhiro, Sekine Akimasa, Inoue Akira, Sugawara Shunichi

International Journal of Clinical Oncology   26 ( 3 )   515 - 522   2021年3月（ ISSN:1341-9625 ）

化学療法未施行の扁平上皮癌に対するカルボプラチン+ナブパクリタキセルとシスプラチン+ゲムシタビンの無作為化第II相試験 North Japan lung cancer study group 1302(Randomized phase II trial of carboplatin + nab-paclitaxel versus cisplatin + gemcitabine for chemotherapy-naieve squamous cell carcinoma: North Japan lung cancer study group 1302)

Kawashima Yosuke, Harada Toshiyuki, Fujita Yuka, Nakagawa Taku, Watanabe Kana, Morikawa Naoto, Takamura Kei, Kanazawa Kenya, Kuda Tomoya, Usui Kazuhiro, Sekine Akimasa, Inoue Akira, Sugawara Shunichi

International Journal of Clinical Oncology   26 ( 3 )   515 - 522   2021年3月（ ISSN:1341-9625 ）

化学療法未施行の扁平上皮癌に対するカルボプラチン+ナブパクリタキセルとシスプラチン+ゲムシタビンの無作為化第II相試験 North Japan lung cancer study group 1302(Randomized phase II trial of carboplatin + nab-paclitaxel versus cisplatin + gemcitabine for chemotherapy-naieve squamous cell carcinoma: North Japan lung cancer study group 1302)

Kawashima Yosuke, Harada Toshiyuki, Fujita Yuka, Nakagawa Taku, Watanabe Kana, Morikawa Naoto, Takamura Kei, Kanazawa Kenya, Kuda Tomoya, Usui Kazuhiro, Sekine Akimasa, Inoue Akira, Sugawara Shunichi

International Journal of Clinical Oncology   26 ( 3 )   515 - 522   2021年3月（ ISSN:1341-9625 ）

化学療法未施行の扁平上皮癌に対するカルボプラチン+ナブパクリタキセルとシスプラチン+ゲムシタビンの無作為化第II相試験 North Japan lung cancer study group 1302(Randomized phase II trial of carboplatin + nab-paclitaxel versus cisplatin + gemcitabine for chemotherapy-naieve squamous cell carcinoma: North Japan lung cancer study group 1302)

Kawashima Yosuke, Harada Toshiyuki, Fujita Yuka, Nakagawa Taku, Watanabe Kana, Morikawa Naoto, Takamura Kei, Kanazawa Kenya, Kuda Tomoya, Usui Kazuhiro, Sekine Akimasa, Inoue Akira, Sugawara Shunichi

International Journal of Clinical Oncology   26 ( 3 )   515 - 522   2021年3月（ ISSN:1341-9625 ）

化学療法未施行の扁平上皮癌に対するカルボプラチン+ナブパクリタキセルとシスプラチン+ゲムシタビンの無作為化第II相試験 North Japan lung cancer study group 1302(Randomized phase II trial of carboplatin + nab-paclitaxel versus cisplatin + gemcitabine for chemotherapy-naieve squamous cell carcinoma: North Japan lung cancer study group 1302)

Kawashima Yosuke, Harada Toshiyuki, Fujita Yuka, Nakagawa Taku, Watanabe Kana, Morikawa Naoto, Takamura Kei, Kanazawa Kenya, Kuda Tomoya, Usui Kazuhiro, Sekine Akimasa, Inoue Akira, Sugawara Shunichi

International Journal of Clinical Oncology   26 ( 3 )   515 - 522   2021年3月（ ISSN:1341-9625 ）

化学療法未施行の扁平上皮癌に対するカルボプラチン+ナブパクリタキセルとシスプラチン+ゲムシタビンの無作為化第II相試験 North Japan lung cancer study group 1302(Randomized phase II trial of carboplatin + nab-paclitaxel versus cisplatin + gemcitabine for chemotherapy-naieve squamous cell carcinoma: North Japan lung cancer study group 1302)

Kawashima Yosuke, Harada Toshiyuki, Fujita Yuka, Nakagawa Taku, Watanabe Kana, Morikawa Naoto, Takamura Kei, Kanazawa Kenya, Kuda Tomoya, Usui Kazuhiro, Sekine Akimasa, Inoue Akira, Sugawara Shunichi

International Journal of Clinical Oncology   26 ( 3 )   515 - 522   2021年3月（ ISSN:1341-9625 ）

Association Between Sleep Characteristics and Asthma Control in Middle-Aged and Older Adults: A Prospective Cohort Study.

Sato S, Saito J, Fukuhara A, Uematsu M, Suzuki Y, Rikimaru M, Kawamata T, Umeda T, Koizumi T, Togawa R, Sato Y, Nikaido T, Minemura H, Kanazawa K, Tanino Y, Shibata Y

Journal of asthma and allergy   14   325 - 334   2021年（ ISSN:1178-6965 ）

Post-Progression Survival Influences Overall Survival among Patients with Advanced Non-Small Cell Lung Cancer Undergoing First-Line Pembrolizumab Monotherapy.

Imai H, Kishikawa T, Minemura H, Yamada Y, Ibe T, Mori K, Yamaguchi O, Mouri A, Hamamoto Y, Kanazawa K, Kasai T, Kaira K, Kaburagi T, Minato K, Kobayashi K, Kagamu H

Oncology   99 ( 9 )   562 - 570   2021年（ ISSN:0030-2414 ）

Association Between Sleep Characteristics and Asthma Control in Middle-Aged and Older Adults: A Prospective Cohort Study.

Sato S, Saito J, Fukuhara A, Uematsu M, Suzuki Y, Rikimaru M, Kawamata T, Umeda T, Koizumi T, Togawa R, Sato Y, Nikaido T, Minemura H, Kanazawa K, Tanino Y, Shibata Y

Journal of asthma and allergy   14   325 - 334   2021年（ ISSN:1178-6965 ）

Post-Progression Survival Influences Overall Survival among Patients with Advanced Non-Small Cell Lung Cancer Undergoing First-Line Pembrolizumab Monotherapy.

Imai H, Kishikawa T, Minemura H, Yamada Y, Ibe T, Mori K, Yamaguchi O, Mouri A, Hamamoto Y, Kanazawa K, Kasai T, Kaira K, Kaburagi T, Minato K, Kobayashi K, Kagamu H

Oncology   99 ( 9 )   562 - 570   2021年（ ISSN:0030-2414 ）

Association Between Sleep Characteristics and Asthma Control in Middle-Aged and Older Adults: A Prospective Cohort Study.

Sato S, Saito J, Fukuhara A, Uematsu M, Suzuki Y, Rikimaru M, Kawamata T, Umeda T, Koizumi T, Togawa R, Sato Y, Nikaido T, Minemura H, Kanazawa K, Tanino Y, Shibata Y

Journal of asthma and allergy   14   325 - 334   2021年（ ISSN:1178-6965 ）

Post-Progression Survival Influences Overall Survival among Patients with Advanced Non-Small Cell Lung Cancer Undergoing First-Line Pembrolizumab Monotherapy.

Imai H, Kishikawa T, Minemura H, Yamada Y, Ibe T, Mori K, Yamaguchi O, Mouri A, Hamamoto Y, Kanazawa K, Kasai T, Kaira K, Kaburagi T, Minato K, Kobayashi K, Kagamu H

Oncology   99 ( 9 )   562 - 570   2021年（ ISSN:0030-2414 ）

Association Between Sleep Characteristics and Asthma Control in Middle-Aged and Older Adults: A Prospective Cohort Study.

Sato S, Saito J, Fukuhara A, Uematsu M, Suzuki Y, Rikimaru M, Kawamata T, Umeda T, Koizumi T, Togawa R, Sato Y, Nikaido T, Minemura H, Kanazawa K, Tanino Y, Shibata Y

Journal of asthma and allergy   14   325 - 334   2021年（ ISSN:1178-6965 ）

Post-Progression Survival Influences Overall Survival among Patients with Advanced Non-Small Cell Lung Cancer Undergoing First-Line Pembrolizumab Monotherapy.

Imai H, Kishikawa T, Minemura H, Yamada Y, Ibe T, Mori K, Yamaguchi O, Mouri A, Hamamoto Y, Kanazawa K, Kasai T, Kaira K, Kaburagi T, Minato K, Kobayashi K, Kagamu H

Oncology   99 ( 9 )   562 - 570   2021年（ ISSN:0030-2414 ）

Association Between Sleep Characteristics and Asthma Control in Middle-Aged and Older Adults: A Prospective Cohort Study.

Sato S, Saito J, Fukuhara A, Uematsu M, Suzuki Y, Rikimaru M, Kawamata T, Umeda T, Koizumi T, Togawa R, Sato Y, Nikaido T, Minemura H, Kanazawa K, Tanino Y, Shibata Y

Journal of asthma and allergy   14   325 - 334   2021年（ ISSN:1178-6965 ）

Post-Progression Survival Influences Overall Survival among Patients with Advanced Non-Small Cell Lung Cancer Undergoing First-Line Pembrolizumab Monotherapy.

Imai H, Kishikawa T, Minemura H, Yamada Y, Ibe T, Mori K, Yamaguchi O, Mouri A, Hamamoto Y, Kanazawa K, Kasai T, Kaira K, Kaburagi T, Minato K, Kobayashi K, Kagamu H

Oncology   99 ( 9 )   562 - 570   2021年（ ISSN:0030-2414 ）

Association Between Sleep Characteristics and Asthma Control in Middle-Aged and Older Adults: A Prospective Cohort Study.

Sato S, Saito J, Fukuhara A, Uematsu M, Suzuki Y, Rikimaru M, Kawamata T, Umeda T, Koizumi T, Togawa R, Sato Y, Nikaido T, Minemura H, Kanazawa K, Tanino Y, Shibata Y

Journal of asthma and allergy   14   325 - 334   2021年（ ISSN:1178-6965 ）

Post-Progression Survival Influences Overall Survival among Patients with Advanced Non-Small Cell Lung Cancer Undergoing First-Line Pembrolizumab Monotherapy.

Imai H, Kishikawa T, Minemura H, Yamada Y, Ibe T, Mori K, Yamaguchi O, Mouri A, Hamamoto Y, Kanazawa K, Kasai T, Kaira K, Kaburagi T, Minato K, Kobayashi K, Kagamu H

Oncology   99 ( 9 )   562 - 570   2021年（ ISSN:0030-2414 ）

Association Between Sleep Characteristics and Asthma Control in Middle-Aged and Older Adults: A Prospective Cohort Study.

Sato S, Saito J, Fukuhara A, Uematsu M, Suzuki Y, Rikimaru M, Kawamata T, Umeda T, Koizumi T, Togawa R, Sato Y, Nikaido T, Minemura H, Kanazawa K, Tanino Y, Shibata Y

Journal of asthma and allergy   14   325 - 334   2021年（ ISSN:1178-6965 ）

Post-Progression Survival Influences Overall Survival among Patients with Advanced Non-Small Cell Lung Cancer Undergoing First-Line Pembrolizumab Monotherapy.

Imai H, Kishikawa T, Minemura H, Yamada Y, Ibe T, Mori K, Yamaguchi O, Mouri A, Hamamoto Y, Kanazawa K, Kasai T, Kaira K, Kaburagi T, Minato K, Kobayashi K, Kagamu H

Oncology   99 ( 9 )   562 - 570   2021年（ ISSN:0030-2414 ）

Association Between Sleep Characteristics and Asthma Control in Middle-Aged and Older Adults: A Prospective Cohort Study.

Sato S, Saito J, Fukuhara A, Uematsu M, Suzuki Y, Rikimaru M, Kawamata T, Umeda T, Koizumi T, Togawa R, Sato Y, Nikaido T, Minemura H, Kanazawa K, Tanino Y, Shibata Y

Journal of asthma and allergy   14   325 - 334   2021年（ ISSN:1178-6965 ）

Post-Progression Survival Influences Overall Survival among Patients with Advanced Non-Small Cell Lung Cancer Undergoing First-Line Pembrolizumab Monotherapy.

Imai H, Kishikawa T, Minemura H, Yamada Y, Ibe T, Mori K, Yamaguchi O, Mouri A, Hamamoto Y, Kanazawa K, Kasai T, Kaira K, Kaburagi T, Minato K, Kobayashi K, Kagamu H

Oncology   99 ( 9 )   562 - 570   2021年（ ISSN:0030-2414 ）

Association Between Sleep Characteristics and Asthma Control in Middle-Aged and Older Adults: A Prospective Cohort Study.

Sato S, Saito J, Fukuhara A, Uematsu M, Suzuki Y, Rikimaru M, Kawamata T, Umeda T, Koizumi T, Togawa R, Sato Y, Nikaido T, Minemura H, Kanazawa K, Tanino Y, Shibata Y

Journal of asthma and allergy   14   325 - 334   2021年（ ISSN:1178-6965 ）

Post-Progression Survival Influences Overall Survival among Patients with Advanced Non-Small Cell Lung Cancer Undergoing First-Line Pembrolizumab Monotherapy.

Imai H, Kishikawa T, Minemura H, Yamada Y, Ibe T, Mori K, Yamaguchi O, Mouri A, Hamamoto Y, Kanazawa K, Kasai T, Kaira K, Kaburagi T, Minato K, Kobayashi K, Kagamu H

Oncology   99 ( 9 )   562 - 570   2021年（ ISSN:0030-2414 ）

Association Between Sleep Characteristics and Asthma Control in Middle-Aged and Older Adults: A Prospective Cohort Study.

Sato S, Saito J, Fukuhara A, Uematsu M, Suzuki Y, Rikimaru M, Kawamata T, Umeda T, Koizumi T, Togawa R, Sato Y, Nikaido T, Minemura H, Kanazawa K, Tanino Y, Shibata Y

Journal of asthma and allergy   14   325 - 334   2021年（ ISSN:1178-6965 ）

Post-Progression Survival Influences Overall Survival among Patients with Advanced Non-Small Cell Lung Cancer Undergoing First-Line Pembrolizumab Monotherapy.

Imai H, Kishikawa T, Minemura H, Yamada Y, Ibe T, Mori K, Yamaguchi O, Mouri A, Hamamoto Y, Kanazawa K, Kasai T, Kaira K, Kaburagi T, Minato K, Kobayashi K, Kagamu H

Oncology   99 ( 9 )   562 - 570   2021年（ ISSN:0030-2414 ）

Association Between Sleep Characteristics and Asthma Control in Middle-Aged and Older Adults: A Prospective Cohort Study.

Sato S, Saito J, Fukuhara A, Uematsu M, Suzuki Y, Rikimaru M, Kawamata T, Umeda T, Koizumi T, Togawa R, Sato Y, Nikaido T, Minemura H, Kanazawa K, Tanino Y, Shibata Y

Journal of asthma and allergy   14   325 - 334   2021年（ ISSN:1178-6965 ）

Post-Progression Survival Influences Overall Survival among Patients with Advanced Non-Small Cell Lung Cancer Undergoing First-Line Pembrolizumab Monotherapy.

Imai H, Kishikawa T, Minemura H, Yamada Y, Ibe T, Mori K, Yamaguchi O, Mouri A, Hamamoto Y, Kanazawa K, Kasai T, Kaira K, Kaburagi T, Minato K, Kobayashi K, Kagamu H

Oncology   99 ( 9 )   562 - 570   2021年（ ISSN:0030-2414 ）

Association Between Sleep Characteristics and Asthma Control in Middle-Aged and Older Adults: A Prospective Cohort Study.

Sato S, Saito J, Fukuhara A, Uematsu M, Suzuki Y, Rikimaru M, Kawamata T, Umeda T, Koizumi T, Togawa R, Sato Y, Nikaido T, Minemura H, Kanazawa K, Tanino Y, Shibata Y

Journal of asthma and allergy   14   325 - 334   2021年（ ISSN:1178-6965 ）

Post-Progression Survival Influences Overall Survival among Patients with Advanced Non-Small Cell Lung Cancer Undergoing First-Line Pembrolizumab Monotherapy.

Imai H, Kishikawa T, Minemura H, Yamada Y, Ibe T, Mori K, Yamaguchi O, Mouri A, Hamamoto Y, Kanazawa K, Kasai T, Kaira K, Kaburagi T, Minato K, Kobayashi K, Kagamu H

Oncology   99 ( 9 )   562 - 570   2021年（ ISSN:0030-2414 ）

Association Between Sleep Characteristics and Asthma Control in Middle-Aged and Older Adults: A Prospective Cohort Study.

Sato S, Saito J, Fukuhara A, Uematsu M, Suzuki Y, Rikimaru M, Kawamata T, Umeda T, Koizumi T, Togawa R, Sato Y, Nikaido T, Minemura H, Kanazawa K, Tanino Y, Shibata Y

Journal of asthma and allergy   14   325 - 334   2021年（ ISSN:1178-6965 ）

Post-Progression Survival Influences Overall Survival among Patients with Advanced Non-Small Cell Lung Cancer Undergoing First-Line Pembrolizumab Monotherapy.

Imai H, Kishikawa T, Minemura H, Yamada Y, Ibe T, Mori K, Yamaguchi O, Mouri A, Hamamoto Y, Kanazawa K, Kasai T, Kaira K, Kaburagi T, Minato K, Kobayashi K, Kagamu H

Oncology   99 ( 9 )   562 - 570   2021年（ ISSN:0030-2414 ）

Association Between Sleep Characteristics and Asthma Control in Middle-Aged and Older Adults: A Prospective Cohort Study.

Sato S, Saito J, Fukuhara A, Uematsu M, Suzuki Y, Rikimaru M, Kawamata T, Umeda T, Koizumi T, Togawa R, Sato Y, Nikaido T, Minemura H, Kanazawa K, Tanino Y, Shibata Y

Journal of asthma and allergy   14   325 - 334   2021年（ ISSN:1178-6965 ）

Post-Progression Survival Influences Overall Survival among Patients with Advanced Non-Small Cell Lung Cancer Undergoing First-Line Pembrolizumab Monotherapy.

Imai H, Kishikawa T, Minemura H, Yamada Y, Ibe T, Mori K, Yamaguchi O, Mouri A, Hamamoto Y, Kanazawa K, Kasai T, Kaira K, Kaburagi T, Minato K, Kobayashi K, Kagamu H

Oncology   99 ( 9 )   562 - 570   2021年（ ISSN:0030-2414 ）

Association Between Sleep Characteristics and Asthma Control in Middle-Aged and Older Adults: A Prospective Cohort Study.

Sato S, Saito J, Fukuhara A, Uematsu M, Suzuki Y, Rikimaru M, Kawamata T, Umeda T, Koizumi T, Togawa R, Sato Y, Nikaido T, Minemura H, Kanazawa K, Tanino Y, Shibata Y

Journal of asthma and allergy   14   325 - 334   2021年（ ISSN:1178-6965 ）

Post-Progression Survival Influences Overall Survival among Patients with Advanced Non-Small Cell Lung Cancer Undergoing First-Line Pembrolizumab Monotherapy.

Imai H, Kishikawa T, Minemura H, Yamada Y, Ibe T, Mori K, Yamaguchi O, Mouri A, Hamamoto Y, Kanazawa K, Kasai T, Kaira K, Kaburagi T, Minato K, Kobayashi K, Kagamu H

Oncology   99 ( 9 )   562 - 570   2021年（ ISSN:0030-2414 ）

Association Between Sleep Characteristics and Asthma Control in Middle-Aged and Older Adults: A Prospective Cohort Study.

Sato S, Saito J, Fukuhara A, Uematsu M, Suzuki Y, Rikimaru M, Kawamata T, Umeda T, Koizumi T, Togawa R, Sato Y, Nikaido T, Minemura H, Kanazawa K, Tanino Y, Shibata Y

Journal of asthma and allergy   14   325 - 334   2021年（ ISSN:1178-6965 ）

Post-Progression Survival Influences Overall Survival among Patients with Advanced Non-Small Cell Lung Cancer Undergoing First-Line Pembrolizumab Monotherapy.

Imai H, Kishikawa T, Minemura H, Yamada Y, Ibe T, Mori K, Yamaguchi O, Mouri A, Hamamoto Y, Kanazawa K, Kasai T, Kaira K, Kaburagi T, Minato K, Kobayashi K, Kagamu H

Oncology   99 ( 9 )   562 - 570   2021年（ ISSN:0030-2414 ）

Association Between Sleep Characteristics and Asthma Control in Middle-Aged and Older Adults: A Prospective Cohort Study.

Sato S, Saito J, Fukuhara A, Uematsu M, Suzuki Y, Rikimaru M, Kawamata T, Umeda T, Koizumi T, Togawa R, Sato Y, Nikaido T, Minemura H, Kanazawa K, Tanino Y, Shibata Y

Journal of asthma and allergy   14   325 - 334   2021年（ ISSN:1178-6965 ）

Post-Progression Survival Influences Overall Survival among Patients with Advanced Non-Small Cell Lung Cancer Undergoing First-Line Pembrolizumab Monotherapy.

Imai H, Kishikawa T, Minemura H, Yamada Y, Ibe T, Mori K, Yamaguchi O, Mouri A, Hamamoto Y, Kanazawa K, Kasai T, Kaira K, Kaburagi T, Minato K, Kobayashi K, Kagamu H

Oncology   99 ( 9 )   562 - 570   2021年（ ISSN:0030-2414 ）

Association Between Sleep Characteristics and Asthma Control in Middle-Aged and Older Adults: A Prospective Cohort Study.

Sato S, Saito J, Fukuhara A, Uematsu M, Suzuki Y, Rikimaru M, Kawamata T, Umeda T, Koizumi T, Togawa R, Sato Y, Nikaido T, Minemura H, Kanazawa K, Tanino Y, Shibata Y

Journal of asthma and allergy   14   325 - 334   2021年（ ISSN:1178-6965 ）

Post-Progression Survival Influences Overall Survival among Patients with Advanced Non-Small Cell Lung Cancer Undergoing First-Line Pembrolizumab Monotherapy.

Imai H, Kishikawa T, Minemura H, Yamada Y, Ibe T, Mori K, Yamaguchi O, Mouri A, Hamamoto Y, Kanazawa K, Kasai T, Kaira K, Kaburagi T, Minato K, Kobayashi K, Kagamu H

Oncology   99 ( 9 )   562 - 570   2021年（ ISSN:0030-2414 ）

Association Between Sleep Characteristics and Asthma Control in Middle-Aged and Older Adults: A Prospective Cohort Study.

Sato S, Saito J, Fukuhara A, Uematsu M, Suzuki Y, Rikimaru M, Kawamata T, Umeda T, Koizumi T, Togawa R, Sato Y, Nikaido T, Minemura H, Kanazawa K, Tanino Y, Shibata Y

Journal of asthma and allergy   14   325 - 334   2021年（ ISSN:1178-6965 ）

Post-Progression Survival Influences Overall Survival among Patients with Advanced Non-Small Cell Lung Cancer Undergoing First-Line Pembrolizumab Monotherapy.

Imai H, Kishikawa T, Minemura H, Yamada Y, Ibe T, Mori K, Yamaguchi O, Mouri A, Hamamoto Y, Kanazawa K, Kasai T, Kaira K, Kaburagi T, Minato K, Kobayashi K, Kagamu H

Oncology   99 ( 9 )   562 - 570   2021年（ ISSN:0030-2414 ）

Association Between Sleep Characteristics and Asthma Control in Middle-Aged and Older Adults: A Prospective Cohort Study.

Sato S, Saito J, Fukuhara A, Uematsu M, Suzuki Y, Rikimaru M, Kawamata T, Umeda T, Koizumi T, Togawa R, Sato Y, Nikaido T, Minemura H, Kanazawa K, Tanino Y, Shibata Y

Journal of asthma and allergy   14   325 - 334   2021年（ ISSN:1178-6965 ）

Post-Progression Survival Influences Overall Survival among Patients with Advanced Non-Small Cell Lung Cancer Undergoing First-Line Pembrolizumab Monotherapy.

Imai H, Kishikawa T, Minemura H, Yamada Y, Ibe T, Mori K, Yamaguchi O, Mouri A, Hamamoto Y, Kanazawa K, Kasai T, Kaira K, Kaburagi T, Minato K, Kobayashi K, Kagamu H

Oncology   99 ( 9 )   562 - 570   2021年（ ISSN:0030-2414 ）

Prognostic value of morphological characteristics assessed by CT scan in patients with non-small cell lung cancer treated with nivolumab.

Minemura H, Moriya H, Imai H, Sugiyama T, Yamada Y, Higuchi M, Kaira K, Ozaki Y, Kanazawa K, Yokouchi H, Kasai T, Kaburagi T, Suzuki H, Minato K, Shibata Y

Thoracic cancer   11 ( 12 )   3521 - 3527   2020年12月（ ISSN:1759-7706 ）

Monomorphic Epitheliotropic Intestinal T-cell Lymphoma Involving the Lung and Brain: A Rare Case Study.

Suzuki Y, Minemura H, Tomita H, Saito M, Watanabe N, Umeda T, Kawamata T, Rikimaru M, Morimoto J, Koizumi T, Togawa R, Sato Y, Hirai K, Uematsu M, Nikaido T, Fukuhara N, Fukuhara A, Sato S, Saito J, Kanazawa K, Tanino Y, Shibata Y

Internal medicine (Tokyo, Japan)   59 ( 20 )   2559 - 2563   2020年10月（ ISSN:0918-2918 ）

Monomorphic Epitheliotropic Intestinal T-cell Lymphoma Involving the Lung and Brain: A Rare Case Study.

Suzuki Y, Minemura H, Tomita H, Saito M, Watanabe N, Umeda T, Kawamata T, Rikimaru M, Morimoto J, Koizumi T, Togawa R, Sato Y, Hirai K, Uematsu M, Nikaido T, Fukuhara N, Fukuhara A, Sato S, Saito J, Kanazawa K, Tanino Y, Shibata Y

Internal medicine (Tokyo, Japan)   59 ( 20 )   2559 - 2563   2020年10月（ ISSN:0918-2918 ）

Monomorphic Epitheliotropic Intestinal T-cell Lymphoma Involving the Lung and Brain: A Rare Case Study.

Suzuki Y, Minemura H, Tomita H, Saito M, Watanabe N, Umeda T, Kawamata T, Rikimaru M, Morimoto J, Koizumi T, Togawa R, Sato Y, Hirai K, Uematsu M, Nikaido T, Fukuhara N, Fukuhara A, Sato S, Saito J, Kanazawa K, Tanino Y, Shibata Y

Internal medicine (Tokyo, Japan)   59 ( 20 )   2559 - 2563   2020年10月（ ISSN:0918-2918 ）

Monomorphic Epitheliotropic Intestinal T-cell Lymphoma Involving the Lung and Brain: A Rare Case Study.

Suzuki Y, Minemura H, Tomita H, Saito M, Watanabe N, Umeda T, Kawamata T, Rikimaru M, Morimoto J, Koizumi T, Togawa R, Sato Y, Hirai K, Uematsu M, Nikaido T, Fukuhara N, Fukuhara A, Sato S, Saito J, Kanazawa K, Tanino Y, Shibata Y

Internal medicine (Tokyo, Japan)   59 ( 20 )   2559 - 2563   2020年10月（ ISSN:0918-2918 ）

Monomorphic Epitheliotropic Intestinal T-cell Lymphoma Involving the Lung and Brain: A Rare Case Study.

Suzuki Y, Minemura H, Tomita H, Saito M, Watanabe N, Umeda T, Kawamata T, Rikimaru M, Morimoto J, Koizumi T, Togawa R, Sato Y, Hirai K, Uematsu M, Nikaido T, Fukuhara N, Fukuhara A, Sato S, Saito J, Kanazawa K, Tanino Y, Shibata Y

Internal medicine (Tokyo, Japan)   59 ( 20 )   2559 - 2563   2020年10月（ ISSN:0918-2918 ）

Monomorphic Epitheliotropic Intestinal T-cell Lymphoma Involving the Lung and Brain: A Rare Case Study.

Suzuki Y, Minemura H, Tomita H, Saito M, Watanabe N, Umeda T, Kawamata T, Rikimaru M, Morimoto J, Koizumi T, Togawa R, Sato Y, Hirai K, Uematsu M, Nikaido T, Fukuhara N, Fukuhara A, Sato S, Saito J, Kanazawa K, Tanino Y, Shibata Y

Internal medicine (Tokyo, Japan)   59 ( 20 )   2559 - 2563   2020年10月（ ISSN:0918-2918 ）

Monomorphic Epitheliotropic Intestinal T-cell Lymphoma Involving the Lung and Brain: A Rare Case Study.

Suzuki Y, Minemura H, Tomita H, Saito M, Watanabe N, Umeda T, Kawamata T, Rikimaru M, Morimoto J, Koizumi T, Togawa R, Sato Y, Hirai K, Uematsu M, Nikaido T, Fukuhara N, Fukuhara A, Sato S, Saito J, Kanazawa K, Tanino Y, Shibata Y

Internal medicine (Tokyo, Japan)   59 ( 20 )   2559 - 2563   2020年10月（ ISSN:0918-2918 ）

Monomorphic Epitheliotropic Intestinal T-cell Lymphoma Involving the Lung and Brain: A Rare Case Study.

Suzuki Y, Minemura H, Tomita H, Saito M, Watanabe N, Umeda T, Kawamata T, Rikimaru M, Morimoto J, Koizumi T, Togawa R, Sato Y, Hirai K, Uematsu M, Nikaido T, Fukuhara N, Fukuhara A, Sato S, Saito J, Kanazawa K, Tanino Y, Shibata Y

Internal medicine (Tokyo, Japan)   59 ( 20 )   2559 - 2563   2020年10月（ ISSN:0918-2918 ）

Monomorphic Epitheliotropic Intestinal T-cell Lymphoma Involving the Lung and Brain: A Rare Case Study.

Suzuki Y, Minemura H, Tomita H, Saito M, Watanabe N, Umeda T, Kawamata T, Rikimaru M, Morimoto J, Koizumi T, Togawa R, Sato Y, Hirai K, Uematsu M, Nikaido T, Fukuhara N, Fukuhara A, Sato S, Saito J, Kanazawa K, Tanino Y, Shibata Y

Internal medicine (Tokyo, Japan)   59 ( 20 )   2559 - 2563   2020年10月（ ISSN:0918-2918 ）

Monomorphic Epitheliotropic Intestinal T-cell Lymphoma Involving the Lung and Brain: A Rare Case Study.

Suzuki Y, Minemura H, Tomita H, Saito M, Watanabe N, Umeda T, Kawamata T, Rikimaru M, Morimoto J, Koizumi T, Togawa R, Sato Y, Hirai K, Uematsu M, Nikaido T, Fukuhara N, Fukuhara A, Sato S, Saito J, Kanazawa K, Tanino Y, Shibata Y

Internal medicine (Tokyo, Japan)   59 ( 20 )   2559 - 2563   2020年10月（ ISSN:0918-2918 ）

Monomorphic Epitheliotropic Intestinal T-cell Lymphoma Involving the Lung and Brain: A Rare Case Study.

Suzuki Y, Minemura H, Tomita H, Saito M, Watanabe N, Umeda T, Kawamata T, Rikimaru M, Morimoto J, Koizumi T, Togawa R, Sato Y, Hirai K, Uematsu M, Nikaido T, Fukuhara N, Fukuhara A, Sato S, Saito J, Kanazawa K, Tanino Y, Shibata Y

Internal medicine (Tokyo, Japan)   59 ( 20 )   2559 - 2563   2020年10月（ ISSN:0918-2918 ）

Monomorphic Epitheliotropic Intestinal T-cell Lymphoma Involving the Lung and Brain: A Rare Case Study.

Suzuki Y, Minemura H, Tomita H, Saito M, Watanabe N, Umeda T, Kawamata T, Rikimaru M, Morimoto J, Koizumi T, Togawa R, Sato Y, Hirai K, Uematsu M, Nikaido T, Fukuhara N, Fukuhara A, Sato S, Saito J, Kanazawa K, Tanino Y, Shibata Y

Internal medicine (Tokyo, Japan)   59 ( 20 )   2559 - 2563   2020年10月（ ISSN:0918-2918 ）

Monomorphic Epitheliotropic Intestinal T-cell Lymphoma Involving the Lung and Brain: A Rare Case Study.

Suzuki Y, Minemura H, Tomita H, Saito M, Watanabe N, Umeda T, Kawamata T, Rikimaru M, Morimoto J, Koizumi T, Togawa R, Sato Y, Hirai K, Uematsu M, Nikaido T, Fukuhara N, Fukuhara A, Sato S, Saito J, Kanazawa K, Tanino Y, Shibata Y

Internal medicine (Tokyo, Japan)   59 ( 20 )   2559 - 2563   2020年10月（ ISSN:0918-2918 ）

Monomorphic Epitheliotropic Intestinal T-cell Lymphoma Involving the Lung and Brain: A Rare Case Study.

Suzuki Y, Minemura H, Tomita H, Saito M, Watanabe N, Umeda T, Kawamata T, Rikimaru M, Morimoto J, Koizumi T, Togawa R, Sato Y, Hirai K, Uematsu M, Nikaido T, Fukuhara N, Fukuhara A, Sato S, Saito J, Kanazawa K, Tanino Y, Shibata Y

Internal medicine (Tokyo, Japan)   59 ( 20 )   2559 - 2563   2020年10月（ ISSN:0918-2918 ）

Monomorphic Epitheliotropic Intestinal T-cell Lymphoma Involving the Lung and Brain: A Rare Case Study.

Suzuki Y, Minemura H, Tomita H, Saito M, Watanabe N, Umeda T, Kawamata T, Rikimaru M, Morimoto J, Koizumi T, Togawa R, Sato Y, Hirai K, Uematsu M, Nikaido T, Fukuhara N, Fukuhara A, Sato S, Saito J, Kanazawa K, Tanino Y, Shibata Y

Internal medicine (Tokyo, Japan)   59 ( 20 )   2559 - 2563   2020年10月（ ISSN:0918-2918 ）

Monomorphic Epitheliotropic Intestinal T-cell Lymphoma Involving the Lung and Brain: A Rare Case Study.

Suzuki Y, Minemura H, Tomita H, Saito M, Watanabe N, Umeda T, Kawamata T, Rikimaru M, Morimoto J, Koizumi T, Togawa R, Sato Y, Hirai K, Uematsu M, Nikaido T, Fukuhara N, Fukuhara A, Sato S, Saito J, Kanazawa K, Tanino Y, Shibata Y

Internal medicine (Tokyo, Japan)   59 ( 20 )   2559 - 2563   2020年10月（ ISSN:0918-2918 ）

Monomorphic Epitheliotropic Intestinal T-cell Lymphoma Involving the Lung and Brain: A Rare Case Study.

Suzuki Y, Minemura H, Tomita H, Saito M, Watanabe N, Umeda T, Kawamata T, Rikimaru M, Morimoto J, Koizumi T, Togawa R, Sato Y, Hirai K, Uematsu M, Nikaido T, Fukuhara N, Fukuhara A, Sato S, Saito J, Kanazawa K, Tanino Y, Shibata Y

Internal medicine (Tokyo, Japan)   59 ( 20 )   2559 - 2563   2020年10月（ ISSN:0918-2918 ）

Monomorphic Epitheliotropic Intestinal T-cell Lymphoma Involving the Lung and Brain: A Rare Case Study.

Suzuki Y, Minemura H, Tomita H, Saito M, Watanabe N, Umeda T, Kawamata T, Rikimaru M, Morimoto J, Koizumi T, Togawa R, Sato Y, Hirai K, Uematsu M, Nikaido T, Fukuhara N, Fukuhara A, Sato S, Saito J, Kanazawa K, Tanino Y, Shibata Y

Internal medicine (Tokyo, Japan)   59 ( 20 )   2559 - 2563   2020年10月（ ISSN:0918-2918 ）

Monomorphic Epitheliotropic Intestinal T-cell Lymphoma Involving the Lung and Brain: A Rare Case Study.

Suzuki Y, Minemura H, Tomita H, Saito M, Watanabe N, Umeda T, Kawamata T, Rikimaru M, Morimoto J, Koizumi T, Togawa R, Sato Y, Hirai K, Uematsu M, Nikaido T, Fukuhara N, Fukuhara A, Sato S, Saito J, Kanazawa K, Tanino Y, Shibata Y

Internal medicine (Tokyo, Japan)   59 ( 20 )   2559 - 2563   2020年10月（ ISSN:0918-2918 ）

Monomorphic Epitheliotropic Intestinal T-cell Lymphoma Involving the Lung and Brain: A Rare Case Study.

Suzuki Y, Minemura H, Tomita H, Saito M, Watanabe N, Umeda T, Kawamata T, Rikimaru M, Morimoto J, Koizumi T, Togawa R, Sato Y, Hirai K, Uematsu M, Nikaido T, Fukuhara N, Fukuhara A, Sato S, Saito J, Kanazawa K, Tanino Y, Shibata Y

Internal medicine (Tokyo, Japan)   59 ( 20 )   2559 - 2563   2020年10月（ ISSN:0918-2918 ）

肺・脳に浸潤する単形性上皮向性腸管T細胞リンパ腫　稀な1症例の研究(Monomorphic Epitheliotropic Intestinal T-cell Lymphoma Involving the Lung and Brain: A Rare Case Study)

Suzuki Yasuhito, Minemura Hiroyuki, Tomita Hikaru, Saito Mikako, Watanabe Natsumi, Umeda Takashi, Kawamata Takaya, Rikimaru Mami, Morimoto Julia, Koizumi Tatsuhiko, Togawa Ryuichi, Sato Yuki, Hirai Kenichiro, Uematsu Manabu, Nikaido Takefumi, Fukuhara Naoko, Fukuhara Atsuro, Sato Suguru, Saito Junpei, Kanazawa Kenya, Tanino Yoshinori, Shibata Yoko

Internal Medicine   59 ( 20 )   2559 - 2563   2020年10月（ ISSN:0918-2918 ）

汎下垂体機能低下症を伴い自然軽快したサルコイドーシスの1例

河俣 貴也, 谷野 功典, 二階堂 雄文, 佐藤 佑樹, 東川 隆一, 鈴木 康仁, 渡邉 菜摘, 齋藤 美加子, 力丸 真美, 梅田 隆志, 小泉 達彦, 平井 健一郎, 植松 学, 峯村 浩之, 福原 敦朗, 佐藤 俊, 斎藤 純平, 金沢 賢也, 蛇沢 晶, 柴田 陽光

日本サルコイドーシス/肉芽腫性疾患学会雑誌   40 ( 1-2 )   29 - 34   2020年10月（ ISSN:1883-1273 ）

Efficacy and safety of S-1 monotherapy in previously treated elderly patients (aged ≥75 years) with non-small cell lung cancer: A retrospective analysis.

Imai H, Minemura H, Kishikawa T, Yamada Y, Suzuki K, Umeda Y, Wasamoto S, Kasahara N, Ishihara S, Yamaguchi O, Naruse I, Uchino J, Mori K, Kanazawa K, Shibata Y, Kasai T, Kaburagi T, Kaira K, Minato K

Thoracic cancer   11 ( 10 )   2867 - 2876   2020年10月（ ISSN:1759-7706 ）

肺・脳に浸潤する単形性上皮向性腸管T細胞リンパ腫 稀な1症例の研究(Monomorphic Epitheliotropic Intestinal T-cell Lymphoma Involving the Lung and Brain: A Rare Case Study)

Suzuki Yasuhito, Minemura Hiroyuki, Tomita Hikaru, Saito Mikako, Watanabe Natsumi, Umeda Takashi, Kawamata Takaya, Rikimaru Mami, Morimoto Julia, Koizumi Tatsuhiko, Togawa Ryuichi, Sato Yuki, Hirai Kenichiro, Uematsu Manabu, Nikaido Takefumi, Fukuhara Naoko, Fukuhara Atsuro, Sato Suguru, Saito Junpei, Kanazawa Kenya, Tanino Yoshinori, Shibata Yoko

Internal Medicine   59 ( 20 )   2559 - 2563   2020年10月（ ISSN:0918-2918 ）

汎下垂体機能低下症を伴い自然軽快したサルコイドーシスの1例

河俣 貴也, 谷野 功典, 二階堂 雄文, 佐藤 佑樹, 東川 隆一, 鈴木 康仁, 渡邉 菜摘, 齋藤 美加子, 力丸 真美, 梅田 隆志, 小泉 達彦, 平井 健一郎, 植松 学, 峯村 浩之, 福原 敦朗, 佐藤 俊, 斎藤 純平, 金沢 賢也, 蛇沢 晶, 柴田 陽光

日本サルコイドーシス/肉芽腫性疾患学会雑誌   40 ( 1-2 )   29 - 34   2020年10月（ ISSN:1883-1273 ）

Efficacy and safety of S-1 monotherapy in previously treated elderly patients (aged ≥75 years) with non-small cell lung cancer: A retrospective analysis.

Imai H, Minemura H, Kishikawa T, Yamada Y, Suzuki K, Umeda Y, Wasamoto S, Kasahara N, Ishihara S, Yamaguchi O, Naruse I, Uchino J, Mori K, Kanazawa K, Shibata Y, Kasai T, Kaburagi T, Kaira K, Minato K

Thoracic cancer   11 ( 10 )   2867 - 2876   2020年10月（ ISSN:1759-7706 ）

肺・脳に浸潤する単形性上皮向性腸管T細胞リンパ腫 稀な1症例の研究(Monomorphic Epitheliotropic Intestinal T-cell Lymphoma Involving the Lung and Brain: A Rare Case Study)

Suzuki Yasuhito, Minemura Hiroyuki, Tomita Hikaru, Saito Mikako, Watanabe Natsumi, Umeda Takashi, Kawamata Takaya, Rikimaru Mami, Morimoto Julia, Koizumi Tatsuhiko, Togawa Ryuichi, Sato Yuki, Hirai Kenichiro, Uematsu Manabu, Nikaido Takefumi, Fukuhara Naoko, Fukuhara Atsuro, Sato Suguru, Saito Junpei, Kanazawa Kenya, Tanino Yoshinori, Shibata Yoko

Internal Medicine   59 ( 20 )   2559 - 2563   2020年10月（ ISSN:0918-2918 ）

汎下垂体機能低下症を伴い自然軽快したサルコイドーシスの1例

河俣 貴也, 谷野 功典, 二階堂 雄文, 佐藤 佑樹, 東川 隆一, 鈴木 康仁, 渡邉 菜摘, 齋藤 美加子, 力丸 真美, 梅田 隆志, 小泉 達彦, 平井 健一郎, 植松 学, 峯村 浩之, 福原 敦朗, 佐藤 俊, 斎藤 純平, 金沢 賢也, 蛇沢 晶, 柴田 陽光

日本サルコイドーシス/肉芽腫性疾患学会雑誌   40 ( 1-2 )   29 - 34   2020年10月（ ISSN:1883-1273 ）

Efficacy and safety of S-1 monotherapy in previously treated elderly patients (aged ≥75 years) with non-small cell lung cancer: A retrospective analysis.

Imai H, Minemura H, Kishikawa T, Yamada Y, Suzuki K, Umeda Y, Wasamoto S, Kasahara N, Ishihara S, Yamaguchi O, Naruse I, Uchino J, Mori K, Kanazawa K, Shibata Y, Kasai T, Kaburagi T, Kaira K, Minato K

Thoracic cancer   11 ( 10 )   2867 - 2876   2020年10月（ ISSN:1759-7706 ）

肺・脳に浸潤する単形性上皮向性腸管T細胞リンパ腫 稀な1症例の研究(Monomorphic Epitheliotropic Intestinal T-cell Lymphoma Involving the Lung and Brain: A Rare Case Study)

Suzuki Yasuhito, Minemura Hiroyuki, Tomita Hikaru, Saito Mikako, Watanabe Natsumi, Umeda Takashi, Kawamata Takaya, Rikimaru Mami, Morimoto Julia, Koizumi Tatsuhiko, Togawa Ryuichi, Sato Yuki, Hirai Kenichiro, Uematsu Manabu, Nikaido Takefumi, Fukuhara Naoko, Fukuhara Atsuro, Sato Suguru, Saito Junpei, Kanazawa Kenya, Tanino Yoshinori, Shibata Yoko

Internal Medicine   59 ( 20 )   2559 - 2563   2020年10月（ ISSN:0918-2918 ）

汎下垂体機能低下症を伴い自然軽快したサルコイドーシスの1例

河俣 貴也, 谷野 功典, 二階堂 雄文, 佐藤 佑樹, 東川 隆一, 鈴木 康仁, 渡邉 菜摘, 齋藤 美加子, 力丸 真美, 梅田 隆志, 小泉 達彦, 平井 健一郎, 植松 学, 峯村 浩之, 福原 敦朗, 佐藤 俊, 斎藤 純平, 金沢 賢也, 蛇沢 晶, 柴田 陽光

日本サルコイドーシス/肉芽腫性疾患学会雑誌   40 ( 1-2 )   29 - 34   2020年10月（ ISSN:1883-1273 ）

Efficacy and safety of S-1 monotherapy in previously treated elderly patients (aged ≥75 years) with non-small cell lung cancer: A retrospective analysis.

Imai H, Minemura H, Kishikawa T, Yamada Y, Suzuki K, Umeda Y, Wasamoto S, Kasahara N, Ishihara S, Yamaguchi O, Naruse I, Uchino J, Mori K, Kanazawa K, Shibata Y, Kasai T, Kaburagi T, Kaira K, Minato K

Thoracic cancer   11 ( 10 )   2867 - 2876   2020年10月（ ISSN:1759-7706 ）

汎下垂体機能低下症を伴い自然軽快したサルコイドーシスの1例

河俣 貴也, 谷野 功典, 二階堂 雄文, 佐藤 佑樹, 東川 隆一, 鈴木 康仁, 渡邉 菜摘, 齋藤 美加子, 力丸 真美, 梅田 隆志, 小泉 達彦, 平井 健一郎, 植松 学, 峯村 浩之, 福原 敦朗, 佐藤 俊, 斎藤 純平, 金沢 賢也, 蛇沢 晶, 柴田 陽光

日本サルコイドーシス/肉芽腫性疾患学会雑誌   40 ( 1-2 )   29 - 34   2020年10月（ ISSN:1883-1273 ）

肺・脳に浸潤する単形性上皮向性腸管T細胞リンパ腫 稀な1症例の研究(Monomorphic Epitheliotropic Intestinal T-cell Lymphoma Involving the Lung and Brain: A Rare Case Study)

Suzuki Yasuhito, Minemura Hiroyuki, Tomita Hikaru, Saito Mikako, Watanabe Natsumi, Umeda Takashi, Kawamata Takaya, Rikimaru Mami, Morimoto Julia, Koizumi Tatsuhiko, Togawa Ryuichi, Sato Yuki, Hirai Kenichiro, Uematsu Manabu, Nikaido Takefumi, Fukuhara Naoko, Fukuhara Atsuro, Sato Suguru, Saito Junpei, Kanazawa Kenya, Tanino Yoshinori, Shibata Yoko

Internal Medicine   59 ( 20 )   2559 - 2563   2020年10月（ ISSN:0918-2918 ）

汎下垂体機能低下症を伴い自然軽快したサルコイドーシスの1例

河俣 貴也, 谷野 功典, 二階堂 雄文, 佐藤 佑樹, 東川 隆一, 鈴木 康仁, 渡邉 菜摘, 齋藤 美加子, 力丸 真美, 梅田 隆志, 小泉 達彦, 平井 健一郎, 植松 学, 峯村 浩之, 福原 敦朗, 佐藤 俊, 斎藤 純平, 金沢 賢也, 蛇沢 晶, 柴田 陽光

日本サルコイドーシス/肉芽腫性疾患学会雑誌   40 ( 1-2 )   29 - 34   2020年10月（ ISSN:1883-1273 ）

Efficacy and safety of S-1 monotherapy in previously treated elderly patients (aged ≥75 years) with non-small cell lung cancer: A retrospective analysis.

Imai H, Minemura H, Kishikawa T, Yamada Y, Suzuki K, Umeda Y, Wasamoto S, Kasahara N, Ishihara S, Yamaguchi O, Naruse I, Uchino J, Mori K, Kanazawa K, Shibata Y, Kasai T, Kaburagi T, Kaira K, Minato K

Thoracic cancer   11 ( 10 )   2867 - 2876   2020年10月（ ISSN:1759-7706 ）

肺・脳に浸潤する単形性上皮向性腸管T細胞リンパ腫 稀な1症例の研究(Monomorphic Epitheliotropic Intestinal T-cell Lymphoma Involving the Lung and Brain: A Rare Case Study)

Suzuki Yasuhito, Minemura Hiroyuki, Tomita Hikaru, Saito Mikako, Watanabe Natsumi, Umeda Takashi, Kawamata Takaya, Rikimaru Mami, Morimoto Julia, Koizumi Tatsuhiko, Togawa Ryuichi, Sato Yuki, Hirai Kenichiro, Uematsu Manabu, Nikaido Takefumi, Fukuhara Naoko, Fukuhara Atsuro, Sato Suguru, Saito Junpei, Kanazawa Kenya, Tanino Yoshinori, Shibata Yoko

Internal Medicine   59 ( 20 )   2559 - 2563   2020年10月（ ISSN:0918-2918 ）

汎下垂体機能低下症を伴い自然軽快したサルコイドーシスの1例

河俣 貴也, 谷野 功典, 二階堂 雄文, 佐藤 佑樹, 東川 隆一, 鈴木 康仁, 渡邉 菜摘, 齋藤 美加子, 力丸 真美, 梅田 隆志, 小泉 達彦, 平井 健一郎, 植松 学, 峯村 浩之, 福原 敦朗, 佐藤 俊, 斎藤 純平, 金沢 賢也, 蛇沢 晶, 柴田 陽光

日本サルコイドーシス/肉芽腫性疾患学会雑誌   40 ( 1-2 )   29 - 34   2020年10月（ ISSN:1883-1273 ）

Efficacy and safety of S-1 monotherapy in previously treated elderly patients (aged ≥75 years) with non-small cell lung cancer: A retrospective analysis.

Imai H, Minemura H, Kishikawa T, Yamada Y, Suzuki K, Umeda Y, Wasamoto S, Kasahara N, Ishihara S, Yamaguchi O, Naruse I, Uchino J, Mori K, Kanazawa K, Shibata Y, Kasai T, Kaburagi T, Kaira K, Minato K

Thoracic cancer   11 ( 10 )   2867 - 2876   2020年10月（ ISSN:1759-7706 ）

肺・脳に浸潤する単形性上皮向性腸管T細胞リンパ腫 稀な1症例の研究(Monomorphic Epitheliotropic Intestinal T-cell Lymphoma Involving the Lung and Brain: A Rare Case Study)

Suzuki Yasuhito, Minemura Hiroyuki, Tomita Hikaru, Saito Mikako, Watanabe Natsumi, Umeda Takashi, Kawamata Takaya, Rikimaru Mami, Morimoto Julia, Koizumi Tatsuhiko, Togawa Ryuichi, Sato Yuki, Hirai Kenichiro, Uematsu Manabu, Nikaido Takefumi, Fukuhara Naoko, Fukuhara Atsuro, Sato Suguru, Saito Junpei, Kanazawa Kenya, Tanino Yoshinori, Shibata Yoko

Internal Medicine   59 ( 20 )   2559 - 2563   2020年10月（ ISSN:0918-2918 ）

汎下垂体機能低下症を伴い自然軽快したサルコイドーシスの1例

河俣 貴也, 谷野 功典, 二階堂 雄文, 佐藤 佑樹, 東川 隆一, 鈴木 康仁, 渡邉 菜摘, 齋藤 美加子, 力丸 真美, 梅田 隆志, 小泉 達彦, 平井 健一郎, 植松 学, 峯村 浩之, 福原 敦朗, 佐藤 俊, 斎藤 純平, 金沢 賢也, 蛇沢 晶, 柴田 陽光

日本サルコイドーシス/肉芽腫性疾患学会雑誌   40 ( 1-2 )   29 - 34   2020年10月（ ISSN:1883-1273 ）

Efficacy and safety of S-1 monotherapy in previously treated elderly patients (aged ≥75 years) with non-small cell lung cancer: A retrospective analysis.

Imai H, Minemura H, Kishikawa T, Yamada Y, Suzuki K, Umeda Y, Wasamoto S, Kasahara N, Ishihara S, Yamaguchi O, Naruse I, Uchino J, Mori K, Kanazawa K, Shibata Y, Kasai T, Kaburagi T, Kaira K, Minato K

Thoracic cancer   11 ( 10 )   2867 - 2876   2020年10月（ ISSN:1759-7706 ）

肺・脳に浸潤する単形性上皮向性腸管T細胞リンパ腫 稀な1症例の研究(Monomorphic Epitheliotropic Intestinal T-cell Lymphoma Involving the Lung and Brain: A Rare Case Study)

Suzuki Yasuhito, Minemura Hiroyuki, Tomita Hikaru, Saito Mikako, Watanabe Natsumi, Umeda Takashi, Kawamata Takaya, Rikimaru Mami, Morimoto Julia, Koizumi Tatsuhiko, Togawa Ryuichi, Sato Yuki, Hirai Kenichiro, Uematsu Manabu, Nikaido Takefumi, Fukuhara Naoko, Fukuhara Atsuro, Sato Suguru, Saito Junpei, Kanazawa Kenya, Tanino Yoshinori, Shibata Yoko

Internal Medicine   59 ( 20 )   2559 - 2563   2020年10月（ ISSN:0918-2918 ）

汎下垂体機能低下症を伴い自然軽快したサルコイドーシスの1例

河俣 貴也, 谷野 功典, 二階堂 雄文, 佐藤 佑樹, 東川 隆一, 鈴木 康仁, 渡邉 菜摘, 齋藤 美加子, 力丸 真美, 梅田 隆志, 小泉 達彦, 平井 健一郎, 植松 学, 峯村 浩之, 福原 敦朗, 佐藤 俊, 斎藤 純平, 金沢 賢也, 蛇沢 晶, 柴田 陽光

日本サルコイドーシス/肉芽腫性疾患学会雑誌   40 ( 1-2 )   29 - 34   2020年10月（ ISSN:1883-1273 ）

Efficacy and safety of S-1 monotherapy in previously treated elderly patients (aged ≥75 years) with non-small cell lung cancer: A retrospective analysis.

Imai H, Minemura H, Kishikawa T, Yamada Y, Suzuki K, Umeda Y, Wasamoto S, Kasahara N, Ishihara S, Yamaguchi O, Naruse I, Uchino J, Mori K, Kanazawa K, Shibata Y, Kasai T, Kaburagi T, Kaira K, Minato K

Thoracic cancer   11 ( 10 )   2867 - 2876   2020年10月（ ISSN:1759-7706 ）

肺・脳に浸潤する単形性上皮向性腸管T細胞リンパ腫 稀な1症例の研究(Monomorphic Epitheliotropic Intestinal T-cell Lymphoma Involving the Lung and Brain: A Rare Case Study)

Suzuki Yasuhito, Minemura Hiroyuki, Tomita Hikaru, Saito Mikako, Watanabe Natsumi, Umeda Takashi, Kawamata Takaya, Rikimaru Mami, Morimoto Julia, Koizumi Tatsuhiko, Togawa Ryuichi, Sato Yuki, Hirai Kenichiro, Uematsu Manabu, Nikaido Takefumi, Fukuhara Naoko, Fukuhara Atsuro, Sato Suguru, Saito Junpei, Kanazawa Kenya, Tanino Yoshinori, Shibata Yoko

Internal Medicine   59 ( 20 )   2559 - 2563   2020年10月（ ISSN:0918-2918 ）

汎下垂体機能低下症を伴い自然軽快したサルコイドーシスの1例

河俣 貴也, 谷野 功典, 二階堂 雄文, 佐藤 佑樹, 東川 隆一, 鈴木 康仁, 渡邉 菜摘, 齋藤 美加子, 力丸 真美, 梅田 隆志, 小泉 達彦, 平井 健一郎, 植松 学, 峯村 浩之, 福原 敦朗, 佐藤 俊, 斎藤 純平, 金沢 賢也, 蛇沢 晶, 柴田 陽光

日本サルコイドーシス/肉芽腫性疾患学会雑誌   40 ( 1-2 )   29 - 34   2020年10月（ ISSN:1883-1273 ）

Efficacy and safety of S-1 monotherapy in previously treated elderly patients (aged ≥75 years) with non-small cell lung cancer: A retrospective analysis.

Imai H, Minemura H, Kishikawa T, Yamada Y, Suzuki K, Umeda Y, Wasamoto S, Kasahara N, Ishihara S, Yamaguchi O, Naruse I, Uchino J, Mori K, Kanazawa K, Shibata Y, Kasai T, Kaburagi T, Kaira K, Minato K

Thoracic cancer   11 ( 10 )   2867 - 2876   2020年10月（ ISSN:1759-7706 ）

肺・脳に浸潤する単形性上皮向性腸管T細胞リンパ腫 稀な1症例の研究(Monomorphic Epitheliotropic Intestinal T-cell Lymphoma Involving the Lung and Brain: A Rare Case Study)

Suzuki Yasuhito, Minemura Hiroyuki, Tomita Hikaru, Saito Mikako, Watanabe Natsumi, Umeda Takashi, Kawamata Takaya, Rikimaru Mami, Morimoto Julia, Koizumi Tatsuhiko, Togawa Ryuichi, Sato Yuki, Hirai Kenichiro, Uematsu Manabu, Nikaido Takefumi, Fukuhara Naoko, Fukuhara Atsuro, Sato Suguru, Saito Junpei, Kanazawa Kenya, Tanino Yoshinori, Shibata Yoko

Internal Medicine   59 ( 20 )   2559 - 2563   2020年10月（ ISSN:0918-2918 ）

汎下垂体機能低下症を伴い自然軽快したサルコイドーシスの1例

河俣 貴也, 谷野 功典, 二階堂 雄文, 佐藤 佑樹, 東川 隆一, 鈴木 康仁, 渡邉 菜摘, 齋藤 美加子, 力丸 真美, 梅田 隆志, 小泉 達彦, 平井 健一郎, 植松 学, 峯村 浩之, 福原 敦朗, 佐藤 俊, 斎藤 純平, 金沢 賢也, 蛇沢 晶, 柴田 陽光

日本サルコイドーシス/肉芽腫性疾患学会雑誌   40 ( 1-2 )   29 - 34   2020年10月（ ISSN:1883-1273 ）

Efficacy and safety of S-1 monotherapy in previously treated elderly patients (aged ≥75 years) with non-small cell lung cancer: A retrospective analysis.

Imai H, Minemura H, Kishikawa T, Yamada Y, Suzuki K, Umeda Y, Wasamoto S, Kasahara N, Ishihara S, Yamaguchi O, Naruse I, Uchino J, Mori K, Kanazawa K, Shibata Y, Kasai T, Kaburagi T, Kaira K, Minato K

Thoracic cancer   11 ( 10 )   2867 - 2876   2020年10月（ ISSN:1759-7706 ）

肺・脳に浸潤する単形性上皮向性腸管T細胞リンパ腫 稀な1症例の研究(Monomorphic Epitheliotropic Intestinal T-cell Lymphoma Involving the Lung and Brain: A Rare Case Study)

Suzuki Yasuhito, Minemura Hiroyuki, Tomita Hikaru, Saito Mikako, Watanabe Natsumi, Umeda Takashi, Kawamata Takaya, Rikimaru Mami, Morimoto Julia, Koizumi Tatsuhiko, Togawa Ryuichi, Sato Yuki, Hirai Kenichiro, Uematsu Manabu, Nikaido Takefumi, Fukuhara Naoko, Fukuhara Atsuro, Sato Suguru, Saito Junpei, Kanazawa Kenya, Tanino Yoshinori, Shibata Yoko

Internal Medicine   59 ( 20 )   2559 - 2563   2020年10月（ ISSN:0918-2918 ）

汎下垂体機能低下症を伴い自然軽快したサルコイドーシスの1例

河俣 貴也, 谷野 功典, 二階堂 雄文, 佐藤 佑樹, 東川 隆一, 鈴木 康仁, 渡邉 菜摘, 齋藤 美加子, 力丸 真美, 梅田 隆志, 小泉 達彦, 平井 健一郎, 植松 学, 峯村 浩之, 福原 敦朗, 佐藤 俊, 斎藤 純平, 金沢 賢也, 蛇沢 晶, 柴田 陽光

日本サルコイドーシス/肉芽腫性疾患学会雑誌   40 ( 1-2 )   29 - 34   2020年10月（ ISSN:1883-1273 ）

Efficacy and safety of S-1 monotherapy in previously treated elderly patients (aged ≥75 years) with non-small cell lung cancer: A retrospective analysis.

Imai H, Minemura H, Kishikawa T, Yamada Y, Suzuki K, Umeda Y, Wasamoto S, Kasahara N, Ishihara S, Yamaguchi O, Naruse I, Uchino J, Mori K, Kanazawa K, Shibata Y, Kasai T, Kaburagi T, Kaira K, Minato K

Thoracic cancer   11 ( 10 )   2867 - 2876   2020年10月（ ISSN:1759-7706 ）

肺・脳に浸潤する単形性上皮向性腸管T細胞リンパ腫 稀な1症例の研究(Monomorphic Epitheliotropic Intestinal T-cell Lymphoma Involving the Lung and Brain: A Rare Case Study)

Suzuki Yasuhito, Minemura Hiroyuki, Tomita Hikaru, Saito Mikako, Watanabe Natsumi, Umeda Takashi, Kawamata Takaya, Rikimaru Mami, Morimoto Julia, Koizumi Tatsuhiko, Togawa Ryuichi, Sato Yuki, Hirai Kenichiro, Uematsu Manabu, Nikaido Takefumi, Fukuhara Naoko, Fukuhara Atsuro, Sato Suguru, Saito Junpei, Kanazawa Kenya, Tanino Yoshinori, Shibata Yoko

Internal Medicine   59 ( 20 )   2559 - 2563   2020年10月（ ISSN:0918-2918 ）

汎下垂体機能低下症を伴い自然軽快したサルコイドーシスの1例

河俣 貴也, 谷野 功典, 二階堂 雄文, 佐藤 佑樹, 東川 隆一, 鈴木 康仁, 渡邉 菜摘, 齋藤 美加子, 力丸 真美, 梅田 隆志, 小泉 達彦, 平井 健一郎, 植松 学, 峯村 浩之, 福原 敦朗, 佐藤 俊, 斎藤 純平, 金沢 賢也, 蛇沢 晶, 柴田 陽光

日本サルコイドーシス/肉芽腫性疾患学会雑誌   40 ( 1-2 )   29 - 34   2020年10月（ ISSN:1883-1273 ）

Efficacy and safety of S-1 monotherapy in previously treated elderly patients (aged ≥75 years) with non-small cell lung cancer: A retrospective analysis.

Imai H, Minemura H, Kishikawa T, Yamada Y, Suzuki K, Umeda Y, Wasamoto S, Kasahara N, Ishihara S, Yamaguchi O, Naruse I, Uchino J, Mori K, Kanazawa K, Shibata Y, Kasai T, Kaburagi T, Kaira K, Minato K

Thoracic cancer   11 ( 10 )   2867 - 2876   2020年10月（ ISSN:1759-7706 ）

肺・脳に浸潤する単形性上皮向性腸管T細胞リンパ腫 稀な1症例の研究(Monomorphic Epitheliotropic Intestinal T-cell Lymphoma Involving the Lung and Brain: A Rare Case Study)

Suzuki Yasuhito, Minemura Hiroyuki, Tomita Hikaru, Saito Mikako, Watanabe Natsumi, Umeda Takashi, Kawamata Takaya, Rikimaru Mami, Morimoto Julia, Koizumi Tatsuhiko, Togawa Ryuichi, Sato Yuki, Hirai Kenichiro, Uematsu Manabu, Nikaido Takefumi, Fukuhara Naoko, Fukuhara Atsuro, Sato Suguru, Saito Junpei, Kanazawa Kenya, Tanino Yoshinori, Shibata Yoko

Internal Medicine   59 ( 20 )   2559 - 2563   2020年10月（ ISSN:0918-2918 ）

汎下垂体機能低下症を伴い自然軽快したサルコイドーシスの1例

河俣 貴也, 谷野 功典, 二階堂 雄文, 佐藤 佑樹, 東川 隆一, 鈴木 康仁, 渡邉 菜摘, 齋藤 美加子, 力丸 真美, 梅田 隆志, 小泉 達彦, 平井 健一郎, 植松 学, 峯村 浩之, 福原 敦朗, 佐藤 俊, 斎藤 純平, 金沢 賢也, 蛇沢 晶, 柴田 陽光

日本サルコイドーシス/肉芽腫性疾患学会雑誌   40 ( 1-2 )   29 - 34   2020年10月（ ISSN:1883-1273 ）

Efficacy and safety of S-1 monotherapy in previously treated elderly patients (aged ≥75 years) with non-small cell lung cancer: A retrospective analysis.

Imai H, Minemura H, Kishikawa T, Yamada Y, Suzuki K, Umeda Y, Wasamoto S, Kasahara N, Ishihara S, Yamaguchi O, Naruse I, Uchino J, Mori K, Kanazawa K, Shibata Y, Kasai T, Kaburagi T, Kaira K, Minato K

Thoracic cancer   11 ( 10 )   2867 - 2876   2020年10月（ ISSN:1759-7706 ）

肺・脳に浸潤する単形性上皮向性腸管T細胞リンパ腫 稀な1症例の研究(Monomorphic Epitheliotropic Intestinal T-cell Lymphoma Involving the Lung and Brain: A Rare Case Study)

Suzuki Yasuhito, Minemura Hiroyuki, Tomita Hikaru, Saito Mikako, Watanabe Natsumi, Umeda Takashi, Kawamata Takaya, Rikimaru Mami, Morimoto Julia, Koizumi Tatsuhiko, Togawa Ryuichi, Sato Yuki, Hirai Kenichiro, Uematsu Manabu, Nikaido Takefumi, Fukuhara Naoko, Fukuhara Atsuro, Sato Suguru, Saito Junpei, Kanazawa Kenya, Tanino Yoshinori, Shibata Yoko

Internal Medicine   59 ( 20 )   2559 - 2563   2020年10月（ ISSN:0918-2918 ）

汎下垂体機能低下症を伴い自然軽快したサルコイドーシスの1例

河俣 貴也, 谷野 功典, 二階堂 雄文, 佐藤 佑樹, 東川 隆一, 鈴木 康仁, 渡邉 菜摘, 齋藤 美加子, 力丸 真美, 梅田 隆志, 小泉 達彦, 平井 健一郎, 植松 学, 峯村 浩之, 福原 敦朗, 佐藤 俊, 斎藤 純平, 金沢 賢也, 蛇沢 晶, 柴田 陽光

日本サルコイドーシス/肉芽腫性疾患学会雑誌   40 ( 1-2 )   29 - 34   2020年10月（ ISSN:1883-1273 ）

Efficacy and safety of S-1 monotherapy in previously treated elderly patients (aged ≥75 years) with non-small cell lung cancer: A retrospective analysis.

Imai H, Minemura H, Kishikawa T, Yamada Y, Suzuki K, Umeda Y, Wasamoto S, Kasahara N, Ishihara S, Yamaguchi O, Naruse I, Uchino J, Mori K, Kanazawa K, Shibata Y, Kasai T, Kaburagi T, Kaira K, Minato K

Thoracic cancer   11 ( 10 )   2867 - 2876   2020年10月（ ISSN:1759-7706 ）

肺・脳に浸潤する単形性上皮向性腸管T細胞リンパ腫 稀な1症例の研究(Monomorphic Epitheliotropic Intestinal T-cell Lymphoma Involving the Lung and Brain: A Rare Case Study)

Suzuki Yasuhito, Minemura Hiroyuki, Tomita Hikaru, Saito Mikako, Watanabe Natsumi, Umeda Takashi, Kawamata Takaya, Rikimaru Mami, Morimoto Julia, Koizumi Tatsuhiko, Togawa Ryuichi, Sato Yuki, Hirai Kenichiro, Uematsu Manabu, Nikaido Takefumi, Fukuhara Naoko, Fukuhara Atsuro, Sato Suguru, Saito Junpei, Kanazawa Kenya, Tanino Yoshinori, Shibata Yoko

Internal Medicine   59 ( 20 )   2559 - 2563   2020年10月（ ISSN:0918-2918 ）

Efficacy and safety of S-1 monotherapy in previously treated elderly patients (aged ≥75 years) with non-small cell lung cancer: A retrospective analysis.

Imai H, Minemura H, Kishikawa T, Yamada Y, Suzuki K, Umeda Y, Wasamoto S, Kasahara N, Ishihara S, Yamaguchi O, Naruse I, Uchino J, Mori K, Kanazawa K, Shibata Y, Kasai T, Kaburagi T, Kaira K, Minato K

Thoracic cancer   11 ( 10 )   2867 - 2876   2020年10月（ ISSN:1759-7706 ）

肺・脳に浸潤する単形性上皮向性腸管T細胞リンパ腫 稀な1症例の研究(Monomorphic Epitheliotropic Intestinal T-cell Lymphoma Involving the Lung and Brain: A Rare Case Study)

Suzuki Yasuhito, Minemura Hiroyuki, Tomita Hikaru, Saito Mikako, Watanabe Natsumi, Umeda Takashi, Kawamata Takaya, Rikimaru Mami, Morimoto Julia, Koizumi Tatsuhiko, Togawa Ryuichi, Sato Yuki, Hirai Kenichiro, Uematsu Manabu, Nikaido Takefumi, Fukuhara Naoko, Fukuhara Atsuro, Sato Suguru, Saito Junpei, Kanazawa Kenya, Tanino Yoshinori, Shibata Yoko

Internal Medicine   59 ( 20 )   2559 - 2563   2020年10月（ ISSN:0918-2918 ）

汎下垂体機能低下症を伴い自然軽快したサルコイドーシスの1例

河俣 貴也, 谷野 功典, 二階堂 雄文, 佐藤 佑樹, 東川 隆一, 鈴木 康仁, 渡邉 菜摘, 齋藤 美加子, 力丸 真美, 梅田 隆志, 小泉 達彦, 平井 健一郎, 植松 学, 峯村 浩之, 福原 敦朗, 佐藤 俊, 斎藤 純平, 金沢 賢也, 蛇沢 晶, 柴田 陽光

日本サルコイドーシス/肉芽腫性疾患学会雑誌   40 ( 1-2 )   29 - 34   2020年10月（ ISSN:1883-1273 ）

Efficacy and safety of S-1 monotherapy in previously treated elderly patients (aged ≥75 years) with non-small cell lung cancer: A retrospective analysis.

Imai H, Minemura H, Kishikawa T, Yamada Y, Suzuki K, Umeda Y, Wasamoto S, Kasahara N, Ishihara S, Yamaguchi O, Naruse I, Uchino J, Mori K, Kanazawa K, Shibata Y, Kasai T, Kaburagi T, Kaira K, Minato K

Thoracic cancer   11 ( 10 )   2867 - 2876   2020年10月（ ISSN:1759-7706 ）

肺・脳に浸潤する単形性上皮向性腸管T細胞リンパ腫 稀な1症例の研究(Monomorphic Epitheliotropic Intestinal T-cell Lymphoma Involving the Lung and Brain: A Rare Case Study)

Suzuki Yasuhito, Minemura Hiroyuki, Tomita Hikaru, Saito Mikako, Watanabe Natsumi, Umeda Takashi, Kawamata Takaya, Rikimaru Mami, Morimoto Julia, Koizumi Tatsuhiko, Togawa Ryuichi, Sato Yuki, Hirai Kenichiro, Uematsu Manabu, Nikaido Takefumi, Fukuhara Naoko, Fukuhara Atsuro, Sato Suguru, Saito Junpei, Kanazawa Kenya, Tanino Yoshinori, Shibata Yoko

Internal Medicine   59 ( 20 )   2559 - 2563   2020年10月（ ISSN:0918-2918 ）

汎下垂体機能低下症を伴い自然軽快したサルコイドーシスの1例

河俣 貴也, 谷野 功典, 二階堂 雄文, 佐藤 佑樹, 東川 隆一, 鈴木 康仁, 渡邉 菜摘, 齋藤 美加子, 力丸 真美, 梅田 隆志, 小泉 達彦, 平井 健一郎, 植松 学, 峯村 浩之, 福原 敦朗, 佐藤 俊, 斎藤 純平, 金沢 賢也, 蛇沢 晶, 柴田 陽光

日本サルコイドーシス/肉芽腫性疾患学会雑誌   40 ( 1-2 )   29 - 34   2020年10月（ ISSN:1883-1273 ）

Efficacy and safety of S-1 monotherapy in previously treated elderly patients (aged ≥75 years) with non-small cell lung cancer: A retrospective analysis.

Imai H, Minemura H, Kishikawa T, Yamada Y, Suzuki K, Umeda Y, Wasamoto S, Kasahara N, Ishihara S, Yamaguchi O, Naruse I, Uchino J, Mori K, Kanazawa K, Shibata Y, Kasai T, Kaburagi T, Kaira K, Minato K

Thoracic cancer   11 ( 10 )   2867 - 2876   2020年10月（ ISSN:1759-7706 ）

肺・脳に浸潤する単形性上皮向性腸管T細胞リンパ腫 稀な1症例の研究(Monomorphic Epitheliotropic Intestinal T-cell Lymphoma Involving the Lung and Brain: A Rare Case Study)

Suzuki Yasuhito, Minemura Hiroyuki, Tomita Hikaru, Saito Mikako, Watanabe Natsumi, Umeda Takashi, Kawamata Takaya, Rikimaru Mami, Morimoto Julia, Koizumi Tatsuhiko, Togawa Ryuichi, Sato Yuki, Hirai Kenichiro, Uematsu Manabu, Nikaido Takefumi, Fukuhara Naoko, Fukuhara Atsuro, Sato Suguru, Saito Junpei, Kanazawa Kenya, Tanino Yoshinori, Shibata Yoko

Internal Medicine   59 ( 20 )   2559 - 2563   2020年10月（ ISSN:0918-2918 ）

汎下垂体機能低下症を伴い自然軽快したサルコイドーシスの1例

河俣 貴也, 谷野 功典, 二階堂 雄文, 佐藤 佑樹, 東川 隆一, 鈴木 康仁, 渡邉 菜摘, 齋藤 美加子, 力丸 真美, 梅田 隆志, 小泉 達彦, 平井 健一郎, 植松 学, 峯村 浩之, 福原 敦朗, 佐藤 俊, 斎藤 純平, 金沢 賢也, 蛇沢 晶, 柴田 陽光

日本サルコイドーシス/肉芽腫性疾患学会雑誌   40 ( 1-2 )   29 - 34   2020年10月（ ISSN:1883-1273 ）

Efficacy and safety of S-1 monotherapy in previously treated elderly patients (aged ≥75 years) with non-small cell lung cancer: A retrospective analysis.

Imai H, Minemura H, Kishikawa T, Yamada Y, Suzuki K, Umeda Y, Wasamoto S, Kasahara N, Ishihara S, Yamaguchi O, Naruse I, Uchino J, Mori K, Kanazawa K, Shibata Y, Kasai T, Kaburagi T, Kaira K, Minato K

Thoracic cancer   11 ( 10 )   2867 - 2876   2020年10月（ ISSN:1759-7706 ）

肺・脳に浸潤する単形性上皮向性腸管T細胞リンパ腫 稀な1症例の研究(Monomorphic Epitheliotropic Intestinal T-cell Lymphoma Involving the Lung and Brain: A Rare Case Study)

Suzuki Yasuhito, Minemura Hiroyuki, Tomita Hikaru, Saito Mikako, Watanabe Natsumi, Umeda Takashi, Kawamata Takaya, Rikimaru Mami, Morimoto Julia, Koizumi Tatsuhiko, Togawa Ryuichi, Sato Yuki, Hirai Kenichiro, Uematsu Manabu, Nikaido Takefumi, Fukuhara Naoko, Fukuhara Atsuro, Sato Suguru, Saito Junpei, Kanazawa Kenya, Tanino Yoshinori, Shibata Yoko

Internal Medicine   59 ( 20 )   2559 - 2563   2020年10月（ ISSN:0918-2918 ）